Input | HPO ID | HPO term | Distance | Gene | Gene id entrez | HGNC ID | DiseaseId | DiseaseName | Frequency | Onset | HGMD variants | ClinVar variants |
---|
HPO disease - gene - phenotype typical associations: |
HPO disease - gene - phenotype less frequent non-typical associations: |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | AARS1 CL E G H | 16 | 20 | OMIM:619661 | LEUKOENCEPHALOPATHY, HEREDITARY DIFFUSE, WITH SPHEROIDS 2; HDLS2 | | | | | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | ABAT CL E G H | 18 | 23 | OMIM:613163 | GABA-transaminase deficiency | | | | 120 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | ABCA7 CL E G H | 10347 | 37 | ORPHA:1020 | Early-onset autosomal dominant Alzheimer disease | | | | 3 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | ABCC8 CL E G H | 6833 | 59 | ORPHA:276575 | Autosomal dominant hyperinsulinism due to SUR1 deficiency | | | | 245 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | ABCC8 CL E G H | 6833 | 59 | OMIM:256450 | Hyperinsulinemic hypoglycemia, familial, 1 | | | | 245 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | ABCC8 CL E G H | 6833 | 59 | OMIM:240800 | Hypoglycemia of infancy, leucine-sensitive | | | | 245 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | ABCC8 CL E G H | 6833 | 59 | ORPHA:99885 | Isolated permanent neonatal diabetes mellitus | | | | 245 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | ABCD1 CL E G H | 215 | 61 | ORPHA:139396 | X-linked cerebral adrenoleukodystrophy | | | | 135 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | ABCD4 CL E G H | 5826 | 68 | OMIM:614857 | Methylmalonic aciduria and homocystinuria, Cblj type | | | | 53 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | ACADM CL E G H | 34 | 89 | OMIM:201450 | Acyl-Coa dehydrogenase, medium-chain, deficiency of | | | | 197 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | ACADM CL E G H | 34 | 89 | ORPHA:42 | Medium chain acyl-CoA dehydrogenase deficiency | | | | 197 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | ACADS CL E G H | 35 | 90 | OMIM:201470 | Acyl-Coa dehydrogenase, short-chain, deficiency of | | | | 90 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | ACADS CL E G H | 35 | 90 | ORPHA:26792 | Short chain acyl-CoA dehydrogenase deficiency | | | | 90 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | ACADSB CL E G H | 36 | 91 | OMIM:610006 | 2-Methylbutyryl-Coa dehydrogenase deficiency | | | | 111 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | ACADVL CL E G H | 37 | 92 | ORPHA:26793 | Very long chain acyl-CoA dehydrogenase deficiency | | | | 200 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | ACADVL CL E G H | 37 | 92 | OMIM:201475 | Very long-chain acyl-CoA dehydrogenase deficiency | | | | 200 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | ACAT1 CL E G H | 38 | 93 | ORPHA:134 | Beta-ketothiolase deficiency | HP:0040282 - Frequent | | | 91 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | ADA2 CL E G H | 51816 | 1839 | ORPHA:124 | Blackfan-Diamond anemia | | | | 22 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | ADAMTS13 CL E G H | 11093 | 1366 | OMIM:274150 | Thrombotic thrombocytopenic purpura, hereditary | | | | 129 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | ADORA2A CL E G H | 135 | 263 | ORPHA:363549 | Acute encephalopathy with biphasic seizures and late reduced diffusion | | | | 1 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | AGRN CL E G H | 375790 | 329 | ORPHA:98913 | Postsynaptic congenital myasthenic syndromes | | | | 127 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | AK9 CL E G H | 221264 | 33814 | ORPHA:98913 | Postsynaptic congenital myasthenic syndromes | | | | 1 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | AKT1 CL E G H | 207 | 391 | ORPHA:2495 | Meningioma | | | | 54 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | AKT2 CL E G H | 208 | 392 | ORPHA:293964 | Hypoinsulinemic hypoglycemia and body hemihypertrophy | | | | 12 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | ALAD CL E G H | 210 | 395 | ORPHA:100924 | Porphyria due to ALA dehydratase deficiency | | | | 62 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | ALDH4A1 CL E G H | 8659 | 406 | ORPHA:79101 | Hyperprolinemia type 2 | | | | 74 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | ALDOB CL E G H | 229 | 417 | OMIM:229600 | Fructose intolerance, hereditary | | | | 73 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | ALDOB CL E G H | 229 | 417 | ORPHA:469 | Hereditary fructose intolerance | | | | 73 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | AMT CL E G H | 275 | 473 | OMIM:605899 | Glycine encephalopathy | | | | 56 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | APP CL E G H | 351 | 620 | ORPHA:324713 | ABeta amyloidosis, Italian type | | | | 74 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | APP CL E G H | 351 | 620 | ORPHA:324703 | ABetaL34V amyloidosis | | | | 74 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | APP CL E G H | 351 | 620 | ORPHA:1020 | Early-onset autosomal dominant Alzheimer disease | | | | 74 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | ARSA CL E G H | 410 | 713 | ORPHA:309271 | Metachromatic leukodystrophy, adult form | | | | 253 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | ARSA CL E G H | 410 | 713 | ORPHA:309263 | Metachromatic leukodystrophy, juvenile form | | | | 253 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | ARSA CL E G H | 410 | 713 | ORPHA:309256 | Metachromatic leukodystrophy, late infantile form | | | | 253 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | ASH1L CL E G H | 55870 | 19088 | OMIM:617796 | Mental retardation, autosomal dominant 52 | | | | 1 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | ASL CL E G H | 435 | 746 | OMIM:207900 | Argininosuccinic aciduria | | | | 81 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | ASPA CL E G H | 443 | 756 | ORPHA:314911 | Severe Canavan disease | | | | 48 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | ASS1 CL E G H | 445 | 758 | OMIM:215700 | Citrullinemia, classic | | | | 119 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | ATP13A2 CL E G H | 23400 | 30213 | ORPHA:306674 | Kufor-Rakeb syndrome | | | | 100 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | ATP1A2 CL E G H | 477 | 800 | ORPHA:569 | Familial or sporadic hemiplegic migraine | | | | 239 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | ATP1A2 CL E G H | 477 | 800 | OMIM:602481 | Migraine, familial hemiplegic, 2 | | | | 239 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | ATP1A3 CL E G H | 478 | 801 | OMIM:601338 | Cerebellar ataxia, areflexia, pes cavus, optic atrophy, and sensorineural hearing loss | | | | 150 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | ATP5F1D CL E G H | 513 | 837 | OMIM:618120 | Mitochondrial complex V (atp synthase) deficiency, nuclear type 5 | | | | | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | ATP5MK CL E G H | 84833 | 30889 | OMIM:618683 | MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 6; MC5DN6 | | | | | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | ATP7B CL E G H | 540 | 870 | OMIM:277900 | Wilson disease | | | | 315 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | AUH CL E G H | 549 | 890 | ORPHA:67046 | 3-methylglutaconic aciduria type 1 | | | | 49 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | AVP CL E G H | 551 | 894 | ORPHA:30925 | Hereditary central diabetes insipidus | | | | 22 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | BAP1 CL E G H | 8314 | 950 | ORPHA:2495 | Meningioma | | | | 184 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | BCKDHA CL E G H | 593 | 986 | OMIM:248600 | Maple syrup urine disease | | | | 120 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | BCKDHB CL E G H | 594 | 987 | OMIM:248600 | Maple syrup urine disease | | | | 162 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | BMP6 CL E G H | 654 | 1073 | ORPHA:465508 | Symptomatic form of hemochromatosis type 1 | | | | | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | BNC2 CL E G H | 54796 | 30988 | ORPHA:93110 | Posterior urethral valve | | | | 22 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | BOLA3 CL E G H | 388962 | 24415 | OMIM:614299 | Multiple mitochondrial dysfunctions syndrome 2 with hyperglycinemia | | | | 14 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | BRAF CL E G H | 673 | 1097 | ORPHA:54595 | Craniopharyngioma | | | | 276 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | BTD CL E G H | 686 | 1122 | ORPHA:79241 | Biotinidase deficiency | | | | 223 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | BTD CL E G H | 686 | 1122 | OMIM:253260 | Biotinidase deficiencymultiple carboxylase deficiency, late-onset | | | | 223 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | C4A CL E G H | 720 | 1323 | ORPHA:117 | Behçet disease | | | | 1 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | CA5A CL E G H | 763 | 1377 | OMIM:615751 | Hyperammonemia due to carbonic anhydrase VA deficiency | | | | 10 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | CACNA1A CL E G H | 773 | 1388 | ORPHA:71518 | Benign paroxysmal torticollis of infancy | | | | 449 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | CACNA1A CL E G H | 773 | 1388 | ORPHA:569 | Familial or sporadic hemiplegic migraine | | | | 449 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | CACNA1A CL E G H | 773 | 1388 | OMIM:141500 | Migraine, familial hemiplegic, 1 | | | | 449 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | CASR CL E G H | 846 | 1514 | ORPHA:428 | Autosomal dominant hypocalcemia | HP:0040283 - Occasional | | | 272 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | CCR1 CL E G H | 1230 | 1602 | ORPHA:117 | Behçet disease | | | | | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | CDKN1A CL E G H | 1026 | 1784 | ORPHA:652 | Multiple endocrine neoplasia type 1 | | | | 2 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | CDKN1B CL E G H | 1027 | 1785 | ORPHA:652 | Multiple endocrine neoplasia type 1 | | | | 102 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | CDKN2B CL E G H | 1030 | 1788 | ORPHA:652 | Multiple endocrine neoplasia type 1 | | | | 1 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | CDKN2C CL E G H | 1031 | 1789 | ORPHA:652 | Multiple endocrine neoplasia type 1 | | | | | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | CDON CL E G H | 50937 | 17104 | ORPHA:93925 | Alobar holoprosencephaly | | | | 200 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | CDON CL E G H | 50937 | 17104 | ORPHA:93924 | Lobar holoprosencephaly | | | | 200 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | CDON CL E G H | 50937 | 17104 | ORPHA:93926 | Midline interhemispheric variant of holoprosencephaly | | | | 200 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | CDON CL E G H | 50937 | 17104 | ORPHA:220386 | Semilobar holoprosencephaly | | | | 200 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | CFH CL E G H | 3075 | 4883 | OMIM:235400 | Hemolytic uremic syndrome, atypical, susceptibility to, 1 | | | | 86 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | CFHR1 CL E G H | 3078 | 4888 | OMIM:235400 | Hemolytic uremic syndrome, atypical, susceptibility to, 1 | | | | | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | CFHR3 CL E G H | 10878 | 16980 | OMIM:235400 | Hemolytic uremic syndrome, atypical, susceptibility to, 1 | | | | | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | CHRNA1 CL E G H | 1134 | 1955 | ORPHA:98913 | Postsynaptic congenital myasthenic syndromes | | | | 74 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | CHRNA2 CL E G H | 1135 | 1956 | OMIM:610353 | Epilepsy, nocturnal frontal lobe, 4 | | | | 188 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | CHRNB1 CL E G H | 1140 | 1961 | ORPHA:98913 | Postsynaptic congenital myasthenic syndromes | | | | 53 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | CHRND CL E G H | 1144 | 1965 | ORPHA:98913 | Postsynaptic congenital myasthenic syndromes | | | | 88 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | CHRNE CL E G H | 1145 | 1966 | ORPHA:98913 | Postsynaptic congenital myasthenic syndromes | | | | 139 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | CLCNKB CL E G H | 1188 | 2027 | ORPHA:358 | Gitelman syndrome | | | | 27 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | COA8 CL E G H | 84334 | 20492 | ORPHA:436271 | Non-progressive predominantly posterior cavitating leukoencephalopathy with peripheral neuropathy | | | | | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | COL13A1 CL E G H | 1305 | 2190 | ORPHA:98913 | Postsynaptic congenital myasthenic syndromes | | | | 6 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | COL3A1 CL E G H | 1281 | 2201 | ORPHA:286 | Vascular Ehlers-Danlos syndrome | HP:0040283 - Occasional | | | 749 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | COX1 CL E G H | 4512 | 7419 | ORPHA:550 | MELAS | HP:0040283 - Occasional | | | | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | COX2 CL E G H | 4513 | 7421 | ORPHA:550 | MELAS | HP:0040283 - Occasional | | | | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | COX3 CL E G H | 4514 | 7422 | ORPHA:550 | MELAS | HP:0040283 - Occasional | | | | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | COX5A CL E G H | 9377 | 2267 | OMIM:619064 | MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 20; MC4DN20 | | | | | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | CPOX CL E G H | 1371 | 2321 | OMIM:121300 | Coproporphyria | | | | 72 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | CPS1 CL E G H | 1373 | 2323 | OMIM:237300 | Carbamoyl phosphate synthetase I deficiency, hyperammonemia due to | | | | 124 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | CPT1A CL E G H | 1374 | 2328 | ORPHA:156 | Carnitine palmitoyl transferase 1A deficiency | | | | 99 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | CPT1A CL E G H | 1374 | 2328 | OMIM:255120 | Carnitine palmitoyltransferase I deficiency | | | | 99 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | CPT2 CL E G H | 1376 | 2330 | ORPHA:228308 | Carnitine palmitoyl transferase II deficiency, neonatal form | | | | 101 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | CPT2 CL E G H | 1376 | 2330 | OMIM:600649 | Carnitine palmitoyltransferase II deficiency, infantile | | | | 101 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | CPT2 CL E G H | 1376 | 2330 | OMIM:608836 | Carnitine palmitoyltransferase II deficiency, lethal neonatal | | | | 101 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | CPT2 CL E G H | 1376 | 2330 | OMIM:614212 | Encephalopathy, acute, infection-induced, susceptibility to, 4 | | | | 101 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | CTNNB1 CL E G H | 1499 | 2514 | ORPHA:54595 | Craniopharyngioma | | | | 88 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | CTSH CL E G H | 1512 | 2535 | ORPHA:2073 | Narcolepsy type 1 | | | | 1 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | CUBN CL E G H | 8029 | 2548 | OMIM:261100 | Megaloblastic anemia 1 | | | | 273 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | CYC1 CL E G H | 1537 | 2579 | OMIM:615453 | Mitochondrial complex III deficiency, nuclear type 6 | | | | 12 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | CYP24A1 CL E G H | 1591 | 2602 | OMIM:143880 | Hypercalcemia, infantile, 1 | | | | 73 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | CYTB CL E G H | 4519 | 7427 | ORPHA:137675 | Histiocytoid cardiomyopathy | | | | | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | DBT CL E G H | 1629 | 2698 | OMIM:248600 | Maple syrup urine disease | | | | 156 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | DDC CL E G H | 1644 | 2719 | OMIM:608643 | Aromatic L-amino acid decarboxylase deficiency | | | | 43 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | DHCR7 CL E G H | 1717 | 2860 | ORPHA:818 | Smith-Lemli-Opitz syndrome | | | | 159 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | DISP1 CL E G H | 84976 | 19711 | ORPHA:93925 | Alobar holoprosencephaly | | | | 22 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | DISP1 CL E G H | 84976 | 19711 | ORPHA:93924 | Lobar holoprosencephaly | | | | 22 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | DISP1 CL E G H | 84976 | 19711 | ORPHA:93926 | Midline interhemispheric variant of holoprosencephaly | | | | 22 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | DISP1 CL E G H | 84976 | 19711 | ORPHA:220386 | Semilobar holoprosencephaly | | | | 22 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | DLD CL E G H | 1738 | 2898 | OMIM:246900 | Dihydrolipoamide dehydrogenase deficiency | | | | 89 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | DLD CL E G H | 1738 | 2898 | ORPHA:2394 | Pyruvate dehydrogenase E3 deficiency | | | | 89 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | DLL1 CL E G H | 28514 | 2908 | ORPHA:93925 | Alobar holoprosencephaly | | | | 3 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | DLL1 CL E G H | 28514 | 2908 | ORPHA:93924 | Lobar holoprosencephaly | | | | 3 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | DLL1 CL E G H | 28514 | 2908 | ORPHA:93926 | Midline interhemispheric variant of holoprosencephaly | | | | 3 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | DLL1 CL E G H | 28514 | 2908 | ORPHA:220386 | Semilobar holoprosencephaly | | | | 3 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | DMPK CL E G H | 1760 | 2933 | OMIM:160900 | Myotonic dystrophy 1 | | | | 152 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | DNMT1 CL E G H | 1786 | 2976 | OMIM:604121 | Cerebellar ataxia, deafness, and narcolepsy, autosomal dominant | | | | 145 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | DNMT1 CL E G H | 1786 | 2976 | OMIM:614116 | Neuropathy, hereditary sensory, type IE | | | | 145 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | DOK7 CL E G H | 285489 | 26594 | ORPHA:994 | Fetal akinesia deformation sequence | | | | 91 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | DOK7 CL E G H | 285489 | 26594 | ORPHA:98913 | Postsynaptic congenital myasthenic syndromes | | | | 91 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | DPYD CL E G H | 1806 | 3012 | OMIM:274270 | Dihydropyrimidine dehydrogenase deficiency | | | | 144 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | DPYS CL E G H | 1807 | 3013 | OMIM:222748 | Dihydropyrimidinuria | | | | 44 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | DUOX2 CL E G H | 50506 | 13273 | ORPHA:95716 | Familial thyroid dyshormonogenesis | | | | 121 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | DUOX2 CL E G H | 50506 | 13273 | ORPHA:226316 | Genetic transient congenital hypothyroidism | | | | 121 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | DUOXA2 CL E G H | 405753 | 32698 | ORPHA:95716 | Familial thyroid dyshormonogenesis | | | | 11 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | EIF2B1 CL E G H | 1967 | 3257 | OMIM:603896 | Leukoencephalopathy with vanishing white matter | | | | 42 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | EIF2B2 CL E G H | 8892 | 3258 | OMIM:603896 | Leukoencephalopathy with vanishing white matter | | | | 24 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | EIF2B3 CL E G H | 8891 | 3259 | OMIM:603896 | Leukoencephalopathy with vanishing white matter | | | | 32 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | EIF2B4 CL E G H | 8890 | 3260 | OMIM:603896 | Leukoencephalopathy with vanishing white matter | | | | 38 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | EIF2B5 CL E G H | 8893 | 3261 | OMIM:603896 | Leukoencephalopathy with vanishing white matter | | | | 48 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | EPM2A CL E G H | 7957 | 3413 | ORPHA:501 | Lafora disease | | | | 83 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | ERAP1 CL E G H | 51752 | 18173 | ORPHA:117 | Behçet disease | | | | 1 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | ERCC2 CL E G H | 2068 | 3434 | ORPHA:220295 | Xeroderma pigmentosum-Cockayne syndrome complex | | | | 106 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | ERCC3 CL E G H | 2071 | 3435 | ORPHA:220295 | Xeroderma pigmentosum-Cockayne syndrome complex | | | | 54 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | ERCC4 CL E G H | 2072 | 3436 | ORPHA:220295 | Xeroderma pigmentosum-Cockayne syndrome complex | | | | 158 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | ERCC5 CL E G H | 2073 | 3437 | ORPHA:220295 | Xeroderma pigmentosum-Cockayne syndrome complex | | | | 83 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | ETFA CL E G H | 2108 | 3481 | OMIM:231680 | Multiple acyl-coa dehydrogenase deficiency | | | | 37 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | ETFB CL E G H | 2109 | 3482 | OMIM:231680 | Multiple acyl-coa dehydrogenase deficiency | | | | 27 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | ETFDH CL E G H | 2110 | 3483 | OMIM:231680 | Multiple acyl-coa dehydrogenase deficiency | | | | 77 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | FAS CL E G H | 355 | 11920 | ORPHA:117 | Behçet disease | | | | 59 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | FBP1 CL E G H | 2203 | 3606 | OMIM:229700 | Fructose-1,6-Bisphosphatase deficiency | | | | 64 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | FBP1 CL E G H | 2203 | 3606 | ORPHA:348 | Fructose-1,6-bisphosphatase deficiency | HP:0040283 - Occasional | | | 64 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | FGF8 CL E G H | 2253 | 3686 | ORPHA:93925 | Alobar holoprosencephaly | | | | 17 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | FGF8 CL E G H | 2253 | 3686 | ORPHA:93924 | Lobar holoprosencephaly | | | | 17 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | FGF8 CL E G H | 2253 | 3686 | ORPHA:93926 | Midline interhemispheric variant of holoprosencephaly | | | | 17 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | FGF8 CL E G H | 2253 | 3686 | ORPHA:220386 | Semilobar holoprosencephaly | | | | 17 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | FGFR1 CL E G H | 2260 | 3688 | ORPHA:93924 | Lobar holoprosencephaly | | | | 172 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | FGFR1 CL E G H | 2260 | 3688 | ORPHA:220386 | Semilobar holoprosencephaly | | | | 172 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | FIG4 CL E G H | 9896 | 16873 | ORPHA:208441 | Bilateral parasagittal parieto-occipital polymicrogyria | | | | 111 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | FIG4 CL E G H | 9896 | 16873 | OMIM:612691 | Polymicrogyria, bilateral temporooccipital | | | | 111 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | FKRP CL E G H | 79147 | 17997 | OMIM:236670 | Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 1 | | | | 157 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | FKTN CL E G H | 2218 | 3622 | OMIM:236670 | Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 1 | | | | 184 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | FOXH1 CL E G H | 8928 | 3814 | ORPHA:93925 | Alobar holoprosencephaly | | | | 48 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | FOXH1 CL E G H | 8928 | 3814 | ORPHA:93924 | Lobar holoprosencephaly | | | | 48 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | FOXH1 CL E G H | 8928 | 3814 | ORPHA:93926 | Midline interhemispheric variant of holoprosencephaly | | | | 48 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | FOXH1 CL E G H | 8928 | 3814 | ORPHA:220386 | Semilobar holoprosencephaly | | | | 48 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | FOXRED1 CL E G H | 55572 | 26927 | ORPHA:2609 | Isolated complex I deficiency | | | | 61 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | GABRB2 CL E G H | 2561 | 4082 | OMIM:617829 | Epileptic encephalopathy, infantile or early childhood, 2 | | | | 44 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | GALT CL E G H | 2592 | 4135 | ORPHA:79239 | Classic galactosemia | | | | 351 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | GAS1 CL E G H | 2619 | 4165 | ORPHA:93925 | Alobar holoprosencephaly | | | | 2 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | GAS1 CL E G H | 2619 | 4165 | ORPHA:93924 | Lobar holoprosencephaly | | | | 2 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | GAS1 CL E G H | 2619 | 4165 | ORPHA:93926 | Midline interhemispheric variant of holoprosencephaly | | | | 2 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | GAS1 CL E G H | 2619 | 4165 | ORPHA:220386 | Semilobar holoprosencephaly | | | | 2 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | GATA1 CL E G H | 2623 | 4170 | ORPHA:124 | Blackfan-Diamond anemia | | | | 29 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | GBA1 CL E G H | 2629 | 4177 | OMIM:127750 | Dementia, lewy body | | | | | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | GCDH CL E G H | 2639 | 4189 | ORPHA:25 | Glutaryl-CoA dehydrogenase deficiency | | | | 115 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | GCH1 CL E G H | 2643 | 4193 | OMIM:233910 | Hyperphenylalaninemia, BH4-deficient, B | | | | 86 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | GCK CL E G H | 2645 | 4195 | OMIM:602485 | Hyperinsulinemic hypoglycemia, familial, 3 | | | | 237 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | GCK CL E G H | 2645 | 4195 | ORPHA:79299 | Hyperinsulinism due to glucokinase deficiency | | | | 237 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | GCK CL E G H | 2645 | 4195 | ORPHA:99885 | Isolated permanent neonatal diabetes mellitus | | | | 237 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | GCSH CL E G H | 2653 | 4208 | OMIM:605899 | Glycine encephalopathy | | | | 5 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | GFAP CL E G H | 2670 | 4235 | OMIM:203450 | Alexander disease | | | | 188 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | GJB1 CL E G H | 2705 | 4283 | ORPHA:101075 | X-linked Charcot-Marie-Tooth disease type 1 | | | | 107 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | GK CL E G H | 2710 | 4289 | OMIM:307030 | Glycerol kinase deficiency | | | | 13 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | GLDC CL E G H | 2731 | 4313 | OMIM:605899 | Glycine encephalopathy | | | | 166 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | GLI2 CL E G H | 2736 | 4318 | ORPHA:93925 | Alobar holoprosencephaly | | | | 173 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | GLI2 CL E G H | 2736 | 4318 | ORPHA:93924 | Lobar holoprosencephaly | | | | 173 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | GLI2 CL E G H | 2736 | 4318 | ORPHA:93926 | Midline interhemispheric variant of holoprosencephaly | | | | 173 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | GLI2 CL E G H | 2736 | 4318 | ORPHA:220386 | Semilobar holoprosencephaly | | | | 173 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | GLUD1 CL E G H | 2746 | 4335 | OMIM:606762 | Hyperinsulinemic hypoglycemia, familial, 6 | | | | 56 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | GLYCTK CL E G H | 132158 | 24247 | ORPHA:941 | D-glyceric aciduria | | | | 6 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | GNA11 CL E G H | 2767 | 4379 | ORPHA:428 | Autosomal dominant hypocalcemia | HP:0040283 - Occasional | | | 16 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | GNAS CL E G H | 2778 | 4392 | ORPHA:79443 | Pseudohypoparathyroidism type 1A | | | | 101 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | GNAS CL E G H | 2778 | 4392 | ORPHA:79444 | Pseudohypoparathyroidism type 1C | | | | 101 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | GUF1 CL E G H | 60558 | 25799 | OMIM:617065 | Epileptic encephalopathy, early infantile, 40 | | | | 2 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | GYS2 CL E G H | 2998 | 4707 | ORPHA:2089 | Glycogen storage disease due to hepatic glycogen synthase deficiency | | | | 100 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | HADH CL E G H | 3033 | 4799 | OMIM:609975 | Hyperinsulinemic hypoglycemia, familial, 4 | | | | 41 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | HADH CL E G H | 3033 | 4799 | ORPHA:71212 | Hyperinsulinism due to short chain 3-hydroxylacyl-CoA dehydrogenase deficiency | | | | 41 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | HADHA CL E G H | 3030 | 4801 | ORPHA:746 | Mitochondrial trifunctional protein deficiency | | | | 99 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | HADHA CL E G H | 3030 | 4801 | OMIM:609015 | Mitochondrial trifunctional protein deficiency | | | | 99 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | HADHB CL E G H | 3032 | 4803 | ORPHA:746 | Mitochondrial trifunctional protein deficiency | | | | 60 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | HADHB CL E G H | 3032 | 4803 | OMIM:609015 | Mitochondrial trifunctional protein deficiency | | | | 60 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | HAMP CL E G H | 57817 | 15598 | ORPHA:79230 | Hemochromatosis type 2 | | | | 15 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | HCRT CL E G H | 3060 | 4847 | OMIM:161400 | Narcolepsy 1 | | | | 1 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | HCRT CL E G H | 3060 | 4847 | ORPHA:2073 | Narcolepsy type 1 | | | | 1 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | HCRT CL E G H | 3060 | 4847 | ORPHA:83465 | Narcolepsy type 2 | | | | 1 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | HESX1 CL E G H | 8820 | 4877 | ORPHA:226307 | Hypothyroidism due to deficient transcription factors involved in pituitary development or function | | | | 21 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | HFE CL E G H | 3077 | 4886 | ORPHA:465508 | Symptomatic form of hemochromatosis type 1 | | | | 38 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | HJV CL E G H | 148738 | 4887 | ORPHA:79230 | Hemochromatosis type 2 | | | | | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | HJV CL E G H | 148738 | 4887 | OMIM:602390 | Hemochromatosis, type 2A | | | | | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | HLA-B CL E G H | 3106 | 4932 | ORPHA:117 | Behçet disease | | | | 4 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | HLA-B CL E G H | 3106 | 4932 | ORPHA:3287 | Takayasu arteritis | HP:0040283 - Occasional | | | 4 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | HLA-DQB1 CL E G H | 3119 | 4944 | OMIM:123400 | Creutzfeldt-Jakob disease | | | | | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | HLA-DQB1 CL E G H | 3119 | 4944 | ORPHA:2073 | Narcolepsy type 1 | | | | | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | HLA-DQB1 CL E G H | 3119 | 4944 | ORPHA:83465 | Narcolepsy type 2 | | | | | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | HLA-DRB1 CL E G H | 3123 | 4948 | ORPHA:2073 | Narcolepsy type 1 | | | | 2 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | HLA-DRB1 CL E G H | 3123 | 4948 | ORPHA:83465 | Narcolepsy type 2 | | | | 2 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | HLCS CL E G H | 3141 | 4976 | OMIM:253270 | Holocarboxylase synthetase deficiency | | | | 148 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | HLCS CL E G H | 3141 | 4976 | ORPHA:79242 | Holocarboxylase synthetase deficiency | | | | 148 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | HMBS CL E G H | 3145 | 4982 | ORPHA:79276 | Acute intermittent porphyria | | | | 81 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | HMGCL CL E G H | 3155 | 5005 | ORPHA:20 | 3-hydroxy-3-methylglutaric aciduria | | | | 35 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | HMGCL CL E G H | 3155 | 5005 | OMIM:246450 | 3-Hydroxy-3-Methylglutaryl-Coa lyase deficiency | | | | 35 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | HNF1A CL E G H | 6927 | 11621 | ORPHA:324575 | Hyperinsulinism due to HNF1A deficiency | | | | 161 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | HNF4A CL E G H | 3172 | 5024 | ORPHA:263455 | Hyperinsulinism due to HNF4A deficiency | | | | 138 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | HTT CL E G H | 3064 | 4851 | ORPHA:399 | Huntington disease | | | | 12 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | IFNGR1 CL E G H | 3459 | 5439 | ORPHA:117 | Behçet disease | | | | 60 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | IL10 CL E G H | 3586 | 5962 | ORPHA:117 | Behçet disease | | | | 2 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | IL12A CL E G H | 3592 | 5969 | ORPHA:117 | Behçet disease | | | | | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | IL12A CL E G H | 3592 | 5969 | ORPHA:186 | Primary biliary cholangitis | | | | | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | IL12A-AS1 CL E G H | 101928376 | 49094 | ORPHA:117 | Behçet disease | | | | | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | IL12B CL E G H | 3593 | 5970 | ORPHA:3287 | Takayasu arteritis | HP:0040283 - Occasional | | | 31 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | IL12RB1 CL E G H | 3594 | 5971 | ORPHA:186 | Primary biliary cholangitis | | | | 46 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | IL18BP CL E G H | 10068 | 5987 | OMIM:618549 | HEPATITIS, FULMINANT VIRAL, SUSCEPTIBILITY TO; FVH | | | | | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | IL23R CL E G H | 149233 | 19100 | ORPHA:117 | Behçet disease | | | | 1 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | INS CL E G H | 3630 | 6081 | ORPHA:99885 | Isolated permanent neonatal diabetes mellitus | | | | 62 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | INSR CL E G H | 3643 | 6091 | OMIM:609968 | Hyperinsulinemic hypoglycemia, familial, 5 | | | | 229 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | INSR CL E G H | 3643 | 6091 | ORPHA:263458 | Hyperinsulinism due to INSR deficiency | | | | 229 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | IRAK1 CL E G H | 3654 | 6112 | ORPHA:93552 | Pediatric systemic lupus erythematosus | HP:0040283 - Occasional | | | | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | IRF5 CL E G H | 3663 | 6120 | ORPHA:186 | Primary biliary cholangitis | | | | 4 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | ISCA2 CL E G H | 122961 | 19857 | OMIM:616370 | Multiple mitochondrial dysfunctions syndrome 4 | | | | 7 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | IVD CL E G H | 3712 | 6186 | OMIM:243500 | Isovaleric acidemia | | | | 105 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | IYD CL E G H | 389434 | 21071 | ORPHA:95716 | Familial thyroid dyshormonogenesis | | | | 130 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | KCNE1 CL E G H | 3753 | 6240 | ORPHA:90647 | Jervell and Lange-Nielsen syndrome | | | | 148 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | KCNJ11 CL E G H | 3767 | 6257 | ORPHA:276580 | Autosomal dominant hyperinsulinism due to Kir6.2 deficiency | | | | 127 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | KCNJ11 CL E G H | 3767 | 6257 | ORPHA:99885 | Isolated permanent neonatal diabetes mellitus | | | | 127 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | KCNQ1 CL E G H | 3784 | 6294 | ORPHA:90647 | Jervell and Lange-Nielsen syndrome | | | | 730 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | KIF1A CL E G H | 547 | 888 | ORPHA:2836 | PEHO syndrome | | | | 276 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | KLRC4 CL E G H | 8302 | 6377 | ORPHA:117 | Behçet disease | | | | | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | KRT18 CL E G H | 3875 | 6430 | OMIM:215600 | Cirrhosis, familial | | | | 19 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | KYNU CL E G H | 8942 | 6469 | ORPHA:79155 | Hydroxykynureninuria | | | | 5 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | LARGE1 CL E G H | 9215 | 6511 | OMIM:236670 | Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 1 | | | | 136 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | LHX3 CL E G H | 8022 | 6595 | ORPHA:226307 | Hypothyroidism due to deficient transcription factors involved in pituitary development or function | | | | 51 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | LHX4 CL E G H | 89884 | 21734 | ORPHA:226307 | Hypothyroidism due to deficient transcription factors involved in pituitary development or function | | | | 43 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | LMBRD1 CL E G H | 55788 | 23038 | ORPHA:79284 | Methylmalonic acidemia with homocystinuria type cblF | | | | 46 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | LMBRD1 CL E G H | 55788 | 23038 | OMIM:277380 | Methylmalonic aciduria and homocystinuria, Cblf type | | | | 46 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | LONP1 CL E G H | 9361 | 9479 | ORPHA:79243 | Pyruvate dehydrogenase E1-alpha deficiency | | | | 8 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | LRP4 CL E G H | 4038 | 6696 | ORPHA:98913 | Postsynaptic congenital myasthenic syndromes | | | | 124 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | LYRM7 CL E G H | 90624 | 28072 | OMIM:615838 | Mitochondrial complex III deficiency, nuclear type 8 | | | | 10 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | MAGEL2 CL E G H | 54551 | 6814 | ORPHA:398069 | MAGEL2-related Prader-Willi-like syndrome | | | | 63 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | MAN2B1 CL E G H | 4125 | 6826 | ORPHA:309288 | Alpha-mannosidosis, adult form | | | | 136 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | MAN2B1 CL E G H | 4125 | 6826 | ORPHA:309282 | Alpha-mannosidosis, infantile form | | | | 136 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | MC2R CL E G H | 4158 | 6930 | ORPHA:361 | Familial glucocorticoid deficiency | | | | 94 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | MC2R CL E G H | 4158 | 6930 | OMIM:202200 | Glucocorticoid deficiency 1 | | | | 94 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | MCCC1 CL E G H | 56922 | 6936 | OMIM:210200 | 3-Methylcrotonyl-CoA carboxylase 1 deficiency | | | | 81 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | MCCC2 CL E G H | 64087 | 6937 | OMIM:210210 | 3-Methylcrotonyl-CoA carboxylase 2 deficiency | | | | 77 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | MEFV CL E G H | 4210 | 6998 | ORPHA:117 | Behçet disease | | | | 281 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | MEN1 CL E G H | 4221 | 7010 | ORPHA:97279 | Insulinoma | HP:0040282 - Frequent | | | 462 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | MEN1 CL E G H | 4221 | 7010 | ORPHA:652 | Multiple endocrine neoplasia type 1 | | | | 462 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | MLX CL E G H | 6945 | 11645 | ORPHA:3287 | Takayasu arteritis | HP:0040283 - Occasional | | | | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | MMAA CL E G H | 166785 | 18871 | OMIM:251100 | Methylmalonic aciduria, Cbla type | | | | 113 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | MMAB CL E G H | 326625 | 19331 | OMIM:251110 | Methylmalonic aciduria, Cblb type | | | | 127 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | MMACHC CL E G H | 25974 | 24525 | ORPHA:79282 | Methylmalonic acidemia with homocystinuria, type cblC | | | | 101 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | MMACHC CL E G H | 25974 | 24525 | OMIM:277400 | Methylmalonic aciduria and homocystinuria, Cblc type | | | | 101 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | MMADHC CL E G H | 27249 | 25221 | ORPHA:79283 | Methylmalonic acidemia with homocystinuria, type cblD | | | | 50 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | MMADHC CL E G H | 27249 | 25221 | OMIM:277410 | Methylmalonic aciduria and homocystinuria, Cbld type | | | | 50 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | MMEL1 CL E G H | 79258 | 14668 | ORPHA:186 | Primary biliary cholangitis | | | | | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | MMUT CL E G H | 4594 | 7526 | OMIM:251000 | Methylmalonic aciduria due to methylmalonyl-coa mutase deficiency | | | | | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | MMUT CL E G H | 4594 | 7526 | ORPHA:79312 | Vitamin B12-unresponsive methylmalonic acidemia type mut- | | | | | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | MMUT CL E G H | 4594 | 7526 | ORPHA:289916 | Vitamin B12-unresponsive methylmalonic acidemia type mut0 | | | | | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | MOG CL E G H | 4340 | 7197 | OMIM:614250 | Narcolepsy 7 | | | | 1 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | MOG CL E G H | 4340 | 7197 | ORPHA:2073 | Narcolepsy type 1 | | | | 1 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | MRAP CL E G H | 56246 | 1304 | ORPHA:361 | Familial glucocorticoid deficiency | | | | 26 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | MRPS16 CL E G H | 51021 | 14048 | OMIM:610498 | Combined oxidative phosphorylation deficiency 2 | | | | 60 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | MTHFR CL E G H | 4524 | 7436 | ORPHA:395 | Homocystinuria due to methylene tetrahydrofolate reductase deficiency | | | | 183 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | MTRR CL E G H | 4552 | 7473 | OMIM:236270 | Homocystinuria-megaloblastic anemia, cbl E type | | | | 88 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | MTRR CL E G H | 4552 | 7473 | ORPHA:2169 | Methylcobalamin deficiency type cblE | | | | 88 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | MUSK CL E G H | 4593 | 7525 | ORPHA:994 | Fetal akinesia deformation sequence | | | | 72 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | MUSK CL E G H | 4593 | 7525 | ORPHA:98913 | Postsynaptic congenital myasthenic syndromes | | | | 72 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | MYD88 CL E G H | 4615 | 7562 | ORPHA:33226 | Waldenström macroglobulinemia | HP:0040283 - Occasional | | | 9 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | MYOD1 CL E G H | 4654 | 7611 | ORPHA:994 | Fetal akinesia deformation sequence | | | | | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | NAA10 CL E G H | 8260 | 18704 | ORPHA:276432 | Ogden syndrome | | | | 23 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | NAB2 CL E G H | 4665 | 7627 | ORPHA:2126 | Solitary fibrous tumor/hemangiopericytoma | | | | | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | NAGS CL E G H | 162417 | 17996 | ORPHA:927 | Hyperammonemia due to N-acetylglutamate synthase deficiency | | | | 36 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | NAGS CL E G H | 162417 | 17996 | OMIM:237310 | N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY | | | | 36 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | NAXD CL E G H | 55739 | 25576 | OMIM:618321 | Encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy, 2 | | | | | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | NAXE CL E G H | 128240 | 18453 | OMIM:617186 | Encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy, 1 | | | | 9 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | NBAS CL E G H | 51594 | 15625 | OMIM:616483 | INFANTILE LIVER FAILURE SYNDROME 2; ILFS2 | | | | 25 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | ND1 CL E G H | 4535 | 7455 | ORPHA:2609 | Isolated complex I deficiency | | | | | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | ND1 CL E G H | 4535 | 7455 | ORPHA:550 | MELAS | HP:0040283 - Occasional | | | | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | ND2 CL E G H | 4536 | 7456 | ORPHA:2609 | Isolated complex I deficiency | | | | | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | ND3 CL E G H | 4537 | 7458 | ORPHA:2609 | Isolated complex I deficiency | | | | | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | ND4 CL E G H | 4538 | 7459 | ORPHA:550 | MELAS | HP:0040283 - Occasional | | | | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | ND5 CL E G H | 4540 | 7461 | ORPHA:550 | MELAS | HP:0040283 - Occasional | | | | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | ND6 CL E G H | 4541 | 7462 | ORPHA:550 | MELAS | HP:0040283 - Occasional | | | | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | NDE1 CL E G H | 54820 | 17619 | ORPHA:2177 | Hydranencephaly | | | | 96 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | NDUFA1 CL E G H | 4694 | 7683 | ORPHA:2609 | Isolated complex I deficiency | | | | 7 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | NDUFA11 CL E G H | 126328 | 20371 | ORPHA:2609 | Isolated complex I deficiency | | | | 32 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | NDUFA6 CL E G H | 4700 | 7690 | ORPHA:2609 | Isolated complex I deficiency | | | | 1 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | NDUFAF1 CL E G H | 51103 | 18828 | ORPHA:2609 | Isolated complex I deficiency | | | | 40 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | NDUFAF2 CL E G H | 91942 | 28086 | ORPHA:2609 | Isolated complex I deficiency | | | | 26 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | NDUFAF3 CL E G H | 25915 | 29918 | ORPHA:2609 | Isolated complex I deficiency | | | | 31 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | NDUFAF3 CL E G H | 25915 | 29918 | ORPHA:70474 | Leigh syndrome with cardiomyopathy | | | | 31 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | NDUFAF4 CL E G H | 29078 | 21034 | ORPHA:2609 | Isolated complex I deficiency | | | | 50 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | NDUFAF5 CL E G H | 79133 | 15899 | ORPHA:2609 | Isolated complex I deficiency | | | | 34 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | NDUFAF8 CL E G H | 284184 | 33551 | ORPHA:2609 | Isolated complex I deficiency | | | | | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | NDUFB10 CL E G H | 4716 | 7696 | ORPHA:2609 | Isolated complex I deficiency | | | | | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | NDUFB11 CL E G H | 54539 | 20372 | ORPHA:2609 | Isolated complex I deficiency | | | | 3 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | NDUFB3 CL E G H | 4709 | 7698 | ORPHA:2609 | Isolated complex I deficiency | | | | 9 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | NDUFB8 CL E G H | 4714 | 7703 | ORPHA:70474 | Leigh syndrome with cardiomyopathy | | | | | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | NDUFB9 CL E G H | 4715 | 7704 | ORPHA:2609 | Isolated complex I deficiency | | | | 16 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | NDUFS1 CL E G H | 4719 | 7707 | ORPHA:2609 | Isolated complex I deficiency | | | | 81 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | NDUFS1 CL E G H | 4719 | 7707 | OMIM:618226 | Mitochondrial complex I deficiency, nuclear type 5 | | | | 81 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | NDUFS2 CL E G H | 4720 | 7708 | ORPHA:2609 | Isolated complex I deficiency | | | | 65 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | NDUFS2 CL E G H | 4720 | 7708 | ORPHA:70474 | Leigh syndrome with cardiomyopathy | | | | 65 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | NDUFS2 CL E G H | 4720 | 7708 | OMIM:618228 | Mitochondrial complex I deficiency, nuclear type 6 | | | | 65 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | NDUFS3 CL E G H | 4722 | 7710 | ORPHA:2609 | Isolated complex I deficiency | | | | 22 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | NDUFS4 CL E G H | 4724 | 7711 | ORPHA:2609 | Isolated complex I deficiency | | | | 27 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | NDUFS4 CL E G H | 4724 | 7711 | OMIM:252010 | Mitochondrial complex I deficiency, nuclear type 1 | | | | 27 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | NDUFS6 CL E G H | 4726 | 7713 | ORPHA:2609 | Isolated complex I deficiency | | | | 21 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | NDUFS6 CL E G H | 4726 | 7713 | OMIM:618232 | Mitochondrial complex I deficiency, nuclear type 9 | | | | 21 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | NDUFS7 CL E G H | 374291 | 7714 | ORPHA:2609 | Isolated complex I deficiency | | | | 38 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | NDUFS7 CL E G H | 374291 | 7714 | OMIM:618224 | Mitochondrial complex I deficiency, nuclear type 3 | | | | 38 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | NDUFS8 CL E G H | 4728 | 7715 | ORPHA:2609 | Isolated complex I deficiency | | | | 42 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | NDUFS8 CL E G H | 4728 | 7715 | OMIM:618222 | Mitochondrial complex I deficiency, nuclear type 2 | | | | 42 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | NDUFV1 CL E G H | 4723 | 7716 | ORPHA:2609 | Isolated complex I deficiency | | | | 74 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | NDUFV1 CL E G H | 4723 | 7716 | OMIM:618225 | Mitochondrial complex I deficiency, nuclear type 4 | | | | 74 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | NDUFV2 CL E G H | 4729 | 7717 | ORPHA:2609 | Isolated complex I deficiency | | | | 27 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | NF2 CL E G H | 4771 | 7773 | ORPHA:2495 | Meningioma | | | | 220 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | NFKB2 CL E G H | 4791 | 7795 | ORPHA:293978 | Deficiency in anterior pituitary function-variable immunodeficiency syndrome | | | | 11 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | NFS1 CL E G H | 9054 | 15910 | OMIM:619386 | COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 52; COXPD52 | | | | 5 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | NFU1 CL E G H | 27247 | 16287 | OMIM:605711 | Multiple mitochondrial dysfunctions syndrome 1 | | | | 34 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | NHLRC1 CL E G H | 378884 | 21576 | ORPHA:501 | Lafora disease | | | | 77 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | NNT CL E G H | 23530 | 7863 | ORPHA:361 | Familial glucocorticoid deficiency | | | | 13 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | NNT CL E G H | 23530 | 7863 | OMIM:614736 | Glucocorticoid deficiency 4 with or without mineralocorticoid deficiency | | | | 13 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | NODAL CL E G H | 4838 | 7865 | ORPHA:93925 | Alobar holoprosencephaly | | | | 45 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | NODAL CL E G H | 4838 | 7865 | ORPHA:93924 | Lobar holoprosencephaly | | | | 45 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | NODAL CL E G H | 4838 | 7865 | ORPHA:93926 | Midline interhemispheric variant of holoprosencephaly | | | | 45 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | NODAL CL E G H | 4838 | 7865 | ORPHA:220386 | Semilobar holoprosencephaly | | | | 45 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | NOTCH2NLC CL E G H | 100996717 | 53924 | OMIM:603472 | NEURONAL INTRANUCLEAR INCLUSION DISEASE | | | | | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | NOTCH3 CL E G H | 4854 | 7883 | ORPHA:136 | Cerebral autosomal dominant arteriopathy-subcortical infarcts-leukoencephalopathy | | | | 144 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | NUBPL CL E G H | 80224 | 20278 | ORPHA:2609 | Isolated complex I deficiency | | | | 89 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | NUP88 CL E G H | 4927 | 8067 | ORPHA:994 | Fetal akinesia deformation sequence | | | | | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | OTC CL E G H | 5009 | 8512 | OMIM:311250 | Ornithine transcarbamylase deficiency, hyperammonemia due to | | | | 369 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | P2RY11 CL E G H | 5032 | 8540 | ORPHA:2073 | Narcolepsy type 1 | | | | 2 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | PAX2 CL E G H | 5076 | 8616 | ORPHA:97362 | Renal hypoplasia, bilateral | | | | 39 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | PAX8 CL E G H | 7849 | 8622 | OMIM:218700 | Hypothyroidism, congenital, nongoitrous, 2 | | | | 63 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | PBX1 CL E G H | 5087 | 8632 | ORPHA:97362 | Renal hypoplasia, bilateral | | | | 3 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | PCCA CL E G H | 5095 | 8653 | OMIM:606054 | Propionic acidemia | | | | 96 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | PCCB CL E G H | 5096 | 8654 | OMIM:606054 | Propionic acidemia | | | | 92 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | PDGFB CL E G H | 5155 | 8800 | ORPHA:2495 | Meningioma | | | | 9 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | PDHA1 CL E G H | 5160 | 8806 | OMIM:312170 | Pyruvate dehydrogenase e1-alpha deficiency | | | | 88 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | PDHA1 CL E G H | 5160 | 8806 | ORPHA:79243 | Pyruvate dehydrogenase E1-alpha deficiency | | | | 88 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | PDX1 CL E G H | 3651 | 6107 | ORPHA:99885 | Isolated permanent neonatal diabetes mellitus | | | | 30 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | PIGA CL E G H | 5277 | 8957 | OMIM:301072 | NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HEMOCHROMATOSIS; NEDEPH | | | | 46 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | PIGA CL E G H | 5277 | 8957 | ORPHA:447 | Paroxysmal nocturnal hemoglobinuria | | | | 46 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | PIGG CL E G H | 54872 | 25985 | ORPHA:488635 | Early-onset epilepsy-intellectual disability-brain anomalies syndrome | | | | 7 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | PIK3CA CL E G H | 5290 | 8975 | ORPHA:2495 | Meningioma | | | | 162 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | PLA2G6 CL E G H | 8398 | 9039 | ORPHA:35069 | Infantile neuroaxonal dystrophy | | | | 133 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | PLCH1 CL E G H | 23007 | 29185 | ORPHA:93925 | Alobar holoprosencephaly | | | | | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | PLP1 CL E G H | 5354 | 9086 | ORPHA:280229 | Pelizaeus-Merzbacher disease in female carriers | | | | 60 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | POLG CL E G H | 5428 | 9179 | ORPHA:726 | Alpers-Huttenlocher syndrome | | | | 464 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | POLG CL E G H | 5428 | 9179 | ORPHA:254892 | Autosomal dominant progressive external ophthalmoplegia | | | | 464 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | POLG2 CL E G H | 11232 | 9180 | ORPHA:254892 | Autosomal dominant progressive external ophthalmoplegia | | | | 45 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | POLR3A CL E G H | 11128 | 30074 | ORPHA:3455 | Wiedemann-Rautenstrauch syndrome | | | | 138 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | POLR3K CL E G H | 51728 | 14121 | OMIM:619310 | LEUKODYSTROPHY, HYPOMYELINATING, 21; HLD21 | | | | | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | POMT1 CL E G H | 10585 | 9202 | OMIM:236670 | Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 1 | | | | 213 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | POMT2 CL E G H | 29954 | 19743 | OMIM:236670 | Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 1 | | | | 221 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | POU1F1 CL E G H | 5449 | 9210 | ORPHA:226307 | Hypothyroidism due to deficient transcription factors involved in pituitary development or function | | | | 36 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | POU2AF1 CL E G H | 5450 | 9211 | ORPHA:186 | Primary biliary cholangitis | | | | | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | PPOX CL E G H | 5498 | 9280 | ORPHA:79473 | Porphyria variegata | | | | 41 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | PRDM8 CL E G H | 56978 | 13993 | ORPHA:324290 | Early-onset Lafora body disease | | | | 1 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | PRDX1 CL E G H | 5052 | 9352 | OMIM:277400 | Methylmalonic aciduria and homocystinuria, Cblc type | | | | | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | PRF1 CL E G H | 5551 | 9360 | ORPHA:540 | Familial hemophagocytic lymphohistiocytosis | | | | 58 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | PRF1 CL E G H | 5551 | 9360 | OMIM:603553 | Hemophagocytic lymphohistiocytosis, familial, 2 | | | | 58 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | PRNP CL E G H | 5621 | 9449 | OMIM:123400 | Creutzfeldt-Jakob disease | | | | 69 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | PRNP CL E G H | 5621 | 9449 | ORPHA:282166 | Inherited Creutzfeldt-Jakob disease | | | | 69 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | PROP1 CL E G H | 5626 | 9455 | ORPHA:226307 | Hypothyroidism due to deficient transcription factors involved in pituitary development or function | | | | 54 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | PRPS1 CL E G H | 5631 | 9462 | ORPHA:99014 | X-linked Charcot-Marie-Tooth disease type 5 | | | | 49 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | PRRT2 CL E G H | 112476 | 30500 | ORPHA:569 | Familial or sporadic hemiplegic migraine | | | | 94 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | PSAP CL E G H | 5660 | 9498 | OMIM:611722 | KRABBE DISEASE, ATYPICAL, DUE TO SAPOSIN A DEFICIENCY | | | | 81 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | PSAP CL E G H | 5660 | 9498 | ORPHA:309271 | Metachromatic leukodystrophy, adult form | | | | 81 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | PSAP CL E G H | 5660 | 9498 | ORPHA:309263 | Metachromatic leukodystrophy, juvenile form | | | | 81 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | PSAP CL E G H | 5660 | 9498 | ORPHA:309256 | Metachromatic leukodystrophy, late infantile form | | | | 81 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | PSEN1 CL E G H | 5663 | 9508 | ORPHA:1020 | Early-onset autosomal dominant Alzheimer disease | | | | 241 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | PSEN2 CL E G H | 5664 | 9509 | ORPHA:1020 | Early-onset autosomal dominant Alzheimer disease | | | | 59 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | PTCH1 CL E G H | 5727 | 9585 | ORPHA:93925 | Alobar holoprosencephaly | | | | 665 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | PTCH1 CL E G H | 5727 | 9585 | ORPHA:93924 | Lobar holoprosencephaly | | | | 665 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | PTCH1 CL E G H | 5727 | 9585 | ORPHA:93926 | Midline interhemispheric variant of holoprosencephaly | | | | 665 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | PTCH1 CL E G H | 5727 | 9585 | ORPHA:220386 | Semilobar holoprosencephaly | | | | 665 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | PTS CL E G H | 5805 | 9689 | ORPHA:13 | 6-pyruvoyl-tetrahydropterin synthase deficiency | | | | 19 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | PTS CL E G H | 5805 | 9689 | OMIM:261640 | Hyperphenylalaninemia, BH4-deficient, A | | | | 19 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | RANBP2 CL E G H | 5903 | 9848 | OMIM:608033 | Encephalopathy, acute, infection-induced, susceptibility to, 3 | | | | 57 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | RANBP2 CL E G H | 5903 | 9848 | ORPHA:88619 | Familial acute necrotizing encephalopathy | | | | 57 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | RAPSN CL E G H | 5913 | 9863 | ORPHA:994 | Fetal akinesia deformation sequence | | | | 73 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | RAPSN CL E G H | 5913 | 9863 | ORPHA:98913 | Postsynaptic congenital myasthenic syndromes | | | | 73 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | RARS2 CL E G H | 57038 | 21406 | OMIM:611523 | Pontocerebellar hypoplasia, type 6 | | | | 93 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | RMND1 CL E G H | 55005 | 21176 | OMIM:614922 | Combined oxidative phosphorylation deficiency 11 | | | | 26 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | RNU4ATAC CL E G H | 100151683 | 34016 | OMIM:210710 | Microcephalic osteodysplastic primordial dwarfism, type I | | | | 15 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | RPL11 CL E G H | 6135 | 10301 | ORPHA:124 | Blackfan-Diamond anemia | | | | 22 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | RPL15 CL E G H | 6138 | 10306 | ORPHA:124 | Blackfan-Diamond anemia | | | | 3 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | RPL18 CL E G H | 6141 | 10310 | ORPHA:124 | Blackfan-Diamond anemia | | | | | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | RPL26 CL E G H | 6154 | 10327 | ORPHA:124 | Blackfan-Diamond anemia | | | | 3 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | RPL27 CL E G H | 6155 | 10328 | ORPHA:124 | Blackfan-Diamond anemia | | | | 1 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | RPL31 CL E G H | 6160 | 10334 | ORPHA:124 | Blackfan-Diamond anemia | | | | | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | RPL35 CL E G H | 11224 | 10344 | ORPHA:124 | Blackfan-Diamond anemia | | | | | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | RPL35A CL E G H | 6165 | 10345 | ORPHA:124 | Blackfan-Diamond anemia | | | | 11 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | RPL5 CL E G H | 6125 | 10360 | ORPHA:124 | Blackfan-Diamond anemia | | | | 40 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | RPS10 CL E G H | 6204 | 10383 | ORPHA:124 | Blackfan-Diamond anemia | | | | 26 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | RPS15A CL E G H | 6210 | 10389 | ORPHA:124 | Blackfan-Diamond anemia | | | | | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | RPS17 CL E G H | 6218 | 10397 | ORPHA:124 | Blackfan-Diamond anemia | | | | 5 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | RPS19 CL E G H | 6223 | 10402 | ORPHA:124 | Blackfan-Diamond anemia | | | | 42 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | RPS20 CL E G H | 6224 | 10405 | ORPHA:124 | Blackfan-Diamond anemia | | | | 1 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | RPS24 CL E G H | 6229 | 10411 | ORPHA:124 | Blackfan-Diamond anemia | | | | 22 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | RPS26 CL E G H | 6231 | 10414 | ORPHA:124 | Blackfan-Diamond anemia | | | | 20 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | RPS27 CL E G H | 6232 | 10416 | ORPHA:124 | Blackfan-Diamond anemia | | | | 1 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | RPS28 CL E G H | 6234 | 10418 | ORPHA:124 | Blackfan-Diamond anemia | | | | 1 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | RPS29 CL E G H | 6235 | 10419 | ORPHA:124 | Blackfan-Diamond anemia | | | | 3 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | RPS7 CL E G H | 6201 | 10440 | ORPHA:124 | Blackfan-Diamond anemia | | | | 20 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | RRM2B CL E G H | 50484 | 17296 | ORPHA:254892 | Autosomal dominant progressive external ophthalmoplegia | | | | 125 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | RYR1 CL E G H | 6261 | 10483 | ORPHA:324581 | Benign Samaritan congenital myopathy | | | | 1200 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | RYR1 CL E G H | 6261 | 10483 | ORPHA:466650 | Exercise-induced malignant hyperthermia | | | | 1200 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | SCN1A CL E G H | 6323 | 10585 | ORPHA:569 | Familial or sporadic hemiplegic migraine | | | | 1053 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | SCN4A CL E G H | 6329 | 10591 | ORPHA:98913 | Postsynaptic congenital myasthenic syndromes | | | | 263 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | SCO2 CL E G H | 9997 | 10604 | OMIM:604377 | Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 1 | | | | 40 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | SCO2 CL E G H | 9997 | 10604 | ORPHA:70474 | Leigh syndrome with cardiomyopathy | | | | 40 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | SHH CL E G H | 6469 | 10848 | ORPHA:93925 | Alobar holoprosencephaly | | | | 67 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | SHH CL E G H | 6469 | 10848 | ORPHA:93924 | Lobar holoprosencephaly | | | | 67 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | SHH CL E G H | 6469 | 10848 | ORPHA:93926 | Midline interhemispheric variant of holoprosencephaly | | | | 67 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | SHH CL E G H | 6469 | 10848 | ORPHA:220386 | Semilobar holoprosencephaly | | | | 67 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | SHQ1 CL E G H | 55164 | 25543 | OMIM:619922 | | | | | | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | SIK1 CL E G H | 150094 | 11142 | ORPHA:1935 | Early myoclonic encephalopathy | | | | 11 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | SIM1 CL E G H | 6492 | 10882 | ORPHA:398079 | SIM1-related Prader-Willi-like syndrome | | | | 40 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | SIX3 CL E G H | 6496 | 10889 | ORPHA:93925 | Alobar holoprosencephaly | | | | 32 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | SIX3 CL E G H | 6496 | 10889 | ORPHA:93924 | Lobar holoprosencephaly | | | | 32 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | SIX3 CL E G H | 6496 | 10889 | ORPHA:93926 | Midline interhemispheric variant of holoprosencephaly | | | | 32 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | SIX3 CL E G H | 6496 | 10889 | ORPHA:220386 | Semilobar holoprosencephaly | | | | 32 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | SLC12A3 CL E G H | 6559 | 10912 | ORPHA:358 | Gitelman syndrome | | | | 145 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | SLC13A3 CL E G H | 64849 | 14430 | OMIM:618384 | Leukoencephalopathy, acute reversible, with increased urinary alpha-ketoglutarate | | | | 2 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | SLC18A3 CL E G H | 6572 | 10936 | ORPHA:994 | Fetal akinesia deformation sequence | | | | 2 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | SLC19A2 CL E G H | 10560 | 10938 | ORPHA:49827 | Thiamine-responsive megaloblastic anemia syndrome | | | | 55 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | SLC19A3 CL E G H | 80704 | 16266 | ORPHA:263410 | Infantile spasms-psychomotor retardation-progressive brain atrophy-basal ganglia disease syndrome | | | | 110 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | SLC19A3 CL E G H | 80704 | 16266 | OMIM:607483 | Thiamine metabolism dysfunction syndrome 2 (biotin- or thiamine-responsive encephalopathy type 2) | | | | 110 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | SLC1A2 CL E G H | 6506 | 10940 | OMIM:617105 | Epileptic encephalopathy, early infantile, 41 | | | | 3 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | SLC22A5 CL E G H | 6584 | 10969 | OMIM:212140 | Carnitine deficiency, systemic primary | | | | 207 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | SLC22A5 CL E G H | 6584 | 10969 | ORPHA:158 | Systemic primary carnitine deficiency | | | | 207 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | SLC25A13 CL E G H | 10165 | 10983 | ORPHA:247585 | Citrullinemia type II | | | | 82 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | SLC25A13 CL E G H | 10165 | 10983 | OMIM:603471 | Citrullinemia, type II, adult-onset | | | | 82 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | SLC25A15 CL E G H | 10166 | 10985 | OMIM:238970 | Hyperornithinemia-Hyperammonemia-Homocitrullinuria syndrome | | | | 88 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | SLC25A15 CL E G H | 10166 | 10985 | ORPHA:415 | Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome | | | | 88 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | SLC25A19 CL E G H | 60386 | 14409 | OMIM:613710 | Thiamine metabolism dysfunction syndrome 4 (bilateral striatal degenerationand progressive polyneuropathy type) | | | | 36 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | SLC25A20 CL E G H | 788 | 1421 | OMIM:212138 | Carnitine-acylcarnitine translocase deficiency | | | | 40 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | SLC25A20 CL E G H | 788 | 1421 | ORPHA:159 | Carnitine-acylcarnitine translocase deficiency | | | | 40 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | SLC25A22 CL E G H | 79751 | 19954 | ORPHA:1935 | Early myoclonic encephalopathy | | | | 166 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | SLC25A4 CL E G H | 291 | 10990 | ORPHA:254892 | Autosomal dominant progressive external ophthalmoplegia | | | | 68 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | SLC2A1 CL E G H | 6513 | 11005 | ORPHA:71277 | Classic glucose transporter type 1 deficiency syndrome | | | | 255 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | SLC2A1 CL E G H | 6513 | 11005 | OMIM:606777 | Glut1 deficiency syndrome 1 | | | | 255 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | SLC2A3 CL E G H | 6515 | 11007 | ORPHA:399 | Huntington disease | | | | 1 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | SLC39A4 CL E G H | 55630 | 17129 | OMIM:201100 | Acrodermatitis enteropathica, Zinc-Deficiency type | | | | 55 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | SLC4A1 CL E G H | 6521 | 11027 | OMIM:611590 | Renal tubular acidosis, distal, with hemolytic anemia | | | | 109 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | SLC52A1 CL E G H | 55065 | 30225 | OMIM:615026 | Riboflavin deficiency | | | | 3 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | SLC5A5 CL E G H | 6528 | 11040 | ORPHA:95716 | Familial thyroid dyshormonogenesis | | | | 59 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | SLC5A5 CL E G H | 6528 | 11040 | OMIM:274400 | Thyroid hormonogenesis, genetic defect in, 1 | | | | 59 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | SLC7A7 CL E G H | 9056 | 11065 | OMIM:222700 | Lysinuric protein intolerance | | | | 104 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | SLC7A7 CL E G H | 9056 | 11065 | ORPHA:470 | Lysinuric protein intolerance | | | | 104 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | SMARCB1 CL E G H | 6598 | 11103 | ORPHA:99966 | Atypical teratoid rhabdoid tumor | HP:0040282 - Frequent | | | 87 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | SMARCB1 CL E G H | 6598 | 11103 | ORPHA:2495 | Meningioma | | | | 87 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | SMARCE1 CL E G H | 6605 | 11109 | ORPHA:2495 | Meningioma | | | | 47 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | SMC1A CL E G H | 8243 | 11111 | ORPHA:220386 | Semilobar holoprosencephaly | | | | 135 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | SMO CL E G H | 6608 | 11119 | ORPHA:2495 | Meningioma | | | | 22 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | SNCA CL E G H | 6622 | 11138 | OMIM:127750 | Dementia, lewy body | | | | 65 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | SNCB CL E G H | 6620 | 11140 | OMIM:127750 | Dementia, lewy body | | | | 2 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | SORL1 CL E G H | 6653 | 11185 | ORPHA:1020 | Early-onset autosomal dominant Alzheimer disease | | | | 3 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | SOX10 CL E G H | 6663 | 11190 | OMIM:609136 | Peripheral demyelinating neuropathy, central dysmyelination, Waardenburg syndrome, and Hirschsprung disease | | | | 61 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | SPIB CL E G H | 6689 | 11242 | ORPHA:186 | Primary biliary cholangitis | | | | | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | SPP1 CL E G H | 6696 | 11255 | ORPHA:93552 | Pediatric systemic lupus erythematosus | HP:0040283 - Occasional | | | | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | SPR CL E G H | 6697 | 11257 | ORPHA:70594 | Dopa-responsive dystonia due to sepiapterin reductase deficiency | | | | 28 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | SQOR CL E G H | 58472 | 20390 | OMIM:619221 | SULFIDE:QUINONE OXIDOREDUCTASE DEFICIENCY; SQORD | | | | | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | STAG2 CL E G H | 10735 | 11355 | ORPHA:93925 | Alobar holoprosencephaly | | | | 1 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | STAG2 CL E G H | 10735 | 11355 | ORPHA:220386 | Semilobar holoprosencephaly | | | | 1 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | STAR CL E G H | 6770 | 11359 | ORPHA:361 | Familial glucocorticoid deficiency | | | | 45 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | STAT3 CL E G H | 6774 | 11364 | ORPHA:99885 | Isolated permanent neonatal diabetes mellitus | | | | 110 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | STAT4 CL E G H | 6775 | 11365 | ORPHA:117 | Behçet disease | | | | 2 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | STAT4 CL E G H | 6775 | 11365 | ORPHA:93552 | Pediatric systemic lupus erythematosus | HP:0040283 - Occasional | | | 2 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | STAT6 CL E G H | 6778 | 11368 | ORPHA:2126 | Solitary fibrous tumor/hemangiopericytoma | | | | 1 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | STIL CL E G H | 6491 | 10879 | ORPHA:93925 | Alobar holoprosencephaly | | | | 99 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | STIL CL E G H | 6491 | 10879 | ORPHA:93924 | Lobar holoprosencephaly | | | | 99 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | STIL CL E G H | 6491 | 10879 | ORPHA:93926 | Midline interhemispheric variant of holoprosencephaly | | | | 99 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | STIL CL E G H | 6491 | 10879 | ORPHA:220386 | Semilobar holoprosencephaly | | | | 99 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | STX11 CL E G H | 8676 | 11429 | ORPHA:540 | Familial hemophagocytic lymphohistiocytosis | | | | 85 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | STXBP2 CL E G H | 6813 | 11445 | ORPHA:540 | Familial hemophagocytic lymphohistiocytosis | | | | 70 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | SUFU CL E G H | 51684 | 16466 | ORPHA:2495 | Meningioma | | | | 124 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | SUGCT CL E G H | 79783 | 16001 | ORPHA:35706 | Glutaric acidemia type 3 | | | | 8 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | SURF1 CL E G H | 6834 | 11474 | ORPHA:70474 | Leigh syndrome with cardiomyopathy | | | | 73 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | TBC1D24 CL E G H | 57465 | 29203 | ORPHA:352596 | Progressive myoclonic epilepsy with dystonia | | | | 271 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | TBK1 CL E G H | 29110 | 11584 | OMIM:617900 | Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 8 | | | | 20 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | TBK1 CL E G H | 29110 | 11584 | ORPHA:1930 | Herpes simplex virus encephalitis | HP:0040281 - Very frequent | | | 20 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | TBP CL E G H | 6908 | 11588 | OMIM:607136 | Spinocerebellar ataxia 17 | | | | 7 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | TCN2 CL E G H | 6948 | 11653 | OMIM:275350 | Transcobalamin II deficiency | | | | 57 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | TDGF1 CL E G H | 6997 | 11701 | ORPHA:93925 | Alobar holoprosencephaly | | | | 1 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | TDGF1 CL E G H | 6997 | 11701 | ORPHA:93924 | Lobar holoprosencephaly | | | | 1 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | TDGF1 CL E G H | 6997 | 11701 | ORPHA:93926 | Midline interhemispheric variant of holoprosencephaly | | | | 1 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | TDGF1 CL E G H | 6997 | 11701 | ORPHA:220386 | Semilobar holoprosencephaly | | | | 1 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | TERT CL E G H | 7015 | 11730 | ORPHA:2495 | Meningioma | | | | 238 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | TG CL E G H | 7038 | 11764 | ORPHA:95716 | Familial thyroid dyshormonogenesis | | | | 155 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | TGIF1 CL E G H | 7050 | 11776 | ORPHA:93925 | Alobar holoprosencephaly | | | | 32 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | TGIF1 CL E G H | 7050 | 11776 | ORPHA:93924 | Lobar holoprosencephaly | | | | 32 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | TGIF1 CL E G H | 7050 | 11776 | ORPHA:93926 | Midline interhemispheric variant of holoprosencephaly | | | | 32 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | TGIF1 CL E G H | 7050 | 11776 | ORPHA:220386 | Semilobar holoprosencephaly | | | | 32 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | TH CL E G H | 7054 | 11782 | ORPHA:101150 | Autosomal recessive dopa-responsive dystonia | | | | 80 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | THRA CL E G H | 7067 | 11796 | OMIM:614450 | Hypothyroidism, congenital, nongoitrous, 6 | | | | 9 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | TICAM1 CL E G H | 148022 | 18348 | ORPHA:1930 | Herpes simplex virus encephalitis | HP:0040281 - Very frequent | | | 6 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | TIMMDC1 CL E G H | 51300 | 1321 | ORPHA:2609 | Isolated complex I deficiency | | | | 1 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | TLR3 CL E G H | 7098 | 11849 | OMIM:613002 | Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 2 | | | | 3 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | TLR3 CL E G H | 7098 | 11849 | ORPHA:1930 | Herpes simplex virus encephalitis | HP:0040281 - Very frequent | | | 3 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | TLR4 CL E G H | 7099 | 11850 | ORPHA:117 | Behçet disease | | | | 3 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | TMEM126B CL E G H | 55863 | 30883 | ORPHA:2609 | Isolated complex I deficiency | | | | 4 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | TNFSF15 CL E G H | 9966 | 11931 | ORPHA:186 | Primary biliary cholangitis | | | | | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | TNFSF4 CL E G H | 7292 | 11934 | ORPHA:2073 | Narcolepsy type 1 | | | | | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | TNPO3 CL E G H | 23534 | 17103 | ORPHA:186 | Primary biliary cholangitis | | | | 71 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | TOMM40 CL E G H | 10452 | 18001 | ORPHA:1020 | Early-onset autosomal dominant Alzheimer disease | | | | | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | TPO CL E G H | 7173 | 12015 | ORPHA:95716 | Familial thyroid dyshormonogenesis | | | | 92 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | TRAF3 CL E G H | 7187 | 12033 | ORPHA:1930 | Herpes simplex virus encephalitis | HP:0040281 - Very frequent | | | 2 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | TRAF7 CL E G H | 84231 | 20456 | ORPHA:2495 | Meningioma | | | | | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | TREM2 CL E G H | 54209 | 17761 | ORPHA:1020 | Early-onset autosomal dominant Alzheimer disease | | | | 31 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | TRHR CL E G H | 7201 | 12299 | OMIM:618573 | HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 7; CHNG7 | | | | 2 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | TRHR CL E G H | 7201 | 12299 | ORPHA:99832 | Resistance to thyrotropin-releasing hormone syndrome | | | | 2 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | TRNE CL E G H | 4556 | 7479 | ORPHA:2596 | Myopathy and diabetes mellitus | | | | | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | TRNF CL E G H | 4558 | 7481 | ORPHA:550 | MELAS | HP:0040283 - Occasional | | | | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | TRNH CL E G H | 4564 | 7487 | ORPHA:550 | MELAS | HP:0040283 - Occasional | | | | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | TRNL1 CL E G H | 4567 | 7490 | ORPHA:550 | MELAS | HP:0040283 - Occasional | | | | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | TRNQ CL E G H | 4572 | 7495 | ORPHA:550 | MELAS | HP:0040283 - Occasional | | | | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | TRNS1 CL E G H | 4574 | 7497 | ORPHA:550 | MELAS | HP:0040283 - Occasional | | | | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | TRNS2 CL E G H | 4575 | 7498 | ORPHA:550 | MELAS | HP:0040283 - Occasional | | | | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | TRNT CL E G H | 4576 | 7499 | ORPHA:254857 | Lethal infantile mitochondrial myopathy | | | | | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | TRNW CL E G H | 4578 | 7501 | ORPHA:550 | MELAS | HP:0040283 - Occasional | | | | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | TSHB CL E G H | 7252 | 12372 | ORPHA:90674 | Isolated thyroid-stimulating hormone deficiency | | | | 9 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | TSHR CL E G H | 7253 | 12373 | ORPHA:90673 | Hypothyroidism due to TSH receptor mutations | | | | 97 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | TSPOAP1 CL E G H | 9256 | 16831 | ORPHA:101150 | Autosomal recessive dopa-responsive dystonia | | | | 2 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | TSR2 CL E G H | 90121 | 25455 | ORPHA:124 | Blackfan-Diamond anemia | | | | 1 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | TTC26 CL E G H | 79989 | 21882 | OMIM:619534 | BILIARY, RENAL, NEUROLOGIC, AND SKELETAL SYNDROME; BRENS | | | | | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | TUBA1A CL E G H | 7846 | 20766 | ORPHA:994 | Fetal akinesia deformation sequence | | | | 106 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | TWNK CL E G H | 56652 | 1160 | ORPHA:254892 | Autosomal dominant progressive external ophthalmoplegia | | | | 113 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | TWNK CL E G H | 56652 | 1160 | OMIM:271245 | Mitochondrial DNA depletion syndrome 7 (hepatocerebral type) | | | | 113 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | TXNRD2 CL E G H | 10587 | 18155 | ORPHA:361 | Familial glucocorticoid deficiency | | | | 85 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | UBAC2 CL E G H | 337867 | 20486 | ORPHA:117 | Behçet disease | | | | | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | UCP2 CL E G H | 7351 | 12518 | ORPHA:276556 | Hyperinsulinism due to UCP2 deficiency | | | | 15 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | UNC13D CL E G H | 201294 | 23147 | ORPHA:540 | Familial hemophagocytic lymphohistiocytosis | | | | 116 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | UNC93B1 CL E G H | 81622 | 13481 | ORPHA:1930 | Herpes simplex virus encephalitis | HP:0040281 - Very frequent | | | 5 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | UPB1 CL E G H | 51733 | 16297 | OMIM:613161 | Beta-Ureidopropionase deficiency | | | | 44 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | USP18 CL E G H | 11274 | 12616 | OMIM:617397 | Pseudo-Torch syndrome 2 | | | | 2 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | YY1 CL E G H | 7528 | 12856 | ORPHA:97279 | Insulinoma | HP:0040282 - Frequent | | | 7 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | ZIC2 CL E G H | 7546 | 12873 | ORPHA:93925 | Alobar holoprosencephaly | | | | 34 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | ZIC2 CL E G H | 7546 | 12873 | ORPHA:93924 | Lobar holoprosencephaly | | | | 34 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | ZIC2 CL E G H | 7546 | 12873 | ORPHA:93926 | Midline interhemispheric variant of holoprosencephaly | | | | 34 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | ZIC2 CL E G H | 7546 | 12873 | ORPHA:220386 | Semilobar holoprosencephaly | | | | 34 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | ZNF365 CL E G H | 22891 | 18194 | ORPHA:2073 | Narcolepsy type 1 | | | | 3 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | ZNF365 CL E G H | 22891 | 18194 | ORPHA:83465 | Narcolepsy type 2 | | | | 3 | | |
HP:0004372 | HP:0004372 | Reduced consciousness/confusion | 0 | ZNHIT3 CL E G H | 9326 | 12309 | ORPHA:2836 | PEHO syndrome | | | | 1 | | |
HP:0004372 | HP:0007200 | Episodic hypersomnia | 1 | CL E G H | | | | | | | | | | |
HP:0004372 | HP:0031358 | Vegetative state | 1 | AARS1 CL E G H | 16 | 20 | OMIM:619661 | LEUKOENCEPHALOPATHY, HEREDITARY DIFFUSE, WITH SPHEROIDS 2; HDLS2 | | | | | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | ABAT CL E G H | 18 | 23 | OMIM:613163 | GABA-transaminase deficiency | . | | | 120 | | |
HP:0004372 | HP:0001289 | Confusion | 1 | ABCA7 CL E G H | 10347 | 37 | ORPHA:1020 | Early-onset autosomal dominant Alzheimer disease | HP:0040281 - Very frequent | | | 3 | | |
HP:0004372 | HP:0002329 | Drowsiness | 1 | ABCC8 CL E G H | 6833 | 59 | ORPHA:276575 | Autosomal dominant hyperinsulinism due to SUR1 deficiency | HP:0040282 - Frequent | | | 245 | | |
HP:0004372 | HP:0001259 | Coma | 1 | ABCC8 CL E G H | 6833 | 59 | ORPHA:276575 | Autosomal dominant hyperinsulinism due to SUR1 deficiency | | | | 245 | | |
HP:0004372 | HP:0007185 | Loss of consciousness | 1 | ABCC8 CL E G H | 6833 | 59 | ORPHA:276575 | Autosomal dominant hyperinsulinism due to SUR1 deficiency | HP:0040283 - Occasional | | | 245 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | ABCC8 CL E G H | 6833 | 59 | ORPHA:276575 | Autosomal dominant hyperinsulinism due to SUR1 deficiency | HP:0040283 - Occasional | | | 245 | | |
HP:0004372 | HP:0001259 | Coma | 1 | ABCC8 CL E G H | 6833 | 59 | OMIM:256450 | Hyperinsulinemic hypoglycemia, familial, 1 | | | | 245 | | |
HP:0004372 | HP:0001259 | Coma | 1 | ABCC8 CL E G H | 6833 | 59 | OMIM:240800 | Hypoglycemia of infancy, leucine-sensitive | . | | | 245 | | |
HP:0004372 | HP:0002329 | Drowsiness | 1 | ABCC8 CL E G H | 6833 | 59 | OMIM:240800 | Hypoglycemia of infancy, leucine-sensitive | . | | | 245 | | |
HP:0004372 | HP:0001259 | Coma | 1 | ABCC8 CL E G H | 6833 | 59 | ORPHA:99885 | Isolated permanent neonatal diabetes mellitus | HP:0040283 - Occasional | | | 245 | | |
HP:0004372 | HP:0001289 | Confusion | 1 | ABCD1 CL E G H | 215 | 61 | ORPHA:139396 | X-linked cerebral adrenoleukodystrophy | HP:0040283 - Occasional | | | 135 | | |
HP:0004372 | HP:0031358 | Vegetative state | 1 | ABCD1 CL E G H | 215 | 61 | ORPHA:139396 | X-linked cerebral adrenoleukodystrophy | HP:0040284 - Very rare | | | 135 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | ABCD4 CL E G H | 5826 | 68 | OMIM:614857 | Methylmalonic aciduria and homocystinuria, Cblj type | . | | | 53 | | |
HP:0004372 | HP:0001259 | Coma | 1 | ACADM CL E G H | 34 | 89 | OMIM:201450 | Acyl-Coa dehydrogenase, medium-chain, deficiency of | . | | | 197 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | ACADM CL E G H | 34 | 89 | OMIM:201450 | Acyl-Coa dehydrogenase, medium-chain, deficiency of | . | | | 197 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | ACADM CL E G H | 34 | 89 | ORPHA:42 | Medium chain acyl-CoA dehydrogenase deficiency | HP:0040283 - Occasional | | | 197 | | |
HP:0004372 | HP:0007185 | Loss of consciousness | 1 | ACADM CL E G H | 34 | 89 | ORPHA:42 | Medium chain acyl-CoA dehydrogenase deficiency | HP:0040283 - Occasional | | | 197 | | |
HP:0004372 | HP:0001259 | Coma | 1 | ACADM CL E G H | 34 | 89 | ORPHA:42 | Medium chain acyl-CoA dehydrogenase deficiency | HP:0040283 - Occasional | | | 197 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | ACADS CL E G H | 35 | 90 | OMIM:201470 | Acyl-Coa dehydrogenase, short-chain, deficiency of | . | | | 90 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | ACADS CL E G H | 35 | 90 | ORPHA:26792 | Short chain acyl-CoA dehydrogenase deficiency | HP:0040283 - Occasional | | | 90 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | ACADSB CL E G H | 36 | 91 | OMIM:610006 | 2-Methylbutyryl-Coa dehydrogenase deficiency | . | | | 111 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | ACADVL CL E G H | 37 | 92 | ORPHA:26793 | Very long chain acyl-CoA dehydrogenase deficiency | HP:0040284 - Very rare | | | 200 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | ACADVL CL E G H | 37 | 92 | OMIM:201475 | Very long-chain acyl-CoA dehydrogenase deficiency | | | | 200 | | |
HP:0004372 | HP:0001259 | Coma | 1 | ACAT1 CL E G H | 38 | 93 | ORPHA:134 | Beta-ketothiolase deficiency | HP:0040282 - Frequent | | | 91 | | |
HP:0004372 | HP:0001262 | Excessive daytime somnolence | 1 | ACAT1 CL E G H | 38 | 93 | ORPHA:134 | Beta-ketothiolase deficiency | HP:0040282 - Frequent | | | 91 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | ADA2 CL E G H | 51816 | 1839 | ORPHA:124 | Blackfan-Diamond anemia | HP:0040282 - Frequent | | | 22 | | |
HP:0004372 | HP:0001289 | Confusion | 1 | ADAMTS13 CL E G H | 11093 | 1366 | OMIM:274150 | Thrombotic thrombocytopenic purpura, hereditary | . | | | 129 | | |
HP:0004372 | HP:0007185 | Loss of consciousness | 1 | ADORA2A CL E G H | 135 | 263 | ORPHA:363549 | Acute encephalopathy with biphasic seizures and late reduced diffusion | HP:0040282 - Frequent | | | 1 | | |
HP:0004372 | HP:0002329 | Drowsiness | 1 | AGRN CL E G H | 375790 | 329 | ORPHA:98913 | Postsynaptic congenital myasthenic syndromes | HP:0040283 - Occasional | | | 127 | | |
HP:0004372 | HP:0002329 | Drowsiness | 1 | AK9 CL E G H | 221264 | 33814 | ORPHA:98913 | Postsynaptic congenital myasthenic syndromes | HP:0040283 - Occasional | | | 1 | | |
HP:0004372 | HP:0001262 | Excessive daytime somnolence | 1 | AKT1 CL E G H | 207 | 391 | ORPHA:2495 | Meningioma | HP:0040284 - Very rare | | | 54 | | |
HP:0004372 | HP:0001259 | Coma | 1 | AKT2 CL E G H | 208 | 392 | ORPHA:293964 | Hypoinsulinemic hypoglycemia and body hemihypertrophy | | | | 12 | | |
HP:0004372 | HP:0007159 | Fluctuations in consciousness | 1 | ALAD CL E G H | 210 | 395 | ORPHA:100924 | Porphyria due to ALA dehydratase deficiency | HP:0040283 - Occasional | | | 62 | | |
HP:0004372 | HP:0001289 | Confusion | 1 | ALAD CL E G H | 210 | 395 | ORPHA:100924 | Porphyria due to ALA dehydratase deficiency | HP:0040283 - Occasional | | | 62 | | |
HP:0004372 | HP:0001289 | Confusion | 1 | ALDH4A1 CL E G H | 8659 | 406 | ORPHA:79101 | Hyperprolinemia type 2 | HP:0040283 - Occasional | | | 74 | | |
HP:0004372 | HP:0001259 | Coma | 1 | ALDOB CL E G H | 229 | 417 | OMIM:229600 | Fructose intolerance, hereditary | . | | | 73 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | ALDOB CL E G H | 229 | 417 | OMIM:229600 | Fructose intolerance, hereditary | . | | | 73 | | |
HP:0004372 | HP:0001259 | Coma | 1 | ALDOB CL E G H | 229 | 417 | ORPHA:469 | Hereditary fructose intolerance | HP:0040284 - Very rare | | | 73 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | ALDOB CL E G H | 229 | 417 | ORPHA:469 | Hereditary fructose intolerance | HP:0040284 - Very rare | | | 73 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | AMT CL E G H | 275 | 473 | OMIM:605899 | Glycine encephalopathy | . | | | 56 | | |
HP:0004372 | HP:0001259 | Coma | 1 | APP CL E G H | 351 | 620 | ORPHA:324713 | ABeta amyloidosis, Italian type | HP:0040282 - Frequent | | | 74 | | |
HP:0004372 | HP:0001259 | Coma | 1 | APP CL E G H | 351 | 620 | ORPHA:324703 | ABetaL34V amyloidosis | HP:0040281 - Very frequent | | | 74 | | |
HP:0004372 | HP:0001289 | Confusion | 1 | APP CL E G H | 351 | 620 | ORPHA:1020 | Early-onset autosomal dominant Alzheimer disease | HP:0040281 - Very frequent | | | 74 | | |
HP:0004372 | HP:0031358 | Vegetative state | 1 | ARSA CL E G H | 410 | 713 | ORPHA:309271 | Metachromatic leukodystrophy, adult form | HP:0040284 - Very rare | | | 253 | | |
HP:0004372 | HP:0031358 | Vegetative state | 1 | ARSA CL E G H | 410 | 713 | ORPHA:309263 | Metachromatic leukodystrophy, juvenile form | HP:0040284 - Very rare | | | 253 | | |
HP:0004372 | HP:0031358 | Vegetative state | 1 | ARSA CL E G H | 410 | 713 | ORPHA:309256 | Metachromatic leukodystrophy, late infantile form | HP:0040284 - Very rare | | | 253 | | |
HP:0004372 | HP:0001262 | Excessive daytime somnolence | 1 | ASH1L CL E G H | 55870 | 19088 | OMIM:617796 | Mental retardation, autosomal dominant 52 | | | | 1 | | |
HP:0004372 | HP:0001259 | Coma | 1 | ASL CL E G H | 435 | 746 | OMIM:207900 | Argininosuccinic aciduria | . | | | 81 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | ASL CL E G H | 435 | 746 | OMIM:207900 | Argininosuccinic aciduria | . | | | 81 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | ASPA CL E G H | 443 | 756 | ORPHA:314911 | Severe Canavan disease | HP:0040282 - Frequent | | | 48 | | |
HP:0004372 | HP:0001259 | Coma | 1 | ASS1 CL E G H | 445 | 758 | OMIM:215700 | Citrullinemia, classic | . | | | 119 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | ASS1 CL E G H | 445 | 758 | OMIM:215700 | Citrullinemia, classic | . | | | 119 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | ATP13A2 CL E G H | 23400 | 30213 | ORPHA:306674 | Kufor-Rakeb syndrome | HP:0040282 - Frequent | | | 100 | | |
HP:0004372 | HP:0001289 | Confusion | 1 | ATP13A2 CL E G H | 23400 | 30213 | ORPHA:306674 | Kufor-Rakeb syndrome | HP:0040282 - Frequent | | | 100 | | |
HP:0004372 | HP:0001259 | Coma | 1 | ATP1A2 CL E G H | 477 | 800 | ORPHA:569 | Familial or sporadic hemiplegic migraine | HP:0040283 - Occasional | | | 239 | | |
HP:0004372 | HP:0032044 | Decreased vigilance | 1 | ATP1A2 CL E G H | 477 | 800 | ORPHA:569 | Familial or sporadic hemiplegic migraine | HP:0040283 - Occasional | | | 239 | | |
HP:0004372 | HP:0001289 | Confusion | 1 | ATP1A2 CL E G H | 477 | 800 | ORPHA:569 | Familial or sporadic hemiplegic migraine | HP:0040282 - Frequent | | | 239 | | |
HP:0004372 | HP:0002329 | Drowsiness | 1 | ATP1A2 CL E G H | 477 | 800 | OMIM:602481 | Migraine, familial hemiplegic, 2 | . | | | 239 | | |
HP:0004372 | HP:0001259 | Coma | 1 | ATP1A2 CL E G H | 477 | 800 | OMIM:602481 | Migraine, familial hemiplegic, 2 | . | | | 239 | | |
HP:0004372 | HP:0001289 | Confusion | 1 | ATP1A2 CL E G H | 477 | 800 | OMIM:602481 | Migraine, familial hemiplegic, 2 | . | | | 239 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | ATP5F1D CL E G H | 513 | 837 | OMIM:618120 | Mitochondrial complex V (atp synthase) deficiency, nuclear type 5 | . | | | | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | ATP5MK CL E G H | 84833 | 30889 | OMIM:618683 | MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 6; MC5DN6 | | | | | | |
HP:0004372 | HP:0001259 | Coma | 1 | ATP7B CL E G H | 540 | 870 | OMIM:277900 | Wilson disease | . | | | 315 | | |
HP:0004372 | HP:0001259 | Coma | 1 | AUH CL E G H | 549 | 890 | ORPHA:67046 | 3-methylglutaconic aciduria type 1 | HP:0040283 - Occasional | | | 49 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | AVP CL E G H | 551 | 894 | ORPHA:30925 | Hereditary central diabetes insipidus | HP:0040282 - Frequent | | | 22 | | |
HP:0004372 | HP:0001262 | Excessive daytime somnolence | 1 | BAP1 CL E G H | 8314 | 950 | ORPHA:2495 | Meningioma | HP:0040284 - Very rare | | | 184 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | BCKDHA CL E G H | 593 | 986 | OMIM:248600 | Maple syrup urine disease | . | | | 120 | | |
HP:0004372 | HP:0001259 | Coma | 1 | BCKDHA CL E G H | 593 | 986 | OMIM:248600 | Maple syrup urine disease | . | | | 120 | | |
HP:0004372 | HP:0001259 | Coma | 1 | BCKDHB CL E G H | 594 | 987 | OMIM:248600 | Maple syrup urine disease | . | | | 162 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | BCKDHB CL E G H | 594 | 987 | OMIM:248600 | Maple syrup urine disease | . | | | 162 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | BMP6 CL E G H | 654 | 1073 | ORPHA:465508 | Symptomatic form of hemochromatosis type 1 | HP:0040283 - Occasional | | | | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | BNC2 CL E G H | 54796 | 30988 | ORPHA:93110 | Posterior urethral valve | HP:0040284 - Very rare | | | 22 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | BOLA3 CL E G H | 388962 | 24415 | OMIM:614299 | Multiple mitochondrial dysfunctions syndrome 2 with hyperglycinemia | . | | | 14 | | |
HP:0004372 | HP:0001259 | Coma | 1 | BRAF CL E G H | 673 | 1097 | ORPHA:54595 | Craniopharyngioma | HP:0040284 - Very rare | | | 276 | | |
HP:0004372 | HP:0001262 | Excessive daytime somnolence | 1 | BRAF CL E G H | 673 | 1097 | ORPHA:54595 | Craniopharyngioma | HP:0040282 - Frequent | | | 276 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | BTD CL E G H | 686 | 1122 | ORPHA:79241 | Biotinidase deficiency | HP:0040283 - Occasional | | | 223 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | BTD CL E G H | 686 | 1122 | OMIM:253260 | Biotinidase deficiencymultiple carboxylase deficiency, late-onset | . | | | 223 | | |
HP:0004372 | HP:0001289 | Confusion | 1 | C4A CL E G H | 720 | 1323 | ORPHA:117 | Behçet disease | HP:0040282 - Frequent | | | 1 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | CA5A CL E G H | 763 | 1377 | OMIM:615751 | Hyperammonemia due to carbonic anhydrase VA deficiency | . | | | 10 | | |
HP:0004372 | HP:0002329 | Drowsiness | 1 | CACNA1A CL E G H | 773 | 1388 | ORPHA:71518 | Benign paroxysmal torticollis of infancy | HP:0040282 - Frequent | | | 449 | | |
HP:0004372 | HP:0032044 | Decreased vigilance | 1 | CACNA1A CL E G H | 773 | 1388 | ORPHA:569 | Familial or sporadic hemiplegic migraine | HP:0040283 - Occasional | | | 449 | | |
HP:0004372 | HP:0001289 | Confusion | 1 | CACNA1A CL E G H | 773 | 1388 | ORPHA:569 | Familial or sporadic hemiplegic migraine | HP:0040282 - Frequent | | | 449 | | |
HP:0004372 | HP:0001259 | Coma | 1 | CACNA1A CL E G H | 773 | 1388 | ORPHA:569 | Familial or sporadic hemiplegic migraine | HP:0040283 - Occasional | | | 449 | | |
HP:0004372 | HP:0001289 | Confusion | 1 | CACNA1A CL E G H | 773 | 1388 | OMIM:141500 | Migraine, familial hemiplegic, 1 | . | | | 449 | | |
HP:0004372 | HP:0001259 | Coma | 1 | CACNA1A CL E G H | 773 | 1388 | OMIM:141500 | Migraine, familial hemiplegic, 1 | . | | | 449 | | |
HP:0004372 | HP:0002329 | Drowsiness | 1 | CACNA1A CL E G H | 773 | 1388 | OMIM:141500 | Migraine, familial hemiplegic, 1 | . | | | 449 | | |
HP:0004372 | HP:0001289 | Confusion | 1 | CCR1 CL E G H | 1230 | 1602 | ORPHA:117 | Behçet disease | HP:0040282 - Frequent | | | | | |
HP:0004372 | HP:0001289 | Confusion | 1 | CDKN1A CL E G H | 1026 | 1784 | ORPHA:652 | Multiple endocrine neoplasia type 1 | HP:0040283 - Occasional | | | 2 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | CDKN1A CL E G H | 1026 | 1784 | ORPHA:652 | Multiple endocrine neoplasia type 1 | HP:0040283 - Occasional | | | 2 | | |
HP:0004372 | HP:0032044 | Decreased vigilance | 1 | CDKN1A CL E G H | 1026 | 1784 | ORPHA:652 | Multiple endocrine neoplasia type 1 | HP:0040283 - Occasional | | | 2 | | |
HP:0004372 | HP:0001259 | Coma | 1 | CDKN1A CL E G H | 1026 | 1784 | ORPHA:652 | Multiple endocrine neoplasia type 1 | HP:0040284 - Very rare | | | 2 | | |
HP:0004372 | HP:0032044 | Decreased vigilance | 1 | CDKN1B CL E G H | 1027 | 1785 | ORPHA:652 | Multiple endocrine neoplasia type 1 | HP:0040283 - Occasional | | | 102 | | |
HP:0004372 | HP:0001259 | Coma | 1 | CDKN1B CL E G H | 1027 | 1785 | ORPHA:652 | Multiple endocrine neoplasia type 1 | HP:0040284 - Very rare | | | 102 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | CDKN1B CL E G H | 1027 | 1785 | ORPHA:652 | Multiple endocrine neoplasia type 1 | HP:0040283 - Occasional | | | 102 | | |
HP:0004372 | HP:0001289 | Confusion | 1 | CDKN1B CL E G H | 1027 | 1785 | ORPHA:652 | Multiple endocrine neoplasia type 1 | HP:0040283 - Occasional | | | 102 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | CDKN2B CL E G H | 1030 | 1788 | ORPHA:652 | Multiple endocrine neoplasia type 1 | HP:0040283 - Occasional | | | 1 | | |
HP:0004372 | HP:0001259 | Coma | 1 | CDKN2B CL E G H | 1030 | 1788 | ORPHA:652 | Multiple endocrine neoplasia type 1 | HP:0040284 - Very rare | | | 1 | | |
HP:0004372 | HP:0032044 | Decreased vigilance | 1 | CDKN2B CL E G H | 1030 | 1788 | ORPHA:652 | Multiple endocrine neoplasia type 1 | HP:0040283 - Occasional | | | 1 | | |
HP:0004372 | HP:0001289 | Confusion | 1 | CDKN2B CL E G H | 1030 | 1788 | ORPHA:652 | Multiple endocrine neoplasia type 1 | HP:0040283 - Occasional | | | 1 | | |
HP:0004372 | HP:0001259 | Coma | 1 | CDKN2C CL E G H | 1031 | 1789 | ORPHA:652 | Multiple endocrine neoplasia type 1 | HP:0040284 - Very rare | | | | | |
HP:0004372 | HP:0001289 | Confusion | 1 | CDKN2C CL E G H | 1031 | 1789 | ORPHA:652 | Multiple endocrine neoplasia type 1 | HP:0040283 - Occasional | | | | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | CDKN2C CL E G H | 1031 | 1789 | ORPHA:652 | Multiple endocrine neoplasia type 1 | HP:0040283 - Occasional | | | | | |
HP:0004372 | HP:0032044 | Decreased vigilance | 1 | CDKN2C CL E G H | 1031 | 1789 | ORPHA:652 | Multiple endocrine neoplasia type 1 | HP:0040283 - Occasional | | | | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | CDON CL E G H | 50937 | 17104 | ORPHA:93925 | Alobar holoprosencephaly | HP:0040282 - Frequent | | | 200 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | CDON CL E G H | 50937 | 17104 | ORPHA:93924 | Lobar holoprosencephaly | HP:0040283 - Occasional | | | 200 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | CDON CL E G H | 50937 | 17104 | ORPHA:93926 | Midline interhemispheric variant of holoprosencephaly | HP:0040282 - Frequent | | | 200 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | CDON CL E G H | 50937 | 17104 | ORPHA:220386 | Semilobar holoprosencephaly | HP:0040282 - Frequent | | | 200 | | |
HP:0004372 | HP:0001259 | Coma | 1 | CFH CL E G H | 3075 | 4883 | OMIM:235400 | Hemolytic uremic syndrome, atypical, susceptibility to, 1 | . | | | 86 | | |
HP:0004372 | HP:0001259 | Coma | 1 | CFHR1 CL E G H | 3078 | 4888 | OMIM:235400 | Hemolytic uremic syndrome, atypical, susceptibility to, 1 | . | | | | | |
HP:0004372 | HP:0001259 | Coma | 1 | CFHR3 CL E G H | 10878 | 16980 | OMIM:235400 | Hemolytic uremic syndrome, atypical, susceptibility to, 1 | . | | | | | |
HP:0004372 | HP:0002329 | Drowsiness | 1 | CHRNA1 CL E G H | 1134 | 1955 | ORPHA:98913 | Postsynaptic congenital myasthenic syndromes | HP:0040283 - Occasional | | | 74 | | |
HP:0004372 | HP:0001289 | Confusion | 1 | CHRNA2 CL E G H | 1135 | 1956 | OMIM:610353 | Epilepsy, nocturnal frontal lobe, 4 | . | | | 188 | | |
HP:0004372 | HP:0002329 | Drowsiness | 1 | CHRNB1 CL E G H | 1140 | 1961 | ORPHA:98913 | Postsynaptic congenital myasthenic syndromes | HP:0040283 - Occasional | | | 53 | | |
HP:0004372 | HP:0002329 | Drowsiness | 1 | CHRND CL E G H | 1144 | 1965 | ORPHA:98913 | Postsynaptic congenital myasthenic syndromes | HP:0040283 - Occasional | | | 88 | | |
HP:0004372 | HP:0002329 | Drowsiness | 1 | CHRNE CL E G H | 1145 | 1966 | ORPHA:98913 | Postsynaptic congenital myasthenic syndromes | HP:0040283 - Occasional | | | 139 | | |
HP:0004372 | HP:0001262 | Excessive daytime somnolence | 1 | CLCNKB CL E G H | 1188 | 2027 | ORPHA:358 | Gitelman syndrome | HP:0040284 - Very rare | | | 27 | | |
HP:0004372 | HP:0001262 | Excessive daytime somnolence | 1 | COA8 CL E G H | 84334 | 20492 | ORPHA:436271 | Non-progressive predominantly posterior cavitating leukoencephalopathy with peripheral neuropathy | HP:0040282 - Frequent | | | | | |
HP:0004372 | HP:0002329 | Drowsiness | 1 | COL13A1 CL E G H | 1305 | 2190 | ORPHA:98913 | Postsynaptic congenital myasthenic syndromes | HP:0040283 - Occasional | | | 6 | | |
HP:0004372 | HP:0007159 | Fluctuations in consciousness | 1 | COX1 CL E G H | 4512 | 7419 | ORPHA:550 | MELAS | HP:0040282 - Frequent | | | | | |
HP:0004372 | HP:0007159 | Fluctuations in consciousness | 1 | COX2 CL E G H | 4513 | 7421 | ORPHA:550 | MELAS | HP:0040282 - Frequent | | | | | |
HP:0004372 | HP:0007159 | Fluctuations in consciousness | 1 | COX3 CL E G H | 4514 | 7422 | ORPHA:550 | MELAS | HP:0040282 - Frequent | | | | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | COX5A CL E G H | 9377 | 2267 | OMIM:619064 | MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 20; MC4DN20 | | | | | | |
HP:0004372 | HP:0001289 | Confusion | 1 | CPOX CL E G H | 1371 | 2321 | OMIM:121300 | Coproporphyria | . | | | 72 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | CPS1 CL E G H | 1373 | 2323 | OMIM:237300 | Carbamoyl phosphate synthetase I deficiency, hyperammonemia due to | . | | | 124 | | |
HP:0004372 | HP:0001259 | Coma | 1 | CPS1 CL E G H | 1373 | 2323 | OMIM:237300 | Carbamoyl phosphate synthetase I deficiency, hyperammonemia due to | . | | | 124 | | |
HP:0004372 | HP:0007185 | Loss of consciousness | 1 | CPT1A CL E G H | 1374 | 2328 | ORPHA:156 | Carnitine palmitoyl transferase 1A deficiency | HP:0040282 - Frequent | | | 99 | | |
HP:0004372 | HP:0001259 | Coma | 1 | CPT1A CL E G H | 1374 | 2328 | ORPHA:156 | Carnitine palmitoyl transferase 1A deficiency | HP:0040282 - Frequent | | | 99 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | CPT1A CL E G H | 1374 | 2328 | ORPHA:156 | Carnitine palmitoyl transferase 1A deficiency | HP:0040282 - Frequent | | | 99 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | CPT1A CL E G H | 1374 | 2328 | OMIM:255120 | Carnitine palmitoyltransferase I deficiency | . | | | 99 | | |
HP:0004372 | HP:0001259 | Coma | 1 | CPT1A CL E G H | 1374 | 2328 | OMIM:255120 | Carnitine palmitoyltransferase I deficiency | . | | | 99 | | |
HP:0004372 | HP:0001259 | Coma | 1 | CPT2 CL E G H | 1376 | 2330 | ORPHA:228308 | Carnitine palmitoyl transferase II deficiency, neonatal form | HP:0040283 - Occasional | | | 101 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | CPT2 CL E G H | 1376 | 2330 | OMIM:600649 | Carnitine palmitoyltransferase II deficiency, infantile | . | | | 101 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | CPT2 CL E G H | 1376 | 2330 | OMIM:608836 | Carnitine palmitoyltransferase II deficiency, lethal neonatal | . | | | 101 | | |
HP:0004372 | HP:0001259 | Coma | 1 | CPT2 CL E G H | 1376 | 2330 | OMIM:614212 | Encephalopathy, acute, infection-induced, susceptibility to, 4 | . | | | 101 | | |
HP:0004372 | HP:0001262 | Excessive daytime somnolence | 1 | CTNNB1 CL E G H | 1499 | 2514 | ORPHA:54595 | Craniopharyngioma | HP:0040282 - Frequent | | | 88 | | |
HP:0004372 | HP:0001259 | Coma | 1 | CTNNB1 CL E G H | 1499 | 2514 | ORPHA:54595 | Craniopharyngioma | HP:0040284 - Very rare | | | 88 | | |
HP:0004372 | HP:0001262 | Excessive daytime somnolence | 1 | CTSH CL E G H | 1512 | 2535 | ORPHA:2073 | Narcolepsy type 1 | HP:0040281 - Very frequent | | | 1 | | |
HP:0004372 | HP:0001289 | Confusion | 1 | CUBN CL E G H | 8029 | 2548 | OMIM:261100 | Megaloblastic anemia 1 | . | | | 273 | | |
HP:0004372 | HP:0001259 | Coma | 1 | CYC1 CL E G H | 1537 | 2579 | OMIM:615453 | Mitochondrial complex III deficiency, nuclear type 6 | | | | 12 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | CYP24A1 CL E G H | 1591 | 2602 | OMIM:143880 | Hypercalcemia, infantile, 1 | . | | | 73 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | CYTB CL E G H | 4519 | 7427 | ORPHA:137675 | Histiocytoid cardiomyopathy | HP:0040284 - Very rare | | | | | |
HP:0004372 | HP:0002329 | Drowsiness | 1 | CYTB CL E G H | 4519 | 7427 | ORPHA:137675 | Histiocytoid cardiomyopathy | HP:0040283 - Occasional | | | | | |
HP:0004372 | HP:0007185 | Loss of consciousness | 1 | CYTB CL E G H | 4519 | 7427 | ORPHA:137675 | Histiocytoid cardiomyopathy | HP:0040284 - Very rare | | | | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | DBT CL E G H | 1629 | 2698 | OMIM:248600 | Maple syrup urine disease | . | | | 156 | | |
HP:0004372 | HP:0001259 | Coma | 1 | DBT CL E G H | 1629 | 2698 | OMIM:248600 | Maple syrup urine disease | . | | | 156 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | DDC CL E G H | 1644 | 2719 | OMIM:608643 | Aromatic L-amino acid decarboxylase deficiency | | | | 43 | | |
HP:0004372 | HP:0001262 | Excessive daytime somnolence | 1 | DHCR7 CL E G H | 1717 | 2860 | ORPHA:818 | Smith-Lemli-Opitz syndrome | HP:0040282 - Frequent | | | 159 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | DISP1 CL E G H | 84976 | 19711 | ORPHA:93925 | Alobar holoprosencephaly | HP:0040282 - Frequent | | | 22 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | DISP1 CL E G H | 84976 | 19711 | ORPHA:93924 | Lobar holoprosencephaly | HP:0040283 - Occasional | | | 22 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | DISP1 CL E G H | 84976 | 19711 | ORPHA:93926 | Midline interhemispheric variant of holoprosencephaly | HP:0040282 - Frequent | | | 22 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | DISP1 CL E G H | 84976 | 19711 | ORPHA:220386 | Semilobar holoprosencephaly | HP:0040282 - Frequent | | | 22 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | DLD CL E G H | 1738 | 2898 | OMIM:246900 | Dihydrolipoamide dehydrogenase deficiency | . | | | 89 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | DLD CL E G H | 1738 | 2898 | ORPHA:2394 | Pyruvate dehydrogenase E3 deficiency | HP:0040282 - Frequent | | | 89 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | DLL1 CL E G H | 28514 | 2908 | ORPHA:93925 | Alobar holoprosencephaly | HP:0040282 - Frequent | | | 3 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | DLL1 CL E G H | 28514 | 2908 | ORPHA:93924 | Lobar holoprosencephaly | HP:0040283 - Occasional | | | 3 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | DLL1 CL E G H | 28514 | 2908 | ORPHA:93926 | Midline interhemispheric variant of holoprosencephaly | HP:0040282 - Frequent | | | 3 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | DLL1 CL E G H | 28514 | 2908 | ORPHA:220386 | Semilobar holoprosencephaly | HP:0040282 - Frequent | | | 3 | | |
HP:0004372 | HP:0001262 | Excessive daytime somnolence | 1 | DMPK CL E G H | 1760 | 2933 | OMIM:160900 | Myotonic dystrophy 1 | . | | | 152 | | |
HP:0004372 | HP:0001262 | Excessive daytime somnolence | 1 | DNMT1 CL E G H | 1786 | 2976 | OMIM:604121 | Cerebellar ataxia, deafness, and narcolepsy, autosomal dominant | . | | | 145 | | |
HP:0004372 | HP:0001262 | Excessive daytime somnolence | 1 | DNMT1 CL E G H | 1786 | 2976 | OMIM:614116 | Neuropathy, hereditary sensory, type IE | . | | | 145 | | |
HP:0004372 | HP:0001289 | Confusion | 1 | DNMT1 CL E G H | 1786 | 2976 | OMIM:614116 | Neuropathy, hereditary sensory, type IE | | | | 145 | | |
HP:0004372 | HP:0001262 | Excessive daytime somnolence | 1 | DOK7 CL E G H | 285489 | 26594 | ORPHA:994 | Fetal akinesia deformation sequence | HP:0040281 - Very frequent | | | 91 | | |
HP:0004372 | HP:0002329 | Drowsiness | 1 | DOK7 CL E G H | 285489 | 26594 | ORPHA:98913 | Postsynaptic congenital myasthenic syndromes | HP:0040283 - Occasional | | | 91 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | DPYD CL E G H | 1806 | 3012 | OMIM:274270 | Dihydropyrimidine dehydrogenase deficiency | . | | | 144 | | |
HP:0004372 | HP:0001262 | Excessive daytime somnolence | 1 | DPYS CL E G H | 1807 | 3013 | OMIM:222748 | Dihydropyrimidinuria | . | | | 44 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | DPYS CL E G H | 1807 | 3013 | OMIM:222748 | Dihydropyrimidinuria | . | | | 44 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | DUOX2 CL E G H | 50506 | 13273 | ORPHA:95716 | Familial thyroid dyshormonogenesis | HP:0040283 - Occasional | | | 121 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | DUOX2 CL E G H | 50506 | 13273 | ORPHA:226316 | Genetic transient congenital hypothyroidism | HP:0040283 - Occasional | | | 121 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | DUOXA2 CL E G H | 405753 | 32698 | ORPHA:95716 | Familial thyroid dyshormonogenesis | HP:0040283 - Occasional | | | 11 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | EIF2B1 CL E G H | 1967 | 3257 | OMIM:603896 | Leukoencephalopathy with vanishing white matter | . | | | 42 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | EIF2B2 CL E G H | 8892 | 3258 | OMIM:603896 | Leukoencephalopathy with vanishing white matter | . | | | 24 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | EIF2B3 CL E G H | 8891 | 3259 | OMIM:603896 | Leukoencephalopathy with vanishing white matter | . | | | 32 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | EIF2B4 CL E G H | 8890 | 3260 | OMIM:603896 | Leukoencephalopathy with vanishing white matter | . | | | 38 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | EIF2B5 CL E G H | 8893 | 3261 | OMIM:603896 | Leukoencephalopathy with vanishing white matter | . | | | 48 | | |
HP:0004372 | HP:0031358 | Vegetative state | 1 | EPM2A CL E G H | 7957 | 3413 | ORPHA:501 | Lafora disease | HP:0040283 - Occasional | | | 83 | | |
HP:0004372 | HP:0001289 | Confusion | 1 | EPM2A CL E G H | 7957 | 3413 | ORPHA:501 | Lafora disease | HP:0040282 - Frequent | | | 83 | | |
HP:0004372 | HP:0001289 | Confusion | 1 | ERAP1 CL E G H | 51752 | 18173 | ORPHA:117 | Behçet disease | HP:0040282 - Frequent | | | 1 | | |
HP:0004372 | HP:0001289 | Confusion | 1 | ERCC2 CL E G H | 2068 | 3434 | ORPHA:220295 | Xeroderma pigmentosum-Cockayne syndrome complex | HP:0040282 - Frequent | | | 106 | | |
HP:0004372 | HP:0001289 | Confusion | 1 | ERCC3 CL E G H | 2071 | 3435 | ORPHA:220295 | Xeroderma pigmentosum-Cockayne syndrome complex | HP:0040282 - Frequent | | | 54 | | |
HP:0004372 | HP:0001289 | Confusion | 1 | ERCC4 CL E G H | 2072 | 3436 | ORPHA:220295 | Xeroderma pigmentosum-Cockayne syndrome complex | HP:0040282 - Frequent | | | 158 | | |
HP:0004372 | HP:0001289 | Confusion | 1 | ERCC5 CL E G H | 2073 | 3437 | ORPHA:220295 | Xeroderma pigmentosum-Cockayne syndrome complex | HP:0040282 - Frequent | | | 83 | | |
HP:0004372 | HP:0001259 | Coma | 1 | ETFA CL E G H | 2108 | 3481 | OMIM:231680 | Multiple acyl-coa dehydrogenase deficiency | | | | 37 | | |
HP:0004372 | HP:0001259 | Coma | 1 | ETFB CL E G H | 2109 | 3482 | OMIM:231680 | Multiple acyl-coa dehydrogenase deficiency | | | | 27 | | |
HP:0004372 | HP:0001259 | Coma | 1 | ETFDH CL E G H | 2110 | 3483 | OMIM:231680 | Multiple acyl-coa dehydrogenase deficiency | | | | 77 | | |
HP:0004372 | HP:0001289 | Confusion | 1 | FAS CL E G H | 355 | 11920 | ORPHA:117 | Behçet disease | HP:0040282 - Frequent | | | 59 | | |
HP:0004372 | HP:0002329 | Drowsiness | 1 | FBP1 CL E G H | 2203 | 3606 | ORPHA:348 | Fructose-1,6-bisphosphatase deficiency | HP:0040283 - Occasional | | | 64 | | |
HP:0004372 | HP:0001259 | Coma | 1 | FBP1 CL E G H | 2203 | 3606 | ORPHA:348 | Fructose-1,6-bisphosphatase deficiency | HP:0040283 - Occasional | | | 64 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | FBP1 CL E G H | 2203 | 3606 | OMIM:229700 | Fructose-1,6-Bisphosphatase deficiency | . | | | 64 | | |
HP:0004372 | HP:0001262 | Excessive daytime somnolence | 1 | FBP1 CL E G H | 2203 | 3606 | ORPHA:348 | Fructose-1,6-bisphosphatase deficiency | HP:0040283 - Occasional | | | 64 | | |
HP:0004372 | HP:0001259 | Coma | 1 | FBP1 CL E G H | 2203 | 3606 | OMIM:229700 | Fructose-1,6-Bisphosphatase deficiency | . | | | 64 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | FGF8 CL E G H | 2253 | 3686 | ORPHA:93925 | Alobar holoprosencephaly | HP:0040282 - Frequent | | | 17 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | FGF8 CL E G H | 2253 | 3686 | ORPHA:93924 | Lobar holoprosencephaly | HP:0040283 - Occasional | | | 17 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | FGF8 CL E G H | 2253 | 3686 | ORPHA:93926 | Midline interhemispheric variant of holoprosencephaly | HP:0040282 - Frequent | | | 17 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | FGF8 CL E G H | 2253 | 3686 | ORPHA:220386 | Semilobar holoprosencephaly | HP:0040282 - Frequent | | | 17 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | FGFR1 CL E G H | 2260 | 3688 | ORPHA:93924 | Lobar holoprosencephaly | HP:0040283 - Occasional | | | 172 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | FGFR1 CL E G H | 2260 | 3688 | ORPHA:220386 | Semilobar holoprosencephaly | HP:0040282 - Frequent | | | 172 | | |
HP:0004372 | HP:0001289 | Confusion | 1 | FIG4 CL E G H | 9896 | 16873 | ORPHA:208441 | Bilateral parasagittal parieto-occipital polymicrogyria | | | | 111 | | |
HP:0004372 | HP:0001289 | Confusion | 1 | FIG4 CL E G H | 9896 | 16873 | OMIM:612691 | Polymicrogyria, bilateral temporooccipital | | | | 111 | | |
HP:0004372 | HP:0001262 | Excessive daytime somnolence | 1 | FKRP CL E G H | 79147 | 17997 | OMIM:236670 | Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 1 | . | | | 157 | | |
HP:0004372 | HP:0001262 | Excessive daytime somnolence | 1 | FKTN CL E G H | 2218 | 3622 | OMIM:236670 | Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 1 | . | | | 184 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | FOXH1 CL E G H | 8928 | 3814 | ORPHA:93925 | Alobar holoprosencephaly | HP:0040282 - Frequent | | | 48 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | FOXH1 CL E G H | 8928 | 3814 | ORPHA:93924 | Lobar holoprosencephaly | HP:0040283 - Occasional | | | 48 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | FOXH1 CL E G H | 8928 | 3814 | ORPHA:93926 | Midline interhemispheric variant of holoprosencephaly | HP:0040282 - Frequent | | | 48 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | FOXH1 CL E G H | 8928 | 3814 | ORPHA:220386 | Semilobar holoprosencephaly | HP:0040282 - Frequent | | | 48 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | FOXRED1 CL E G H | 55572 | 26927 | ORPHA:2609 | Isolated complex I deficiency | HP:0040281 - Very frequent | | | 61 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | GABRB2 CL E G H | 2561 | 4082 | OMIM:617829 | Epileptic encephalopathy, infantile or early childhood, 2 | . | | | 44 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | GALT CL E G H | 2592 | 4135 | ORPHA:79239 | Classic galactosemia | HP:0040283 - Occasional | | | 351 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | GAS1 CL E G H | 2619 | 4165 | ORPHA:93925 | Alobar holoprosencephaly | HP:0040282 - Frequent | | | 2 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | GAS1 CL E G H | 2619 | 4165 | ORPHA:93924 | Lobar holoprosencephaly | HP:0040283 - Occasional | | | 2 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | GAS1 CL E G H | 2619 | 4165 | ORPHA:93926 | Midline interhemispheric variant of holoprosencephaly | HP:0040282 - Frequent | | | 2 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | GAS1 CL E G H | 2619 | 4165 | ORPHA:220386 | Semilobar holoprosencephaly | HP:0040282 - Frequent | | | 2 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | GATA1 CL E G H | 2623 | 4170 | ORPHA:124 | Blackfan-Diamond anemia | HP:0040282 - Frequent | | | 29 | | |
HP:0004372 | HP:0007159 | Fluctuations in consciousness | 1 | GBA1 CL E G H | 2629 | 4177 | OMIM:127750 | Dementia, lewy body | . | | | | | |
HP:0004372 | HP:0007185 | Loss of consciousness | 1 | GCDH CL E G H | 2639 | 4189 | ORPHA:25 | Glutaryl-CoA dehydrogenase deficiency | HP:0040283 - Occasional | | | 115 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | GCH1 CL E G H | 2643 | 4193 | OMIM:233910 | Hyperphenylalaninemia, BH4-deficient, B | . | | | 86 | | |
HP:0004372 | HP:0001259 | Coma | 1 | GCK CL E G H | 2645 | 4195 | OMIM:602485 | Hyperinsulinemic hypoglycemia, familial, 3 | | | | 237 | | |
HP:0004372 | HP:0001259 | Coma | 1 | GCK CL E G H | 2645 | 4195 | ORPHA:79299 | Hyperinsulinism due to glucokinase deficiency | HP:0040283 - Occasional | | | 237 | | |
HP:0004372 | HP:0001259 | Coma | 1 | GCK CL E G H | 2645 | 4195 | ORPHA:99885 | Isolated permanent neonatal diabetes mellitus | HP:0040283 - Occasional | | | 237 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | GCSH CL E G H | 2653 | 4208 | OMIM:605899 | Glycine encephalopathy | . | | | 5 | | |
HP:0004372 | HP:0002329 | Drowsiness | 1 | GFAP CL E G H | 2670 | 4235 | OMIM:203450 | Alexander disease | | | | 188 | | |
HP:0004372 | HP:0001262 | Excessive daytime somnolence | 1 | GJB1 CL E G H | 2705 | 4283 | ORPHA:101075 | X-linked Charcot-Marie-Tooth disease type 1 | HP:0040283 - Occasional | | | 107 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | GK CL E G H | 2710 | 4289 | OMIM:307030 | Glycerol kinase deficiency | . | | | 13 | | |
HP:0004372 | HP:0001259 | Coma | 1 | GK CL E G H | 2710 | 4289 | OMIM:307030 | Glycerol kinase deficiency | . | | | 13 | | |
HP:0004372 | HP:0007185 | Loss of consciousness | 1 | GK CL E G H | 2710 | 4289 | OMIM:307030 | Glycerol kinase deficiency | . | | | 13 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | GLDC CL E G H | 2731 | 4313 | OMIM:605899 | Glycine encephalopathy | . | | | 166 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | GLI2 CL E G H | 2736 | 4318 | ORPHA:93925 | Alobar holoprosencephaly | HP:0040282 - Frequent | | | 173 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | GLI2 CL E G H | 2736 | 4318 | ORPHA:93924 | Lobar holoprosencephaly | HP:0040283 - Occasional | | | 173 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | GLI2 CL E G H | 2736 | 4318 | ORPHA:93926 | Midline interhemispheric variant of holoprosencephaly | HP:0040282 - Frequent | | | 173 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | GLI2 CL E G H | 2736 | 4318 | ORPHA:220386 | Semilobar holoprosencephaly | HP:0040282 - Frequent | | | 173 | | |
HP:0004372 | HP:0001259 | Coma | 1 | GLUD1 CL E G H | 2746 | 4335 | OMIM:606762 | Hyperinsulinemic hypoglycemia, familial, 6 | | | | 56 | | |
HP:0004372 | HP:0007185 | Loss of consciousness | 1 | GLYCTK CL E G H | 132158 | 24247 | ORPHA:941 | D-glyceric aciduria | HP:0040283 - Occasional | | | 6 | | |
HP:0004372 | HP:0001289 | Confusion | 1 | GNAS CL E G H | 2778 | 4392 | ORPHA:79443 | Pseudohypoparathyroidism type 1A | HP:0040283 - Occasional | | | 101 | | |
HP:0004372 | HP:0001289 | Confusion | 1 | GNAS CL E G H | 2778 | 4392 | ORPHA:79444 | Pseudohypoparathyroidism type 1C | HP:0040283 - Occasional | | | 101 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | GUF1 CL E G H | 60558 | 25799 | OMIM:617065 | Epileptic encephalopathy, early infantile, 40 | | | | 2 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | GYS2 CL E G H | 2998 | 4707 | ORPHA:2089 | Glycogen storage disease due to hepatic glycogen synthase deficiency | HP:0040283 - Occasional | | | 100 | | |
HP:0004372 | HP:0001259 | Coma | 1 | HADH CL E G H | 3033 | 4799 | OMIM:609975 | Hyperinsulinemic hypoglycemia, familial, 4 | | | | 41 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | HADH CL E G H | 3033 | 4799 | ORPHA:71212 | Hyperinsulinism due to short chain 3-hydroxylacyl-CoA dehydrogenase deficiency | HP:0040281 - Very frequent | | | 41 | | |
HP:0004372 | HP:0001289 | Confusion | 1 | HADH CL E G H | 3033 | 4799 | ORPHA:71212 | Hyperinsulinism due to short chain 3-hydroxylacyl-CoA dehydrogenase deficiency | HP:0040281 - Very frequent | | | 41 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | HADHA CL E G H | 3030 | 4801 | OMIM:609015 | Mitochondrial trifunctional protein deficiency | | | | 99 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | HADHA CL E G H | 3030 | 4801 | ORPHA:746 | Mitochondrial trifunctional protein deficiency | HP:0040282 - Frequent | | | 99 | | |
HP:0004372 | HP:0001259 | Coma | 1 | HADHA CL E G H | 3030 | 4801 | ORPHA:746 | Mitochondrial trifunctional protein deficiency | HP:0040283 - Occasional | | | 99 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | HADHB CL E G H | 3032 | 4803 | OMIM:609015 | Mitochondrial trifunctional protein deficiency | | | | 60 | | |
HP:0004372 | HP:0001259 | Coma | 1 | HADHB CL E G H | 3032 | 4803 | ORPHA:746 | Mitochondrial trifunctional protein deficiency | HP:0040283 - Occasional | | | 60 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | HADHB CL E G H | 3032 | 4803 | ORPHA:746 | Mitochondrial trifunctional protein deficiency | HP:0040282 - Frequent | | | 60 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | HAMP CL E G H | 57817 | 15598 | ORPHA:79230 | Hemochromatosis type 2 | HP:0040282 - Frequent | | | 15 | | |
HP:0004372 | HP:0002329 | Drowsiness | 1 | HCRT CL E G H | 3060 | 4847 | OMIM:161400 | Narcolepsy 1 | | | | 1 | | |
HP:0004372 | HP:0001262 | Excessive daytime somnolence | 1 | HCRT CL E G H | 3060 | 4847 | OMIM:161400 | Narcolepsy 1 | . | | | 1 | | |
HP:0004372 | HP:0001262 | Excessive daytime somnolence | 1 | HCRT CL E G H | 3060 | 4847 | ORPHA:2073 | Narcolepsy type 1 | HP:0040281 - Very frequent | | | 1 | | |
HP:0004372 | HP:0001262 | Excessive daytime somnolence | 1 | HCRT CL E G H | 3060 | 4847 | ORPHA:83465 | Narcolepsy type 2 | HP:0040281 - Very frequent | | | 1 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | HESX1 CL E G H | 8820 | 4877 | ORPHA:226307 | Hypothyroidism due to deficient transcription factors involved in pituitary development or function | HP:0040282 - Frequent | | | 21 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | HFE CL E G H | 3077 | 4886 | ORPHA:465508 | Symptomatic form of hemochromatosis type 1 | HP:0040283 - Occasional | | | 38 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | HJV CL E G H | 148738 | 4887 | ORPHA:79230 | Hemochromatosis type 2 | HP:0040282 - Frequent | | | | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | HJV CL E G H | 148738 | 4887 | OMIM:602390 | Hemochromatosis, type 2A | . | | | | | |
HP:0004372 | HP:0001289 | Confusion | 1 | HLA-B CL E G H | 3106 | 4932 | ORPHA:117 | Behçet disease | HP:0040282 - Frequent | | | 4 | | |
HP:0004372 | HP:0001289 | Confusion | 1 | HLA-DQB1 CL E G H | 3119 | 4944 | OMIM:123400 | Creutzfeldt-Jakob disease | . | | | | | |
HP:0004372 | HP:0001262 | Excessive daytime somnolence | 1 | HLA-DQB1 CL E G H | 3119 | 4944 | ORPHA:2073 | Narcolepsy type 1 | HP:0040281 - Very frequent | | | | | |
HP:0004372 | HP:0001262 | Excessive daytime somnolence | 1 | HLA-DQB1 CL E G H | 3119 | 4944 | ORPHA:83465 | Narcolepsy type 2 | HP:0040281 - Very frequent | | | | | |
HP:0004372 | HP:0001262 | Excessive daytime somnolence | 1 | HLA-DRB1 CL E G H | 3123 | 4948 | ORPHA:2073 | Narcolepsy type 1 | HP:0040281 - Very frequent | | | 2 | | |
HP:0004372 | HP:0001262 | Excessive daytime somnolence | 1 | HLA-DRB1 CL E G H | 3123 | 4948 | ORPHA:83465 | Narcolepsy type 2 | HP:0040281 - Very frequent | | | 2 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | HLCS CL E G H | 3141 | 4976 | ORPHA:79242 | Holocarboxylase synthetase deficiency | HP:0040283 - Occasional | | | 148 | | |
HP:0004372 | HP:0001259 | Coma | 1 | HLCS CL E G H | 3141 | 4976 | OMIM:253270 | Holocarboxylase synthetase deficiency | . | | | 148 | | |
HP:0004372 | HP:0001259 | Coma | 1 | HLCS CL E G H | 3141 | 4976 | ORPHA:79242 | Holocarboxylase synthetase deficiency | HP:0040283 - Occasional | | | 148 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | HLCS CL E G H | 3141 | 4976 | OMIM:253270 | Holocarboxylase synthetase deficiency | . | | | 148 | | |
HP:0004372 | HP:0001289 | Confusion | 1 | HMBS CL E G H | 3145 | 4982 | ORPHA:79276 | Acute intermittent porphyria | HP:0040283 - Occasional | | | 81 | | |
HP:0004372 | HP:0001262 | Excessive daytime somnolence | 1 | HMBS CL E G H | 3145 | 4982 | ORPHA:79276 | Acute intermittent porphyria | HP:0040283 - Occasional | | | 81 | | |
HP:0004372 | HP:0001259 | Coma | 1 | HMBS CL E G H | 3145 | 4982 | ORPHA:79276 | Acute intermittent porphyria | HP:0040284 - Very rare | | | 81 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | HMGCL CL E G H | 3155 | 5005 | ORPHA:20 | 3-hydroxy-3-methylglutaric aciduria | HP:0040282 - Frequent | | | 35 | | |
HP:0004372 | HP:0001259 | Coma | 1 | HMGCL CL E G H | 3155 | 5005 | ORPHA:20 | 3-hydroxy-3-methylglutaric aciduria | HP:0040283 - Occasional | | | 35 | | |
HP:0004372 | HP:0001259 | Coma | 1 | HMGCL CL E G H | 3155 | 5005 | OMIM:246450 | 3-Hydroxy-3-Methylglutaryl-Coa lyase deficiency | . | | | 35 | | |
HP:0004372 | HP:0001262 | Excessive daytime somnolence | 1 | HMGCL CL E G H | 3155 | 5005 | OMIM:246450 | 3-Hydroxy-3-Methylglutaryl-Coa lyase deficiency | . | | | 35 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | HNF1A CL E G H | 6927 | 11621 | ORPHA:324575 | Hyperinsulinism due to HNF1A deficiency | HP:0040283 - Occasional | | | 161 | | |
HP:0004372 | HP:0007185 | Loss of consciousness | 1 | HNF1A CL E G H | 6927 | 11621 | ORPHA:324575 | Hyperinsulinism due to HNF1A deficiency | HP:0040283 - Occasional | | | 161 | | |
HP:0004372 | HP:0001259 | Coma | 1 | HNF1A CL E G H | 6927 | 11621 | ORPHA:324575 | Hyperinsulinism due to HNF1A deficiency | | | | 161 | | |
HP:0004372 | HP:0002329 | Drowsiness | 1 | HNF1A CL E G H | 6927 | 11621 | ORPHA:324575 | Hyperinsulinism due to HNF1A deficiency | HP:0040282 - Frequent | | | 161 | | |
HP:0004372 | HP:0001259 | Coma | 1 | HNF4A CL E G H | 3172 | 5024 | ORPHA:263455 | Hyperinsulinism due to HNF4A deficiency | HP:0040281 - Very frequent | | | 138 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | HNF4A CL E G H | 3172 | 5024 | ORPHA:263455 | Hyperinsulinism due to HNF4A deficiency | HP:0040281 - Very frequent | | | 138 | | |
HP:0004372 | HP:0002329 | Drowsiness | 1 | HNF4A CL E G H | 3172 | 5024 | ORPHA:263455 | Hyperinsulinism due to HNF4A deficiency | HP:0040281 - Very frequent | | | 138 | | |
HP:0004372 | HP:0001262 | Excessive daytime somnolence | 1 | HTT CL E G H | 3064 | 4851 | ORPHA:399 | Huntington disease | HP:0040283 - Occasional | | | 12 | | |
HP:0004372 | HP:0001289 | Confusion | 1 | IFNGR1 CL E G H | 3459 | 5439 | ORPHA:117 | Behçet disease | HP:0040282 - Frequent | | | 60 | | |
HP:0004372 | HP:0001289 | Confusion | 1 | IL10 CL E G H | 3586 | 5962 | ORPHA:117 | Behçet disease | HP:0040282 - Frequent | | | 2 | | |
HP:0004372 | HP:0001289 | Confusion | 1 | IL12A CL E G H | 3592 | 5969 | ORPHA:117 | Behçet disease | HP:0040282 - Frequent | | | | | |
HP:0004372 | HP:0001262 | Excessive daytime somnolence | 1 | IL12A CL E G H | 3592 | 5969 | ORPHA:186 | Primary biliary cholangitis | HP:0040283 - Occasional | | | | | |
HP:0004372 | HP:0001289 | Confusion | 1 | IL12A-AS1 CL E G H | 101928376 | 49094 | ORPHA:117 | Behçet disease | HP:0040282 - Frequent | | | | | |
HP:0004372 | HP:0001262 | Excessive daytime somnolence | 1 | IL12RB1 CL E G H | 3594 | 5971 | ORPHA:186 | Primary biliary cholangitis | HP:0040283 - Occasional | | | 46 | | |
HP:0004372 | HP:0001259 | Coma | 1 | IL18BP CL E G H | 10068 | 5987 | OMIM:618549 | HEPATITIS, FULMINANT VIRAL, SUSCEPTIBILITY TO; FVH | | | | | | |
HP:0004372 | HP:0001289 | Confusion | 1 | IL23R CL E G H | 149233 | 19100 | ORPHA:117 | Behçet disease | HP:0040282 - Frequent | | | 1 | | |
HP:0004372 | HP:0001259 | Coma | 1 | INS CL E G H | 3630 | 6081 | ORPHA:99885 | Isolated permanent neonatal diabetes mellitus | HP:0040283 - Occasional | | | 62 | | |
HP:0004372 | HP:0001259 | Coma | 1 | INSR CL E G H | 3643 | 6091 | OMIM:609968 | Hyperinsulinemic hypoglycemia, familial, 5 | | | | 229 | | |
HP:0004372 | HP:0001259 | Coma | 1 | INSR CL E G H | 3643 | 6091 | ORPHA:263458 | Hyperinsulinism due to INSR deficiency | HP:0040283 - Occasional | | | 229 | | |
HP:0004372 | HP:0001262 | Excessive daytime somnolence | 1 | IRF5 CL E G H | 3663 | 6120 | ORPHA:186 | Primary biliary cholangitis | HP:0040283 - Occasional | | | 4 | | |
HP:0004372 | HP:0031358 | Vegetative state | 1 | ISCA2 CL E G H | 122961 | 19857 | OMIM:616370 | Multiple mitochondrial dysfunctions syndrome 4 | . | | | 7 | | |
HP:0004372 | HP:0001259 | Coma | 1 | IVD CL E G H | 3712 | 6186 | OMIM:243500 | Isovaleric acidemia | . | | | 105 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | IVD CL E G H | 3712 | 6186 | OMIM:243500 | Isovaleric acidemia | . | | | 105 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | IYD CL E G H | 389434 | 21071 | ORPHA:95716 | Familial thyroid dyshormonogenesis | HP:0040283 - Occasional | | | 130 | | |
HP:0004372 | HP:0007185 | Loss of consciousness | 1 | KCNE1 CL E G H | 3753 | 6240 | ORPHA:90647 | Jervell and Lange-Nielsen syndrome | HP:0040282 - Frequent | | | 148 | | |
HP:0004372 | HP:0002329 | Drowsiness | 1 | KCNJ11 CL E G H | 3767 | 6257 | ORPHA:276580 | Autosomal dominant hyperinsulinism due to Kir6.2 deficiency | HP:0040282 - Frequent | | | 127 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | KCNJ11 CL E G H | 3767 | 6257 | ORPHA:276580 | Autosomal dominant hyperinsulinism due to Kir6.2 deficiency | HP:0040283 - Occasional | | | 127 | | |
HP:0004372 | HP:0007185 | Loss of consciousness | 1 | KCNJ11 CL E G H | 3767 | 6257 | ORPHA:276580 | Autosomal dominant hyperinsulinism due to Kir6.2 deficiency | HP:0040283 - Occasional | | | 127 | | |
HP:0004372 | HP:0001259 | Coma | 1 | KCNJ11 CL E G H | 3767 | 6257 | ORPHA:276580 | Autosomal dominant hyperinsulinism due to Kir6.2 deficiency | | | | 127 | | |
HP:0004372 | HP:0001259 | Coma | 1 | KCNJ11 CL E G H | 3767 | 6257 | ORPHA:99885 | Isolated permanent neonatal diabetes mellitus | HP:0040283 - Occasional | | | 127 | | |
HP:0004372 | HP:0007185 | Loss of consciousness | 1 | KCNQ1 CL E G H | 3784 | 6294 | ORPHA:90647 | Jervell and Lange-Nielsen syndrome | HP:0040282 - Frequent | | | 730 | | |
HP:0004372 | HP:0002329 | Drowsiness | 1 | KIF1A CL E G H | 547 | 888 | ORPHA:2836 | PEHO syndrome | HP:0040281 - Very frequent | | | 276 | | |
HP:0004372 | HP:0001289 | Confusion | 1 | KLRC4 CL E G H | 8302 | 6377 | ORPHA:117 | Behçet disease | HP:0040282 - Frequent | | | | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | KRT18 CL E G H | 3875 | 6430 | OMIM:215600 | Cirrhosis, familial | . | | | 19 | | |
HP:0004372 | HP:0001259 | Coma | 1 | KYNU CL E G H | 8942 | 6469 | ORPHA:79155 | Hydroxykynureninuria | HP:0040283 - Occasional | | | 5 | | |
HP:0004372 | HP:0001262 | Excessive daytime somnolence | 1 | LARGE1 CL E G H | 9215 | 6511 | OMIM:236670 | Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 1 | . | | | 136 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | LHX3 CL E G H | 8022 | 6595 | ORPHA:226307 | Hypothyroidism due to deficient transcription factors involved in pituitary development or function | HP:0040282 - Frequent | | | 51 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | LHX4 CL E G H | 89884 | 21734 | ORPHA:226307 | Hypothyroidism due to deficient transcription factors involved in pituitary development or function | HP:0040282 - Frequent | | | 43 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | LMBRD1 CL E G H | 55788 | 23038 | ORPHA:79284 | Methylmalonic acidemia with homocystinuria type cblF | HP:0040282 - Frequent | | | 46 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | LMBRD1 CL E G H | 55788 | 23038 | OMIM:277380 | Methylmalonic aciduria and homocystinuria, Cblf type | . | | | 46 | | |
HP:0004372 | HP:0002329 | Drowsiness | 1 | LONP1 CL E G H | 9361 | 9479 | ORPHA:79243 | Pyruvate dehydrogenase E1-alpha deficiency | HP:0040283 - Occasional | | | 8 | | |
HP:0004372 | HP:0002329 | Drowsiness | 1 | LRP4 CL E G H | 4038 | 6696 | ORPHA:98913 | Postsynaptic congenital myasthenic syndromes | HP:0040283 - Occasional | | | 124 | | |
HP:0004372 | HP:0001259 | Coma | 1 | LYRM7 CL E G H | 90624 | 28072 | OMIM:615838 | Mitochondrial complex III deficiency, nuclear type 8 | | | | 10 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | LYRM7 CL E G H | 90624 | 28072 | OMIM:615838 | Mitochondrial complex III deficiency, nuclear type 8 | . | | | 10 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | MAGEL2 CL E G H | 54551 | 6814 | ORPHA:398069 | MAGEL2-related Prader-Willi-like syndrome | HP:0040283 - Occasional | | | 63 | | |
HP:0004372 | HP:0001289 | Confusion | 1 | MAN2B1 CL E G H | 4125 | 6826 | ORPHA:309288 | Alpha-mannosidosis, adult form | HP:0040283 - Occasional | | | 136 | | |
HP:0004372 | HP:0002329 | Drowsiness | 1 | MAN2B1 CL E G H | 4125 | 6826 | ORPHA:309288 | Alpha-mannosidosis, adult form | HP:0040283 - Occasional | | | 136 | | |
HP:0004372 | HP:0001289 | Confusion | 1 | MAN2B1 CL E G H | 4125 | 6826 | ORPHA:309282 | Alpha-mannosidosis, infantile form | HP:0040283 - Occasional | | | 136 | | |
HP:0004372 | HP:0002329 | Drowsiness | 1 | MAN2B1 CL E G H | 4125 | 6826 | ORPHA:309282 | Alpha-mannosidosis, infantile form | HP:0040283 - Occasional | | | 136 | | |
HP:0004372 | HP:0001259 | Coma | 1 | MC2R CL E G H | 4158 | 6930 | ORPHA:361 | Familial glucocorticoid deficiency | | | | 94 | | |
HP:0004372 | HP:0001259 | Coma | 1 | MC2R CL E G H | 4158 | 6930 | OMIM:202200 | Glucocorticoid deficiency 1 | . | | | 94 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | MCCC1 CL E G H | 56922 | 6936 | OMIM:210200 | 3-Methylcrotonyl-CoA carboxylase 1 deficiency | . | | | 81 | | |
HP:0004372 | HP:0001259 | Coma | 1 | MCCC1 CL E G H | 56922 | 6936 | OMIM:210200 | 3-Methylcrotonyl-CoA carboxylase 1 deficiency | . | | | 81 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | MCCC2 CL E G H | 64087 | 6937 | OMIM:210210 | 3-Methylcrotonyl-CoA carboxylase 2 deficiency | . | | | 77 | | |
HP:0004372 | HP:0001259 | Coma | 1 | MCCC2 CL E G H | 64087 | 6937 | OMIM:210210 | 3-Methylcrotonyl-CoA carboxylase 2 deficiency | . | | | 77 | | |
HP:0004372 | HP:0001289 | Confusion | 1 | MEFV CL E G H | 4210 | 6998 | ORPHA:117 | Behçet disease | HP:0040282 - Frequent | | | 281 | | |
HP:0004372 | HP:0001259 | Coma | 1 | MEN1 CL E G H | 4221 | 7010 | ORPHA:97279 | Insulinoma | HP:0040283 - Occasional | | | 462 | | |
HP:0004372 | HP:0007159 | Fluctuations in consciousness | 1 | MEN1 CL E G H | 4221 | 7010 | ORPHA:97279 | Insulinoma | HP:0040282 - Frequent | | | 462 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | MEN1 CL E G H | 4221 | 7010 | ORPHA:97279 | Insulinoma | HP:0040283 - Occasional | | | 462 | | |
HP:0004372 | HP:0001259 | Coma | 1 | MEN1 CL E G H | 4221 | 7010 | ORPHA:652 | Multiple endocrine neoplasia type 1 | HP:0040284 - Very rare | | | 462 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | MEN1 CL E G H | 4221 | 7010 | ORPHA:652 | Multiple endocrine neoplasia type 1 | HP:0040283 - Occasional | | | 462 | | |
HP:0004372 | HP:0032044 | Decreased vigilance | 1 | MEN1 CL E G H | 4221 | 7010 | ORPHA:652 | Multiple endocrine neoplasia type 1 | HP:0040283 - Occasional | | | 462 | | |
HP:0004372 | HP:0001289 | Confusion | 1 | MEN1 CL E G H | 4221 | 7010 | ORPHA:652 | Multiple endocrine neoplasia type 1 | HP:0040283 - Occasional | | | 462 | | |
HP:0004372 | HP:0001259 | Coma | 1 | MMAA CL E G H | 166785 | 18871 | OMIM:251100 | Methylmalonic aciduria, Cbla type | . | | | 113 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | MMAA CL E G H | 166785 | 18871 | OMIM:251100 | Methylmalonic aciduria, Cbla type | . | | | 113 | | |
HP:0004372 | HP:0001259 | Coma | 1 | MMAB CL E G H | 326625 | 19331 | OMIM:251110 | Methylmalonic aciduria, Cblb type | . | | | 127 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | MMAB CL E G H | 326625 | 19331 | OMIM:251110 | Methylmalonic aciduria, Cblb type | . | | | 127 | | |
HP:0004372 | HP:0001289 | Confusion | 1 | MMACHC CL E G H | 25974 | 24525 | ORPHA:79282 | Methylmalonic acidemia with homocystinuria, type cblC | | | | 101 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | MMACHC CL E G H | 25974 | 24525 | ORPHA:79282 | Methylmalonic acidemia with homocystinuria, type cblC | HP:0040283 - Occasional | | | 101 | | |
HP:0004372 | HP:0001289 | Confusion | 1 | MMACHC CL E G H | 25974 | 24525 | OMIM:277400 | Methylmalonic aciduria and homocystinuria, Cblc type | . | | | 101 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | MMACHC CL E G H | 25974 | 24525 | OMIM:277400 | Methylmalonic aciduria and homocystinuria, Cblc type | . | | | 101 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | MMADHC CL E G H | 27249 | 25221 | ORPHA:79283 | Methylmalonic acidemia with homocystinuria, type cblD | HP:0040281 - Very frequent | | | 50 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | MMADHC CL E G H | 27249 | 25221 | OMIM:277410 | Methylmalonic aciduria and homocystinuria, Cbld type | . | | | 50 | | |
HP:0004372 | HP:0001262 | Excessive daytime somnolence | 1 | MMEL1 CL E G H | 79258 | 14668 | ORPHA:186 | Primary biliary cholangitis | HP:0040283 - Occasional | | | | | |
HP:0004372 | HP:0001259 | Coma | 1 | MMUT CL E G H | 4594 | 7526 | OMIM:251000 | Methylmalonic aciduria due to methylmalonyl-coa mutase deficiency | . | | | | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | MMUT CL E G H | 4594 | 7526 | OMIM:251000 | Methylmalonic aciduria due to methylmalonyl-coa mutase deficiency | . | | | | | |
HP:0004372 | HP:0001259 | Coma | 1 | MMUT CL E G H | 4594 | 7526 | ORPHA:79312 | Vitamin B12-unresponsive methylmalonic acidemia type mut- | HP:0040281 - Very frequent | | | | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | MMUT CL E G H | 4594 | 7526 | ORPHA:79312 | Vitamin B12-unresponsive methylmalonic acidemia type mut- | HP:0040281 - Very frequent | | | | | |
HP:0004372 | HP:0001259 | Coma | 1 | MMUT CL E G H | 4594 | 7526 | ORPHA:289916 | Vitamin B12-unresponsive methylmalonic acidemia type mut0 | HP:0040281 - Very frequent | | | | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | MMUT CL E G H | 4594 | 7526 | ORPHA:289916 | Vitamin B12-unresponsive methylmalonic acidemia type mut0 | HP:0040281 - Very frequent | | | | | |
HP:0004372 | HP:0001262 | Excessive daytime somnolence | 1 | MOG CL E G H | 4340 | 7197 | OMIM:614250 | Narcolepsy 7 | . | | | 1 | | |
HP:0004372 | HP:0001262 | Excessive daytime somnolence | 1 | MOG CL E G H | 4340 | 7197 | ORPHA:2073 | Narcolepsy type 1 | HP:0040281 - Very frequent | | | 1 | | |
HP:0004372 | HP:0001259 | Coma | 1 | MRAP CL E G H | 56246 | 1304 | ORPHA:361 | Familial glucocorticoid deficiency | | | | 26 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | MRPS16 CL E G H | 51021 | 14048 | OMIM:610498 | Combined oxidative phosphorylation deficiency 2 | . | | | 60 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | MTHFR CL E G H | 4524 | 7436 | ORPHA:395 | Homocystinuria due to methylene tetrahydrofolate reductase deficiency | HP:0040283 - Occasional | | | 183 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | MTRR CL E G H | 4552 | 7473 | OMIM:236270 | Homocystinuria-megaloblastic anemia, cbl E type | . | | | 88 | | |
HP:0004372 | HP:0002329 | Drowsiness | 1 | MTRR CL E G H | 4552 | 7473 | ORPHA:2169 | Methylcobalamin deficiency type cblE | HP:0040282 - Frequent | | | 88 | | |
HP:0004372 | HP:0007185 | Loss of consciousness | 1 | MTRR CL E G H | 4552 | 7473 | ORPHA:2169 | Methylcobalamin deficiency type cblE | HP:0040282 - Frequent | | | 88 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | MTRR CL E G H | 4552 | 7473 | ORPHA:2169 | Methylcobalamin deficiency type cblE | HP:0040283 - Occasional | | | 88 | | |
HP:0004372 | HP:0001262 | Excessive daytime somnolence | 1 | MTRR CL E G H | 4552 | 7473 | ORPHA:2169 | Methylcobalamin deficiency type cblE | HP:0040283 - Occasional | | | 88 | | |
HP:0004372 | HP:0001262 | Excessive daytime somnolence | 1 | MUSK CL E G H | 4593 | 7525 | ORPHA:994 | Fetal akinesia deformation sequence | HP:0040281 - Very frequent | | | 72 | | |
HP:0004372 | HP:0002329 | Drowsiness | 1 | MUSK CL E G H | 4593 | 7525 | ORPHA:98913 | Postsynaptic congenital myasthenic syndromes | HP:0040283 - Occasional | | | 72 | | |
HP:0004372 | HP:0001262 | Excessive daytime somnolence | 1 | MYOD1 CL E G H | 4654 | 7611 | ORPHA:994 | Fetal akinesia deformation sequence | HP:0040281 - Very frequent | | | | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | NAA10 CL E G H | 8260 | 18704 | ORPHA:276432 | Ogden syndrome | HP:0040283 - Occasional | | | 23 | | |
HP:0004372 | HP:0001262 | Excessive daytime somnolence | 1 | NAA10 CL E G H | 8260 | 18704 | ORPHA:276432 | Ogden syndrome | HP:0040282 - Frequent | | | 23 | | |
HP:0004372 | HP:0007185 | Loss of consciousness | 1 | NAB2 CL E G H | 4665 | 7627 | ORPHA:2126 | Solitary fibrous tumor/hemangiopericytoma | HP:0040284 - Very rare | | | | | |
HP:0004372 | HP:0007185 | Loss of consciousness | 1 | NAGS CL E G H | 162417 | 17996 | ORPHA:927 | Hyperammonemia due to N-acetylglutamate synthase deficiency | HP:0040283 - Occasional | | | 36 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | NAGS CL E G H | 162417 | 17996 | ORPHA:927 | Hyperammonemia due to N-acetylglutamate synthase deficiency | HP:0040283 - Occasional | | | 36 | | |
HP:0004372 | HP:0002329 | Drowsiness | 1 | NAGS CL E G H | 162417 | 17996 | ORPHA:927 | Hyperammonemia due to N-acetylglutamate synthase deficiency | HP:0040283 - Occasional | | | 36 | | |
HP:0004372 | HP:0001289 | Confusion | 1 | NAGS CL E G H | 162417 | 17996 | ORPHA:927 | Hyperammonemia due to N-acetylglutamate synthase deficiency | HP:0040283 - Occasional | | | 36 | | |
HP:0004372 | HP:0001259 | Coma | 1 | NAGS CL E G H | 162417 | 17996 | ORPHA:927 | Hyperammonemia due to N-acetylglutamate synthase deficiency | HP:0040283 - Occasional | | | 36 | | |
HP:0004372 | HP:0001289 | Confusion | 1 | NAGS CL E G H | 162417 | 17996 | OMIM:237310 | N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY | . | | | 36 | | |
HP:0004372 | HP:0001259 | Coma | 1 | NAGS CL E G H | 162417 | 17996 | OMIM:237310 | N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY | . | | | 36 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | NAGS CL E G H | 162417 | 17996 | OMIM:237310 | N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY | . | | | 36 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | NAXD CL E G H | 55739 | 25576 | OMIM:618321 | Encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy, 2 | . | | | | | |
HP:0004372 | HP:0001259 | Coma | 1 | NAXE CL E G H | 128240 | 18453 | OMIM:617186 | Encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy, 1 | . | | | 9 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | NBAS CL E G H | 51594 | 15625 | OMIM:616483 | INFANTILE LIVER FAILURE SYNDROME 2; ILFS2 | | | | 25 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | ND1 CL E G H | 4535 | 7455 | ORPHA:2609 | Isolated complex I deficiency | HP:0040281 - Very frequent | | | | | |
HP:0004372 | HP:0007159 | Fluctuations in consciousness | 1 | ND1 CL E G H | 4535 | 7455 | ORPHA:550 | MELAS | HP:0040282 - Frequent | | | | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | ND2 CL E G H | 4536 | 7456 | ORPHA:2609 | Isolated complex I deficiency | HP:0040281 - Very frequent | | | | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | ND3 CL E G H | 4537 | 7458 | ORPHA:2609 | Isolated complex I deficiency | HP:0040281 - Very frequent | | | | | |
HP:0004372 | HP:0007159 | Fluctuations in consciousness | 1 | ND4 CL E G H | 4538 | 7459 | ORPHA:550 | MELAS | HP:0040282 - Frequent | | | | | |
HP:0004372 | HP:0007159 | Fluctuations in consciousness | 1 | ND5 CL E G H | 4540 | 7461 | ORPHA:550 | MELAS | HP:0040282 - Frequent | | | | | |
HP:0004372 | HP:0007159 | Fluctuations in consciousness | 1 | ND6 CL E G H | 4541 | 7462 | ORPHA:550 | MELAS | HP:0040282 - Frequent | | | | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | NDE1 CL E G H | 54820 | 17619 | ORPHA:2177 | Hydranencephaly | HP:0040282 - Frequent | | | 96 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | NDUFA1 CL E G H | 4694 | 7683 | ORPHA:2609 | Isolated complex I deficiency | HP:0040281 - Very frequent | | | 7 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | NDUFA11 CL E G H | 126328 | 20371 | ORPHA:2609 | Isolated complex I deficiency | HP:0040281 - Very frequent | | | 32 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | NDUFA6 CL E G H | 4700 | 7690 | ORPHA:2609 | Isolated complex I deficiency | HP:0040281 - Very frequent | | | 1 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | NDUFAF1 CL E G H | 51103 | 18828 | ORPHA:2609 | Isolated complex I deficiency | HP:0040281 - Very frequent | | | 40 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | NDUFAF2 CL E G H | 91942 | 28086 | ORPHA:2609 | Isolated complex I deficiency | HP:0040281 - Very frequent | | | 26 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | NDUFAF3 CL E G H | 25915 | 29918 | ORPHA:2609 | Isolated complex I deficiency | HP:0040281 - Very frequent | | | 31 | | |
HP:0004372 | HP:0007159 | Fluctuations in consciousness | 1 | NDUFAF3 CL E G H | 25915 | 29918 | ORPHA:70474 | Leigh syndrome with cardiomyopathy | HP:0040282 - Frequent | | | 31 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | NDUFAF4 CL E G H | 29078 | 21034 | ORPHA:2609 | Isolated complex I deficiency | HP:0040281 - Very frequent | | | 50 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | NDUFAF5 CL E G H | 79133 | 15899 | ORPHA:2609 | Isolated complex I deficiency | HP:0040281 - Very frequent | | | 34 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | NDUFAF8 CL E G H | 284184 | 33551 | ORPHA:2609 | Isolated complex I deficiency | HP:0040281 - Very frequent | | | | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | NDUFB10 CL E G H | 4716 | 7696 | ORPHA:2609 | Isolated complex I deficiency | HP:0040281 - Very frequent | | | | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | NDUFB11 CL E G H | 54539 | 20372 | ORPHA:2609 | Isolated complex I deficiency | HP:0040281 - Very frequent | | | 3 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | NDUFB3 CL E G H | 4709 | 7698 | ORPHA:2609 | Isolated complex I deficiency | HP:0040281 - Very frequent | | | 9 | | |
HP:0004372 | HP:0007159 | Fluctuations in consciousness | 1 | NDUFB8 CL E G H | 4714 | 7703 | ORPHA:70474 | Leigh syndrome with cardiomyopathy | HP:0040282 - Frequent | | | | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | NDUFB9 CL E G H | 4715 | 7704 | ORPHA:2609 | Isolated complex I deficiency | HP:0040281 - Very frequent | | | 16 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | NDUFS1 CL E G H | 4719 | 7707 | ORPHA:2609 | Isolated complex I deficiency | HP:0040281 - Very frequent | | | 81 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | NDUFS1 CL E G H | 4719 | 7707 | OMIM:618226 | Mitochondrial complex I deficiency, nuclear type 5 | . | | | 81 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | NDUFS2 CL E G H | 4720 | 7708 | ORPHA:2609 | Isolated complex I deficiency | HP:0040281 - Very frequent | | | 65 | | |
HP:0004372 | HP:0007159 | Fluctuations in consciousness | 1 | NDUFS2 CL E G H | 4720 | 7708 | ORPHA:70474 | Leigh syndrome with cardiomyopathy | HP:0040282 - Frequent | | | 65 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | NDUFS2 CL E G H | 4720 | 7708 | OMIM:618228 | Mitochondrial complex I deficiency, nuclear type 6 | . | | | 65 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | NDUFS3 CL E G H | 4722 | 7710 | ORPHA:2609 | Isolated complex I deficiency | HP:0040281 - Very frequent | | | 22 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | NDUFS4 CL E G H | 4724 | 7711 | ORPHA:2609 | Isolated complex I deficiency | HP:0040281 - Very frequent | | | 27 | | |
HP:0004372 | HP:0001259 | Coma | 1 | NDUFS4 CL E G H | 4724 | 7711 | OMIM:252010 | Mitochondrial complex I deficiency, nuclear type 1 | . | | | 27 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | NDUFS4 CL E G H | 4724 | 7711 | OMIM:252010 | Mitochondrial complex I deficiency, nuclear type 1 | | | | 27 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | NDUFS6 CL E G H | 4726 | 7713 | ORPHA:2609 | Isolated complex I deficiency | HP:0040281 - Very frequent | | | 21 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | NDUFS6 CL E G H | 4726 | 7713 | OMIM:618232 | Mitochondrial complex I deficiency, nuclear type 9 | . | | | 21 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | NDUFS7 CL E G H | 374291 | 7714 | ORPHA:2609 | Isolated complex I deficiency | HP:0040281 - Very frequent | | | 38 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | NDUFS7 CL E G H | 374291 | 7714 | OMIM:618224 | Mitochondrial complex I deficiency, nuclear type 3 | . | | | 38 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | NDUFS8 CL E G H | 4728 | 7715 | ORPHA:2609 | Isolated complex I deficiency | HP:0040281 - Very frequent | | | 42 | | |
HP:0004372 | HP:0002329 | Drowsiness | 1 | NDUFS8 CL E G H | 4728 | 7715 | OMIM:618222 | Mitochondrial complex I deficiency, nuclear type 2 | | | | 42 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | NDUFV1 CL E G H | 4723 | 7716 | ORPHA:2609 | Isolated complex I deficiency | HP:0040281 - Very frequent | | | 74 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | NDUFV1 CL E G H | 4723 | 7716 | OMIM:618225 | Mitochondrial complex I deficiency, nuclear type 4 | . | | | 74 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | NDUFV2 CL E G H | 4729 | 7717 | ORPHA:2609 | Isolated complex I deficiency | HP:0040281 - Very frequent | | | 27 | | |
HP:0004372 | HP:0001262 | Excessive daytime somnolence | 1 | NF2 CL E G H | 4771 | 7773 | ORPHA:2495 | Meningioma | HP:0040284 - Very rare | | | 220 | | |
HP:0004372 | HP:0001259 | Coma | 1 | NFKB2 CL E G H | 4791 | 7795 | ORPHA:293978 | Deficiency in anterior pituitary function-variable immunodeficiency syndrome | | | | 11 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | NFS1 CL E G H | 9054 | 15910 | OMIM:619386 | COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 52; COXPD52 | | | | 5 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | NFU1 CL E G H | 27247 | 16287 | OMIM:605711 | Multiple mitochondrial dysfunctions syndrome 1 | . | | | 34 | | |
HP:0004372 | HP:0001289 | Confusion | 1 | NHLRC1 CL E G H | 378884 | 21576 | ORPHA:501 | Lafora disease | HP:0040282 - Frequent | | | 77 | | |
HP:0004372 | HP:0031358 | Vegetative state | 1 | NHLRC1 CL E G H | 378884 | 21576 | ORPHA:501 | Lafora disease | HP:0040283 - Occasional | | | 77 | | |
HP:0004372 | HP:0001259 | Coma | 1 | NNT CL E G H | 23530 | 7863 | ORPHA:361 | Familial glucocorticoid deficiency | | | | 13 | | |
HP:0004372 | HP:0001259 | Coma | 1 | NNT CL E G H | 23530 | 7863 | OMIM:614736 | Glucocorticoid deficiency 4 with or without mineralocorticoid deficiency | | | | 13 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | NODAL CL E G H | 4838 | 7865 | ORPHA:93925 | Alobar holoprosencephaly | HP:0040282 - Frequent | | | 45 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | NODAL CL E G H | 4838 | 7865 | ORPHA:93924 | Lobar holoprosencephaly | HP:0040283 - Occasional | | | 45 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | NODAL CL E G H | 4838 | 7865 | ORPHA:93926 | Midline interhemispheric variant of holoprosencephaly | HP:0040282 - Frequent | | | 45 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | NODAL CL E G H | 4838 | 7865 | ORPHA:220386 | Semilobar holoprosencephaly | HP:0040282 - Frequent | | | 45 | | |
HP:0004372 | HP:0007185 | Loss of consciousness | 1 | NOTCH2NLC CL E G H | 100996717 | 53924 | OMIM:603472 | NEURONAL INTRANUCLEAR INCLUSION DISEASE | | | | | | |
HP:0004372 | HP:0007185 | Loss of consciousness | 1 | NOTCH3 CL E G H | 4854 | 7883 | ORPHA:136 | Cerebral autosomal dominant arteriopathy-subcortical infarcts-leukoencephalopathy | HP:0040283 - Occasional | | | 144 | | |
HP:0004372 | HP:0001289 | Confusion | 1 | NOTCH3 CL E G H | 4854 | 7883 | ORPHA:136 | Cerebral autosomal dominant arteriopathy-subcortical infarcts-leukoencephalopathy | HP:0040283 - Occasional | | | 144 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | NUBPL CL E G H | 80224 | 20278 | ORPHA:2609 | Isolated complex I deficiency | HP:0040281 - Very frequent | | | 89 | | |
HP:0004372 | HP:0001262 | Excessive daytime somnolence | 1 | NUP88 CL E G H | 4927 | 8067 | ORPHA:994 | Fetal akinesia deformation sequence | HP:0040281 - Very frequent | | | | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | OTC CL E G H | 5009 | 8512 | OMIM:311250 | Ornithine transcarbamylase deficiency, hyperammonemia due to | . | | | 369 | | |
HP:0004372 | HP:0001259 | Coma | 1 | OTC CL E G H | 5009 | 8512 | OMIM:311250 | Ornithine transcarbamylase deficiency, hyperammonemia due to | . | | | 369 | | |
HP:0004372 | HP:0001262 | Excessive daytime somnolence | 1 | P2RY11 CL E G H | 5032 | 8540 | ORPHA:2073 | Narcolepsy type 1 | HP:0040281 - Very frequent | | | 2 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | PAX2 CL E G H | 5076 | 8616 | ORPHA:97362 | Renal hypoplasia, bilateral | | | | 39 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | PAX8 CL E G H | 7849 | 8622 | OMIM:218700 | Hypothyroidism, congenital, nongoitrous, 2 | . | | | 63 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | PBX1 CL E G H | 5087 | 8632 | ORPHA:97362 | Renal hypoplasia, bilateral | | | | 3 | | |
HP:0004372 | HP:0001259 | Coma | 1 | PCCA CL E G H | 5095 | 8653 | OMIM:606054 | Propionic acidemia | . | | | 96 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | PCCA CL E G H | 5095 | 8653 | OMIM:606054 | Propionic acidemia | . | | | 96 | | |
HP:0004372 | HP:0001259 | Coma | 1 | PCCB CL E G H | 5096 | 8654 | OMIM:606054 | Propionic acidemia | . | | | 92 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | PCCB CL E G H | 5096 | 8654 | OMIM:606054 | Propionic acidemia | . | | | 92 | | |
HP:0004372 | HP:0001262 | Excessive daytime somnolence | 1 | PDGFB CL E G H | 5155 | 8800 | ORPHA:2495 | Meningioma | HP:0040284 - Very rare | | | 9 | | |
HP:0004372 | HP:0002329 | Drowsiness | 1 | PDHA1 CL E G H | 5160 | 8806 | ORPHA:79243 | Pyruvate dehydrogenase E1-alpha deficiency | HP:0040283 - Occasional | | | 88 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | PDHA1 CL E G H | 5160 | 8806 | OMIM:312170 | Pyruvate dehydrogenase e1-alpha deficiency | . | | | 88 | | |
HP:0004372 | HP:0001259 | Coma | 1 | PDX1 CL E G H | 3651 | 6107 | ORPHA:99885 | Isolated permanent neonatal diabetes mellitus | HP:0040283 - Occasional | | | 30 | | |
HP:0004372 | HP:0031358 | Vegetative state | 1 | PIGA CL E G H | 5277 | 8957 | OMIM:301072 | NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HEMOCHROMATOSIS; NEDEPH | | | | 46 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | PIGA CL E G H | 5277 | 8957 | ORPHA:447 | Paroxysmal nocturnal hemoglobinuria | HP:0040283 - Occasional | | | 46 | | |
HP:0004372 | HP:0002329 | Drowsiness | 1 | PIGG CL E G H | 54872 | 25985 | ORPHA:488635 | Early-onset epilepsy-intellectual disability-brain anomalies syndrome | HP:0040283 - Occasional | | | 7 | | |
HP:0004372 | HP:0001262 | Excessive daytime somnolence | 1 | PIK3CA CL E G H | 5290 | 8975 | ORPHA:2495 | Meningioma | HP:0040284 - Very rare | | | 162 | | |
HP:0004372 | HP:0031358 | Vegetative state | 1 | PLA2G6 CL E G H | 8398 | 9039 | ORPHA:35069 | Infantile neuroaxonal dystrophy | HP:0040284 - Very rare | | | 133 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | PLCH1 CL E G H | 23007 | 29185 | ORPHA:93925 | Alobar holoprosencephaly | HP:0040282 - Frequent | | | | | |
HP:0004372 | HP:0032044 | Decreased vigilance | 1 | PLP1 CL E G H | 5354 | 9086 | ORPHA:280229 | Pelizaeus-Merzbacher disease in female carriers | HP:0040283 - Occasional | | | 60 | | |
HP:0004372 | HP:0001259 | Coma | 1 | POLG CL E G H | 5428 | 9179 | ORPHA:726 | Alpers-Huttenlocher syndrome | HP:0040282 - Frequent | | | 464 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | POLG CL E G H | 5428 | 9179 | ORPHA:254892 | Autosomal dominant progressive external ophthalmoplegia | HP:0040283 - Occasional | | | 464 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | POLG2 CL E G H | 11232 | 9180 | ORPHA:254892 | Autosomal dominant progressive external ophthalmoplegia | HP:0040283 - Occasional | | | 45 | | |
HP:0004372 | HP:0001289 | Confusion | 1 | POLR3A CL E G H | 11128 | 30074 | ORPHA:3455 | Wiedemann-Rautenstrauch syndrome | HP:0040282 - Frequent | | | 138 | | |
HP:0004372 | HP:0001259 | Coma | 1 | POLR3K CL E G H | 51728 | 14121 | OMIM:619310 | LEUKODYSTROPHY, HYPOMYELINATING, 21; HLD21 | | | | | | |
HP:0004372 | HP:0001262 | Excessive daytime somnolence | 1 | POMT1 CL E G H | 10585 | 9202 | OMIM:236670 | Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 1 | . | | | 213 | | |
HP:0004372 | HP:0001262 | Excessive daytime somnolence | 1 | POMT2 CL E G H | 29954 | 19743 | OMIM:236670 | Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 1 | . | | | 221 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | POU1F1 CL E G H | 5449 | 9210 | ORPHA:226307 | Hypothyroidism due to deficient transcription factors involved in pituitary development or function | HP:0040282 - Frequent | | | 36 | | |
HP:0004372 | HP:0001262 | Excessive daytime somnolence | 1 | POU2AF1 CL E G H | 5450 | 9211 | ORPHA:186 | Primary biliary cholangitis | HP:0040283 - Occasional | | | | | |
HP:0004372 | HP:0001259 | Coma | 1 | PPOX CL E G H | 5498 | 9280 | ORPHA:79473 | Porphyria variegata | HP:0040284 - Very rare | | | 41 | | |
HP:0004372 | HP:0001289 | Confusion | 1 | PRDM8 CL E G H | 56978 | 13993 | ORPHA:324290 | Early-onset Lafora body disease | HP:0040283 - Occasional | | | 1 | | |
HP:0004372 | HP:0001289 | Confusion | 1 | PRDX1 CL E G H | 5052 | 9352 | OMIM:277400 | Methylmalonic aciduria and homocystinuria, Cblc type | . | | | | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | PRDX1 CL E G H | 5052 | 9352 | OMIM:277400 | Methylmalonic aciduria and homocystinuria, Cblc type | . | | | | | |
HP:0004372 | HP:0001259 | Coma | 1 | PRF1 CL E G H | 5551 | 9360 | ORPHA:540 | Familial hemophagocytic lymphohistiocytosis | HP:0040283 - Occasional | | | 58 | | |
HP:0004372 | HP:0001259 | Coma | 1 | PRF1 CL E G H | 5551 | 9360 | OMIM:603553 | Hemophagocytic lymphohistiocytosis, familial, 2 | . | | | 58 | | |
HP:0004372 | HP:0001289 | Confusion | 1 | PRNP CL E G H | 5621 | 9449 | OMIM:123400 | Creutzfeldt-Jakob disease | . | | | 69 | | |
HP:0004372 | HP:0001289 | Confusion | 1 | PRNP CL E G H | 5621 | 9449 | ORPHA:282166 | Inherited Creutzfeldt-Jakob disease | HP:0040282 - Frequent | | | 69 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | PROP1 CL E G H | 5626 | 9455 | ORPHA:226307 | Hypothyroidism due to deficient transcription factors involved in pituitary development or function | HP:0040282 - Frequent | | | 54 | | |
HP:0004372 | HP:0001262 | Excessive daytime somnolence | 1 | PRPS1 CL E G H | 5631 | 9462 | ORPHA:99014 | X-linked Charcot-Marie-Tooth disease type 5 | HP:0040283 - Occasional | | | 49 | | |
HP:0004372 | HP:0001289 | Confusion | 1 | PRRT2 CL E G H | 112476 | 30500 | ORPHA:569 | Familial or sporadic hemiplegic migraine | HP:0040282 - Frequent | | | 94 | | |
HP:0004372 | HP:0032044 | Decreased vigilance | 1 | PRRT2 CL E G H | 112476 | 30500 | ORPHA:569 | Familial or sporadic hemiplegic migraine | HP:0040283 - Occasional | | | 94 | | |
HP:0004372 | HP:0001259 | Coma | 1 | PRRT2 CL E G H | 112476 | 30500 | ORPHA:569 | Familial or sporadic hemiplegic migraine | HP:0040283 - Occasional | | | 94 | | |
HP:0004372 | HP:0031358 | Vegetative state | 1 | PSAP CL E G H | 5660 | 9498 | OMIM:611722 | KRABBE DISEASE, ATYPICAL, DUE TO SAPOSIN A DEFICIENCY | | | | 81 | | |
HP:0004372 | HP:0031358 | Vegetative state | 1 | PSAP CL E G H | 5660 | 9498 | ORPHA:309271 | Metachromatic leukodystrophy, adult form | HP:0040284 - Very rare | | | 81 | | |
HP:0004372 | HP:0031358 | Vegetative state | 1 | PSAP CL E G H | 5660 | 9498 | ORPHA:309263 | Metachromatic leukodystrophy, juvenile form | HP:0040284 - Very rare | | | 81 | | |
HP:0004372 | HP:0031358 | Vegetative state | 1 | PSAP CL E G H | 5660 | 9498 | ORPHA:309256 | Metachromatic leukodystrophy, late infantile form | HP:0040284 - Very rare | | | 81 | | |
HP:0004372 | HP:0001289 | Confusion | 1 | PSEN1 CL E G H | 5663 | 9508 | ORPHA:1020 | Early-onset autosomal dominant Alzheimer disease | HP:0040281 - Very frequent | | | 241 | | |
HP:0004372 | HP:0001289 | Confusion | 1 | PSEN2 CL E G H | 5664 | 9509 | ORPHA:1020 | Early-onset autosomal dominant Alzheimer disease | HP:0040281 - Very frequent | | | 59 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | PTCH1 CL E G H | 5727 | 9585 | ORPHA:93925 | Alobar holoprosencephaly | HP:0040282 - Frequent | | | 665 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | PTCH1 CL E G H | 5727 | 9585 | ORPHA:93924 | Lobar holoprosencephaly | HP:0040283 - Occasional | | | 665 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | PTCH1 CL E G H | 5727 | 9585 | ORPHA:93926 | Midline interhemispheric variant of holoprosencephaly | HP:0040282 - Frequent | | | 665 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | PTCH1 CL E G H | 5727 | 9585 | ORPHA:220386 | Semilobar holoprosencephaly | HP:0040282 - Frequent | | | 665 | | |
HP:0004372 | HP:0002329 | Drowsiness | 1 | PTS CL E G H | 5805 | 9689 | ORPHA:13 | 6-pyruvoyl-tetrahydropterin synthase deficiency | HP:0040283 - Occasional | | | 19 | | |
HP:0004372 | HP:0001262 | Excessive daytime somnolence | 1 | PTS CL E G H | 5805 | 9689 | OMIM:261640 | Hyperphenylalaninemia, BH4-deficient, A | . | | | 19 | | |
HP:0004372 | HP:0001259 | Coma | 1 | RANBP2 CL E G H | 5903 | 9848 | OMIM:608033 | Encephalopathy, acute, infection-induced, susceptibility to, 3 | . | | | 57 | | |
HP:0004372 | HP:0001259 | Coma | 1 | RANBP2 CL E G H | 5903 | 9848 | ORPHA:88619 | Familial acute necrotizing encephalopathy | HP:0040281 - Very frequent | | | 57 | | |
HP:0004372 | HP:0001262 | Excessive daytime somnolence | 1 | RAPSN CL E G H | 5913 | 9863 | ORPHA:994 | Fetal akinesia deformation sequence | HP:0040281 - Very frequent | | | 73 | | |
HP:0004372 | HP:0002329 | Drowsiness | 1 | RAPSN CL E G H | 5913 | 9863 | ORPHA:98913 | Postsynaptic congenital myasthenic syndromes | HP:0040283 - Occasional | | | 73 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | RARS2 CL E G H | 57038 | 21406 | OMIM:611523 | Pontocerebellar hypoplasia, type 6 | | | | 93 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | RMND1 CL E G H | 55005 | 21176 | OMIM:614922 | Combined oxidative phosphorylation deficiency 11 | . | | | 26 | | |
HP:0004372 | HP:0007185 | Loss of consciousness | 1 | RNU4ATAC CL E G H | 100151683 | 34016 | OMIM:210710 | Microcephalic osteodysplastic primordial dwarfism, type I | | | | 15 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | RPL11 CL E G H | 6135 | 10301 | ORPHA:124 | Blackfan-Diamond anemia | HP:0040282 - Frequent | | | 22 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | RPL15 CL E G H | 6138 | 10306 | ORPHA:124 | Blackfan-Diamond anemia | HP:0040282 - Frequent | | | 3 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | RPL18 CL E G H | 6141 | 10310 | ORPHA:124 | Blackfan-Diamond anemia | HP:0040282 - Frequent | | | | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | RPL26 CL E G H | 6154 | 10327 | ORPHA:124 | Blackfan-Diamond anemia | HP:0040282 - Frequent | | | 3 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | RPL27 CL E G H | 6155 | 10328 | ORPHA:124 | Blackfan-Diamond anemia | HP:0040282 - Frequent | | | 1 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | RPL31 CL E G H | 6160 | 10334 | ORPHA:124 | Blackfan-Diamond anemia | HP:0040282 - Frequent | | | | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | RPL35 CL E G H | 11224 | 10344 | ORPHA:124 | Blackfan-Diamond anemia | HP:0040282 - Frequent | | | | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | RPL35A CL E G H | 6165 | 10345 | ORPHA:124 | Blackfan-Diamond anemia | HP:0040282 - Frequent | | | 11 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | RPL5 CL E G H | 6125 | 10360 | ORPHA:124 | Blackfan-Diamond anemia | HP:0040282 - Frequent | | | 40 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | RPS10 CL E G H | 6204 | 10383 | ORPHA:124 | Blackfan-Diamond anemia | HP:0040282 - Frequent | | | 26 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | RPS15A CL E G H | 6210 | 10389 | ORPHA:124 | Blackfan-Diamond anemia | HP:0040282 - Frequent | | | | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | RPS17 CL E G H | 6218 | 10397 | ORPHA:124 | Blackfan-Diamond anemia | HP:0040282 - Frequent | | | 5 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | RPS19 CL E G H | 6223 | 10402 | ORPHA:124 | Blackfan-Diamond anemia | HP:0040282 - Frequent | | | 42 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | RPS20 CL E G H | 6224 | 10405 | ORPHA:124 | Blackfan-Diamond anemia | HP:0040282 - Frequent | | | 1 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | RPS24 CL E G H | 6229 | 10411 | ORPHA:124 | Blackfan-Diamond anemia | HP:0040282 - Frequent | | | 22 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | RPS26 CL E G H | 6231 | 10414 | ORPHA:124 | Blackfan-Diamond anemia | HP:0040282 - Frequent | | | 20 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | RPS27 CL E G H | 6232 | 10416 | ORPHA:124 | Blackfan-Diamond anemia | HP:0040282 - Frequent | | | 1 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | RPS28 CL E G H | 6234 | 10418 | ORPHA:124 | Blackfan-Diamond anemia | HP:0040282 - Frequent | | | 1 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | RPS29 CL E G H | 6235 | 10419 | ORPHA:124 | Blackfan-Diamond anemia | HP:0040282 - Frequent | | | 3 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | RPS7 CL E G H | 6201 | 10440 | ORPHA:124 | Blackfan-Diamond anemia | HP:0040282 - Frequent | | | 20 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | RRM2B CL E G H | 50484 | 17296 | ORPHA:254892 | Autosomal dominant progressive external ophthalmoplegia | HP:0040283 - Occasional | | | 125 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | RYR1 CL E G H | 6261 | 10483 | ORPHA:324581 | Benign Samaritan congenital myopathy | HP:0040283 - Occasional | | | 1200 | | |
HP:0004372 | HP:0001289 | Confusion | 1 | RYR1 CL E G H | 6261 | 10483 | ORPHA:466650 | Exercise-induced malignant hyperthermia | HP:0040283 - Occasional | | | 1200 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | RYR1 CL E G H | 6261 | 10483 | ORPHA:466650 | Exercise-induced malignant hyperthermia | HP:0040283 - Occasional | | | 1200 | | |
HP:0004372 | HP:0001259 | Coma | 1 | SCN1A CL E G H | 6323 | 10585 | ORPHA:569 | Familial or sporadic hemiplegic migraine | HP:0040283 - Occasional | | | 1053 | | |
HP:0004372 | HP:0032044 | Decreased vigilance | 1 | SCN1A CL E G H | 6323 | 10585 | ORPHA:569 | Familial or sporadic hemiplegic migraine | HP:0040283 - Occasional | | | 1053 | | |
HP:0004372 | HP:0001289 | Confusion | 1 | SCN1A CL E G H | 6323 | 10585 | ORPHA:569 | Familial or sporadic hemiplegic migraine | HP:0040282 - Frequent | | | 1053 | | |
HP:0004372 | HP:0002329 | Drowsiness | 1 | SCN4A CL E G H | 6329 | 10591 | ORPHA:98913 | Postsynaptic congenital myasthenic syndromes | HP:0040283 - Occasional | | | 263 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | SCO2 CL E G H | 9997 | 10604 | OMIM:604377 | Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 1 | | | | 40 | | |
HP:0004372 | HP:0007159 | Fluctuations in consciousness | 1 | SCO2 CL E G H | 9997 | 10604 | ORPHA:70474 | Leigh syndrome with cardiomyopathy | HP:0040282 - Frequent | | | 40 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | SHH CL E G H | 6469 | 10848 | ORPHA:93925 | Alobar holoprosencephaly | HP:0040282 - Frequent | | | 67 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | SHH CL E G H | 6469 | 10848 | ORPHA:93924 | Lobar holoprosencephaly | HP:0040283 - Occasional | | | 67 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | SHH CL E G H | 6469 | 10848 | ORPHA:93926 | Midline interhemispheric variant of holoprosencephaly | HP:0040282 - Frequent | | | 67 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | SHH CL E G H | 6469 | 10848 | ORPHA:220386 | Semilobar holoprosencephaly | HP:0040282 - Frequent | | | 67 | | |
HP:0004372 | HP:0031358 | Vegetative state | 1 | SHQ1 CL E G H | 55164 | 25543 | OMIM:619922 | | | | | | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | SIK1 CL E G H | 150094 | 11142 | ORPHA:1935 | Early myoclonic encephalopathy | HP:0040282 - Frequent | | | 11 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | SIM1 CL E G H | 6492 | 10882 | ORPHA:398079 | SIM1-related Prader-Willi-like syndrome | HP:0040283 - Occasional | | | 40 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | SIX3 CL E G H | 6496 | 10889 | ORPHA:93925 | Alobar holoprosencephaly | HP:0040282 - Frequent | | | 32 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | SIX3 CL E G H | 6496 | 10889 | ORPHA:93924 | Lobar holoprosencephaly | HP:0040283 - Occasional | | | 32 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | SIX3 CL E G H | 6496 | 10889 | ORPHA:93926 | Midline interhemispheric variant of holoprosencephaly | HP:0040282 - Frequent | | | 32 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | SIX3 CL E G H | 6496 | 10889 | ORPHA:220386 | Semilobar holoprosencephaly | HP:0040282 - Frequent | | | 32 | | |
HP:0004372 | HP:0001262 | Excessive daytime somnolence | 1 | SLC12A3 CL E G H | 6559 | 10912 | ORPHA:358 | Gitelman syndrome | HP:0040284 - Very rare | | | 145 | | |
HP:0004372 | HP:0002329 | Drowsiness | 1 | SLC13A3 CL E G H | 64849 | 14430 | OMIM:618384 | Leukoencephalopathy, acute reversible, with increased urinary alpha-ketoglutarate | . | | | 2 | | |
HP:0004372 | HP:0001262 | Excessive daytime somnolence | 1 | SLC18A3 CL E G H | 6572 | 10936 | ORPHA:994 | Fetal akinesia deformation sequence | HP:0040281 - Very frequent | | | 2 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | SLC19A2 CL E G H | 10560 | 10938 | ORPHA:49827 | Thiamine-responsive megaloblastic anemia syndrome | HP:0040281 - Very frequent | | | 55 | | |
HP:0004372 | HP:0001289 | Confusion | 1 | SLC19A3 CL E G H | 80704 | 16266 | ORPHA:263410 | Infantile spasms-psychomotor retardation-progressive brain atrophy-basal ganglia disease syndrome | HP:0040282 - Frequent | | | 110 | | |
HP:0004372 | HP:0002329 | Drowsiness | 1 | SLC19A3 CL E G H | 80704 | 16266 | ORPHA:263410 | Infantile spasms-psychomotor retardation-progressive brain atrophy-basal ganglia disease syndrome | HP:0040282 - Frequent | | | 110 | | |
HP:0004372 | HP:0007185 | Loss of consciousness | 1 | SLC19A3 CL E G H | 80704 | 16266 | ORPHA:263410 | Infantile spasms-psychomotor retardation-progressive brain atrophy-basal ganglia disease syndrome | HP:0040282 - Frequent | | | 110 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | SLC19A3 CL E G H | 80704 | 16266 | OMIM:607483 | Thiamine metabolism dysfunction syndrome 2 (biotin- or thiamine-responsive encephalopathy type 2) | | | | 110 | | |
HP:0004372 | HP:0001259 | Coma | 1 | SLC19A3 CL E G H | 80704 | 16266 | OMIM:607483 | Thiamine metabolism dysfunction syndrome 2 (biotin- or thiamine-responsive encephalopathy type 2) | | | | 110 | | |
HP:0004372 | HP:0001289 | Confusion | 1 | SLC19A3 CL E G H | 80704 | 16266 | OMIM:607483 | Thiamine metabolism dysfunction syndrome 2 (biotin- or thiamine-responsive encephalopathy type 2) | | | | 110 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | SLC1A2 CL E G H | 6506 | 10940 | OMIM:617105 | Epileptic encephalopathy, early infantile, 41 | . | | | 3 | | |
HP:0004372 | HP:0001289 | Confusion | 1 | SLC22A5 CL E G H | 6584 | 10969 | OMIM:212140 | Carnitine deficiency, systemic primary | . | | | 207 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | SLC22A5 CL E G H | 6584 | 10969 | OMIM:212140 | Carnitine deficiency, systemic primary | . | | | 207 | | |
HP:0004372 | HP:0001262 | Excessive daytime somnolence | 1 | SLC22A5 CL E G H | 6584 | 10969 | OMIM:212140 | Carnitine deficiency, systemic primary | . | | | 207 | | |
HP:0004372 | HP:0001259 | Coma | 1 | SLC22A5 CL E G H | 6584 | 10969 | OMIM:212140 | Carnitine deficiency, systemic primary | . | | | 207 | | |
HP:0004372 | HP:0001289 | Confusion | 1 | SLC22A5 CL E G H | 6584 | 10969 | ORPHA:158 | Systemic primary carnitine deficiency | HP:0040281 - Very frequent | | | 207 | | |
HP:0004372 | HP:0002329 | Drowsiness | 1 | SLC25A13 CL E G H | 10165 | 10983 | ORPHA:247585 | Citrullinemia type II | HP:0040282 - Frequent | | | 82 | | |
HP:0004372 | HP:0001289 | Confusion | 1 | SLC25A13 CL E G H | 10165 | 10983 | ORPHA:247585 | Citrullinemia type II | HP:0040282 - Frequent | | | 82 | | |
HP:0004372 | HP:0001259 | Coma | 1 | SLC25A13 CL E G H | 10165 | 10983 | ORPHA:247585 | Citrullinemia type II | HP:0040283 - Occasional | | | 82 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | SLC25A13 CL E G H | 10165 | 10983 | ORPHA:247585 | Citrullinemia type II | HP:0040282 - Frequent | | | 82 | | |
HP:0004372 | HP:0007159 | Fluctuations in consciousness | 1 | SLC25A13 CL E G H | 10165 | 10983 | ORPHA:247585 | Citrullinemia type II | HP:0040282 - Frequent | | | 82 | | |
HP:0004372 | HP:0001259 | Coma | 1 | SLC25A13 CL E G H | 10165 | 10983 | OMIM:603471 | Citrullinemia, type II, adult-onset | . | | | 82 | | |
HP:0004372 | HP:0001289 | Confusion | 1 | SLC25A13 CL E G H | 10165 | 10983 | OMIM:603471 | Citrullinemia, type II, adult-onset | . | | | 82 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | SLC25A15 CL E G H | 10166 | 10985 | OMIM:238970 | Hyperornithinemia-Hyperammonemia-Homocitrullinuria syndrome | . | | | 88 | | |
HP:0004372 | HP:0001289 | Confusion | 1 | SLC25A15 CL E G H | 10166 | 10985 | ORPHA:415 | Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome | HP:0040282 - Frequent | | | 88 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | SLC25A15 CL E G H | 10166 | 10985 | ORPHA:415 | Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome | HP:0040282 - Frequent | | | 88 | | |
HP:0004372 | HP:0001289 | Confusion | 1 | SLC25A15 CL E G H | 10166 | 10985 | OMIM:238970 | Hyperornithinemia-Hyperammonemia-Homocitrullinuria syndrome | . | | | 88 | | |
HP:0004372 | HP:0001259 | Coma | 1 | SLC25A15 CL E G H | 10166 | 10985 | OMIM:238970 | Hyperornithinemia-Hyperammonemia-Homocitrullinuria syndrome | . | | | 88 | | |
HP:0004372 | HP:0001259 | Coma | 1 | SLC25A15 CL E G H | 10166 | 10985 | ORPHA:415 | Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome | HP:0040283 - Occasional | | | 88 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | SLC25A19 CL E G H | 60386 | 14409 | OMIM:613710 | Thiamine metabolism dysfunction syndrome 4 (bilateral striatal degenerationand progressive polyneuropathy type) | . | | | 36 | | |
HP:0004372 | HP:0001259 | Coma | 1 | SLC25A20 CL E G H | 788 | 1421 | OMIM:212138 | Carnitine-acylcarnitine translocase deficiency | . | | | 40 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | SLC25A20 CL E G H | 788 | 1421 | ORPHA:159 | Carnitine-acylcarnitine translocase deficiency | HP:0040281 - Very frequent | | | 40 | | |
HP:0004372 | HP:0001259 | Coma | 1 | SLC25A20 CL E G H | 788 | 1421 | ORPHA:159 | Carnitine-acylcarnitine translocase deficiency | HP:0040283 - Occasional | | | 40 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | SLC25A20 CL E G H | 788 | 1421 | OMIM:212138 | Carnitine-acylcarnitine translocase deficiency | | | | 40 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | SLC25A22 CL E G H | 79751 | 19954 | ORPHA:1935 | Early myoclonic encephalopathy | HP:0040282 - Frequent | | | 166 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | SLC25A4 CL E G H | 291 | 10990 | ORPHA:254892 | Autosomal dominant progressive external ophthalmoplegia | HP:0040283 - Occasional | | | 68 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | SLC2A1 CL E G H | 6513 | 11005 | ORPHA:71277 | Classic glucose transporter type 1 deficiency syndrome | HP:0040282 - Frequent | | | 255 | | |
HP:0004372 | HP:0001289 | Confusion | 1 | SLC2A1 CL E G H | 6513 | 11005 | ORPHA:71277 | Classic glucose transporter type 1 deficiency syndrome | HP:0040282 - Frequent | | | 255 | | |
HP:0004372 | HP:0001289 | Confusion | 1 | SLC2A1 CL E G H | 6513 | 11005 | OMIM:606777 | Glut1 deficiency syndrome 1 | . | | | 255 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | SLC2A1 CL E G H | 6513 | 11005 | OMIM:606777 | Glut1 deficiency syndrome 1 | . | | | 255 | | |
HP:0004372 | HP:0001262 | Excessive daytime somnolence | 1 | SLC2A3 CL E G H | 6515 | 11007 | ORPHA:399 | Huntington disease | HP:0040283 - Occasional | | | 1 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | SLC39A4 CL E G H | 55630 | 17129 | OMIM:201100 | Acrodermatitis enteropathica, Zinc-Deficiency type | . | | | 55 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | SLC4A1 CL E G H | 6521 | 11027 | OMIM:611590 | Renal tubular acidosis, distal, with hemolytic anemia | . | | | 109 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | SLC52A1 CL E G H | 55065 | 30225 | OMIM:615026 | Riboflavin deficiency | | | | 3 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | SLC5A5 CL E G H | 6528 | 11040 | ORPHA:95716 | Familial thyroid dyshormonogenesis | HP:0040283 - Occasional | | | 59 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | SLC5A5 CL E G H | 6528 | 11040 | OMIM:274400 | Thyroid hormonogenesis, genetic defect in, 1 | . | | | 59 | | |
HP:0004372 | HP:0001259 | Coma | 1 | SLC7A7 CL E G H | 9056 | 11065 | OMIM:222700 | Lysinuric protein intolerance | . | | | 104 | | |
HP:0004372 | HP:0001259 | Coma | 1 | SLC7A7 CL E G H | 9056 | 11065 | ORPHA:470 | Lysinuric protein intolerance | HP:0040283 - Occasional | | | 104 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | SLC7A7 CL E G H | 9056 | 11065 | ORPHA:470 | Lysinuric protein intolerance | HP:0040283 - Occasional | | | 104 | | |
HP:0004372 | HP:0001262 | Excessive daytime somnolence | 1 | SMARCB1 CL E G H | 6598 | 11103 | ORPHA:2495 | Meningioma | HP:0040284 - Very rare | | | 87 | | |
HP:0004372 | HP:0001262 | Excessive daytime somnolence | 1 | SMARCE1 CL E G H | 6605 | 11109 | ORPHA:2495 | Meningioma | HP:0040284 - Very rare | | | 47 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | SMC1A CL E G H | 8243 | 11111 | ORPHA:220386 | Semilobar holoprosencephaly | HP:0040282 - Frequent | | | 135 | | |
HP:0004372 | HP:0001262 | Excessive daytime somnolence | 1 | SMO CL E G H | 6608 | 11119 | ORPHA:2495 | Meningioma | HP:0040284 - Very rare | | | 22 | | |
HP:0004372 | HP:0007159 | Fluctuations in consciousness | 1 | SNCA CL E G H | 6622 | 11138 | OMIM:127750 | Dementia, lewy body | . | | | 65 | | |
HP:0004372 | HP:0007159 | Fluctuations in consciousness | 1 | SNCB CL E G H | 6620 | 11140 | OMIM:127750 | Dementia, lewy body | . | | | 2 | | |
HP:0004372 | HP:0001289 | Confusion | 1 | SORL1 CL E G H | 6653 | 11185 | ORPHA:1020 | Early-onset autosomal dominant Alzheimer disease | HP:0040281 - Very frequent | | | 3 | | |
HP:0004372 | HP:0001259 | Coma | 1 | SOX10 CL E G H | 6663 | 11190 | OMIM:609136 | Peripheral demyelinating neuropathy, central dysmyelination, Waardenburg syndrome, and Hirschsprung disease | | | | 61 | | |
HP:0004372 | HP:0001262 | Excessive daytime somnolence | 1 | SPIB CL E G H | 6689 | 11242 | ORPHA:186 | Primary biliary cholangitis | HP:0040283 - Occasional | | | | | |
HP:0004372 | HP:0002329 | Drowsiness | 1 | SPR CL E G H | 6697 | 11257 | ORPHA:70594 | Dopa-responsive dystonia due to sepiapterin reductase deficiency | HP:0040282 - Frequent | | | 28 | | |
HP:0004372 | HP:0001259 | Coma | 1 | SQOR CL E G H | 58472 | 20390 | OMIM:619221 | SULFIDE:QUINONE OXIDOREDUCTASE DEFICIENCY; SQORD | | | | | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | STAG2 CL E G H | 10735 | 11355 | ORPHA:93925 | Alobar holoprosencephaly | HP:0040282 - Frequent | | | 1 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | STAG2 CL E G H | 10735 | 11355 | ORPHA:220386 | Semilobar holoprosencephaly | HP:0040282 - Frequent | | | 1 | | |
HP:0004372 | HP:0001259 | Coma | 1 | STAR CL E G H | 6770 | 11359 | ORPHA:361 | Familial glucocorticoid deficiency | | | | 45 | | |
HP:0004372 | HP:0001259 | Coma | 1 | STAT3 CL E G H | 6774 | 11364 | ORPHA:99885 | Isolated permanent neonatal diabetes mellitus | HP:0040283 - Occasional | | | 110 | | |
HP:0004372 | HP:0001289 | Confusion | 1 | STAT4 CL E G H | 6775 | 11365 | ORPHA:117 | Behçet disease | HP:0040282 - Frequent | | | 2 | | |
HP:0004372 | HP:0007185 | Loss of consciousness | 1 | STAT6 CL E G H | 6778 | 11368 | ORPHA:2126 | Solitary fibrous tumor/hemangiopericytoma | HP:0040284 - Very rare | | | 1 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | STIL CL E G H | 6491 | 10879 | ORPHA:93925 | Alobar holoprosencephaly | HP:0040282 - Frequent | | | 99 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | STIL CL E G H | 6491 | 10879 | ORPHA:93924 | Lobar holoprosencephaly | HP:0040283 - Occasional | | | 99 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | STIL CL E G H | 6491 | 10879 | ORPHA:93926 | Midline interhemispheric variant of holoprosencephaly | HP:0040282 - Frequent | | | 99 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | STIL CL E G H | 6491 | 10879 | ORPHA:220386 | Semilobar holoprosencephaly | HP:0040282 - Frequent | | | 99 | | |
HP:0004372 | HP:0001259 | Coma | 1 | STX11 CL E G H | 8676 | 11429 | ORPHA:540 | Familial hemophagocytic lymphohistiocytosis | HP:0040283 - Occasional | | | 85 | | |
HP:0004372 | HP:0001259 | Coma | 1 | STXBP2 CL E G H | 6813 | 11445 | ORPHA:540 | Familial hemophagocytic lymphohistiocytosis | HP:0040283 - Occasional | | | 70 | | |
HP:0004372 | HP:0001262 | Excessive daytime somnolence | 1 | SUFU CL E G H | 51684 | 16466 | ORPHA:2495 | Meningioma | HP:0040284 - Very rare | | | 124 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | SUGCT CL E G H | 79783 | 16001 | ORPHA:35706 | Glutaric acidemia type 3 | HP:0040283 - Occasional | | | 8 | | |
HP:0004372 | HP:0007159 | Fluctuations in consciousness | 1 | SURF1 CL E G H | 6834 | 11474 | ORPHA:70474 | Leigh syndrome with cardiomyopathy | HP:0040282 - Frequent | | | 73 | | |
HP:0004372 | HP:0001262 | Excessive daytime somnolence | 1 | TBC1D24 CL E G H | 57465 | 29203 | ORPHA:352596 | Progressive myoclonic epilepsy with dystonia | HP:0040283 - Occasional | | | 271 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | TBK1 CL E G H | 29110 | 11584 | OMIM:617900 | Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 8 | . | | | 20 | | |
HP:0004372 | HP:0001289 | Confusion | 1 | TBK1 CL E G H | 29110 | 11584 | OMIM:617900 | Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 8 | . | | | 20 | | |
HP:0004372 | HP:0007185 | Loss of consciousness | 1 | TBK1 CL E G H | 29110 | 11584 | ORPHA:1930 | Herpes simplex virus encephalitis | HP:0040282 - Frequent | | | 20 | | |
HP:0004372 | HP:0001262 | Excessive daytime somnolence | 1 | TBK1 CL E G H | 29110 | 11584 | ORPHA:1930 | Herpes simplex virus encephalitis | HP:0040283 - Occasional | | | 20 | | |
HP:0004372 | HP:0001259 | Coma | 1 | TBK1 CL E G H | 29110 | 11584 | ORPHA:1930 | Herpes simplex virus encephalitis | HP:0040283 - Occasional | | | 20 | | |
HP:0004372 | HP:0001289 | Confusion | 1 | TBP CL E G H | 6908 | 11588 | OMIM:607136 | Spinocerebellar ataxia 17 | . | | | 7 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | TCN2 CL E G H | 6948 | 11653 | OMIM:275350 | Transcobalamin II deficiency | . | | | 57 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | TDGF1 CL E G H | 6997 | 11701 | ORPHA:93925 | Alobar holoprosencephaly | HP:0040282 - Frequent | | | 1 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | TDGF1 CL E G H | 6997 | 11701 | ORPHA:93924 | Lobar holoprosencephaly | HP:0040283 - Occasional | | | 1 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | TDGF1 CL E G H | 6997 | 11701 | ORPHA:93926 | Midline interhemispheric variant of holoprosencephaly | HP:0040282 - Frequent | | | 1 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | TDGF1 CL E G H | 6997 | 11701 | ORPHA:220386 | Semilobar holoprosencephaly | HP:0040282 - Frequent | | | 1 | | |
HP:0004372 | HP:0001262 | Excessive daytime somnolence | 1 | TERT CL E G H | 7015 | 11730 | ORPHA:2495 | Meningioma | HP:0040284 - Very rare | | | 238 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | TG CL E G H | 7038 | 11764 | ORPHA:95716 | Familial thyroid dyshormonogenesis | HP:0040283 - Occasional | | | 155 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | TGIF1 CL E G H | 7050 | 11776 | ORPHA:93925 | Alobar holoprosencephaly | HP:0040282 - Frequent | | | 32 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | TGIF1 CL E G H | 7050 | 11776 | ORPHA:93924 | Lobar holoprosencephaly | HP:0040283 - Occasional | | | 32 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | TGIF1 CL E G H | 7050 | 11776 | ORPHA:93926 | Midline interhemispheric variant of holoprosencephaly | HP:0040282 - Frequent | | | 32 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | TGIF1 CL E G H | 7050 | 11776 | ORPHA:220386 | Semilobar holoprosencephaly | HP:0040282 - Frequent | | | 32 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | TH CL E G H | 7054 | 11782 | ORPHA:101150 | Autosomal recessive dopa-responsive dystonia | HP:0040282 - Frequent | | | 80 | | |
HP:0004372 | HP:0002329 | Drowsiness | 1 | THRA CL E G H | 7067 | 11796 | OMIM:614450 | Hypothyroidism, congenital, nongoitrous, 6 | . | | | 9 | | |
HP:0004372 | HP:0001262 | Excessive daytime somnolence | 1 | TICAM1 CL E G H | 148022 | 18348 | ORPHA:1930 | Herpes simplex virus encephalitis | HP:0040283 - Occasional | | | 6 | | |
HP:0004372 | HP:0007185 | Loss of consciousness | 1 | TICAM1 CL E G H | 148022 | 18348 | ORPHA:1930 | Herpes simplex virus encephalitis | HP:0040282 - Frequent | | | 6 | | |
HP:0004372 | HP:0001259 | Coma | 1 | TICAM1 CL E G H | 148022 | 18348 | ORPHA:1930 | Herpes simplex virus encephalitis | HP:0040283 - Occasional | | | 6 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | TIMMDC1 CL E G H | 51300 | 1321 | ORPHA:2609 | Isolated complex I deficiency | HP:0040281 - Very frequent | | | 1 | | |
HP:0004372 | HP:0001289 | Confusion | 1 | TLR3 CL E G H | 7098 | 11849 | OMIM:613002 | Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 2 | . | | | 3 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | TLR3 CL E G H | 7098 | 11849 | OMIM:613002 | Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 2 | . | | | 3 | | |
HP:0004372 | HP:0007185 | Loss of consciousness | 1 | TLR3 CL E G H | 7098 | 11849 | ORPHA:1930 | Herpes simplex virus encephalitis | HP:0040282 - Frequent | | | 3 | | |
HP:0004372 | HP:0001259 | Coma | 1 | TLR3 CL E G H | 7098 | 11849 | ORPHA:1930 | Herpes simplex virus encephalitis | HP:0040283 - Occasional | | | 3 | | |
HP:0004372 | HP:0001262 | Excessive daytime somnolence | 1 | TLR3 CL E G H | 7098 | 11849 | ORPHA:1930 | Herpes simplex virus encephalitis | HP:0040283 - Occasional | | | 3 | | |
HP:0004372 | HP:0001289 | Confusion | 1 | TLR4 CL E G H | 7099 | 11850 | ORPHA:117 | Behçet disease | HP:0040282 - Frequent | | | 3 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | TMEM126B CL E G H | 55863 | 30883 | ORPHA:2609 | Isolated complex I deficiency | HP:0040281 - Very frequent | | | 4 | | |
HP:0004372 | HP:0001262 | Excessive daytime somnolence | 1 | TNFSF15 CL E G H | 9966 | 11931 | ORPHA:186 | Primary biliary cholangitis | HP:0040283 - Occasional | | | | | |
HP:0004372 | HP:0001262 | Excessive daytime somnolence | 1 | TNFSF4 CL E G H | 7292 | 11934 | ORPHA:2073 | Narcolepsy type 1 | HP:0040281 - Very frequent | | | | | |
HP:0004372 | HP:0001262 | Excessive daytime somnolence | 1 | TNPO3 CL E G H | 23534 | 17103 | ORPHA:186 | Primary biliary cholangitis | HP:0040283 - Occasional | | | 71 | | |
HP:0004372 | HP:0001289 | Confusion | 1 | TOMM40 CL E G H | 10452 | 18001 | ORPHA:1020 | Early-onset autosomal dominant Alzheimer disease | HP:0040281 - Very frequent | | | | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | TPO CL E G H | 7173 | 12015 | ORPHA:95716 | Familial thyroid dyshormonogenesis | HP:0040283 - Occasional | | | 92 | | |
HP:0004372 | HP:0001262 | Excessive daytime somnolence | 1 | TRAF3 CL E G H | 7187 | 12033 | ORPHA:1930 | Herpes simplex virus encephalitis | HP:0040283 - Occasional | | | 2 | | |
HP:0004372 | HP:0001259 | Coma | 1 | TRAF3 CL E G H | 7187 | 12033 | ORPHA:1930 | Herpes simplex virus encephalitis | HP:0040283 - Occasional | | | 2 | | |
HP:0004372 | HP:0007185 | Loss of consciousness | 1 | TRAF3 CL E G H | 7187 | 12033 | ORPHA:1930 | Herpes simplex virus encephalitis | HP:0040282 - Frequent | | | 2 | | |
HP:0004372 | HP:0001262 | Excessive daytime somnolence | 1 | TRAF7 CL E G H | 84231 | 20456 | ORPHA:2495 | Meningioma | HP:0040284 - Very rare | | | | | |
HP:0004372 | HP:0001289 | Confusion | 1 | TREM2 CL E G H | 54209 | 17761 | ORPHA:1020 | Early-onset autosomal dominant Alzheimer disease | HP:0040281 - Very frequent | | | 31 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | TRHR CL E G H | 7201 | 12299 | OMIM:618573 | HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 7; CHNG7 | | | | 2 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | TRHR CL E G H | 7201 | 12299 | ORPHA:99832 | Resistance to thyrotropin-releasing hormone syndrome | HP:0040282 - Frequent | | | 2 | | |
HP:0004372 | HP:0001289 | Confusion | 1 | TRNE CL E G H | 4556 | 7479 | ORPHA:2596 | Myopathy and diabetes mellitus | | | | | | |
HP:0004372 | HP:0007159 | Fluctuations in consciousness | 1 | TRNF CL E G H | 4558 | 7481 | ORPHA:550 | MELAS | HP:0040282 - Frequent | | | | | |
HP:0004372 | HP:0007159 | Fluctuations in consciousness | 1 | TRNH CL E G H | 4564 | 7487 | ORPHA:550 | MELAS | HP:0040282 - Frequent | | | | | |
HP:0004372 | HP:0007159 | Fluctuations in consciousness | 1 | TRNL1 CL E G H | 4567 | 7490 | ORPHA:550 | MELAS | HP:0040282 - Frequent | | | | | |
HP:0004372 | HP:0007159 | Fluctuations in consciousness | 1 | TRNQ CL E G H | 4572 | 7495 | ORPHA:550 | MELAS | HP:0040282 - Frequent | | | | | |
HP:0004372 | HP:0007159 | Fluctuations in consciousness | 1 | TRNS1 CL E G H | 4574 | 7497 | ORPHA:550 | MELAS | HP:0040282 - Frequent | | | | | |
HP:0004372 | HP:0007159 | Fluctuations in consciousness | 1 | TRNS2 CL E G H | 4575 | 7498 | ORPHA:550 | MELAS | HP:0040282 - Frequent | | | | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | TRNT CL E G H | 4576 | 7499 | ORPHA:254857 | Lethal infantile mitochondrial myopathy | HP:0040283 - Occasional | | | | | |
HP:0004372 | HP:0007159 | Fluctuations in consciousness | 1 | TRNW CL E G H | 4578 | 7501 | ORPHA:550 | MELAS | HP:0040282 - Frequent | | | | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | TSHB CL E G H | 7252 | 12372 | ORPHA:90674 | Isolated thyroid-stimulating hormone deficiency | HP:0040283 - Occasional | | | 9 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | TSHR CL E G H | 7253 | 12373 | ORPHA:90673 | Hypothyroidism due to TSH receptor mutations | HP:0040283 - Occasional | | | 97 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | TSPOAP1 CL E G H | 9256 | 16831 | ORPHA:101150 | Autosomal recessive dopa-responsive dystonia | HP:0040282 - Frequent | | | 2 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | TSR2 CL E G H | 90121 | 25455 | ORPHA:124 | Blackfan-Diamond anemia | HP:0040282 - Frequent | | | 1 | | |
HP:0004372 | HP:0031358 | Vegetative state | 1 | TTC26 CL E G H | 79989 | 21882 | OMIM:619534 | BILIARY, RENAL, NEUROLOGIC, AND SKELETAL SYNDROME; BRENS | | | | | | |
HP:0004372 | HP:0001262 | Excessive daytime somnolence | 1 | TUBA1A CL E G H | 7846 | 20766 | ORPHA:994 | Fetal akinesia deformation sequence | HP:0040281 - Very frequent | | | 106 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | TWNK CL E G H | 56652 | 1160 | ORPHA:254892 | Autosomal dominant progressive external ophthalmoplegia | HP:0040283 - Occasional | | | 113 | | |
HP:0004372 | HP:0001262 | Excessive daytime somnolence | 1 | TWNK CL E G H | 56652 | 1160 | OMIM:271245 | Mitochondrial DNA depletion syndrome 7 (hepatocerebral type) | . | | | 113 | | |
HP:0004372 | HP:0001259 | Coma | 1 | TXNRD2 CL E G H | 10587 | 18155 | ORPHA:361 | Familial glucocorticoid deficiency | | | | 85 | | |
HP:0004372 | HP:0001289 | Confusion | 1 | UBAC2 CL E G H | 337867 | 20486 | ORPHA:117 | Behçet disease | HP:0040282 - Frequent | | | | | |
HP:0004372 | HP:0001259 | Coma | 1 | UCP2 CL E G H | 7351 | 12518 | ORPHA:276556 | Hyperinsulinism due to UCP2 deficiency | | | | 15 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | UCP2 CL E G H | 7351 | 12518 | ORPHA:276556 | Hyperinsulinism due to UCP2 deficiency | HP:0040283 - Occasional | | | 15 | | |
HP:0004372 | HP:0007185 | Loss of consciousness | 1 | UCP2 CL E G H | 7351 | 12518 | ORPHA:276556 | Hyperinsulinism due to UCP2 deficiency | HP:0040283 - Occasional | | | 15 | | |
HP:0004372 | HP:0002329 | Drowsiness | 1 | UCP2 CL E G H | 7351 | 12518 | ORPHA:276556 | Hyperinsulinism due to UCP2 deficiency | HP:0040282 - Frequent | | | 15 | | |
HP:0004372 | HP:0001259 | Coma | 1 | UNC13D CL E G H | 201294 | 23147 | ORPHA:540 | Familial hemophagocytic lymphohistiocytosis | HP:0040283 - Occasional | | | 116 | | |
HP:0004372 | HP:0007185 | Loss of consciousness | 1 | UNC93B1 CL E G H | 81622 | 13481 | ORPHA:1930 | Herpes simplex virus encephalitis | HP:0040282 - Frequent | | | 5 | | |
HP:0004372 | HP:0001262 | Excessive daytime somnolence | 1 | UNC93B1 CL E G H | 81622 | 13481 | ORPHA:1930 | Herpes simplex virus encephalitis | HP:0040283 - Occasional | | | 5 | | |
HP:0004372 | HP:0001259 | Coma | 1 | UNC93B1 CL E G H | 81622 | 13481 | ORPHA:1930 | Herpes simplex virus encephalitis | HP:0040283 - Occasional | | | 5 | | |
HP:0004372 | HP:0007185 | Loss of consciousness | 1 | UPB1 CL E G H | 51733 | 16297 | OMIM:613161 | Beta-Ureidopropionase deficiency | | | | 44 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | USP18 CL E G H | 11274 | 12616 | OMIM:617397 | Pseudo-Torch syndrome 2 | . | | | 2 | | |
HP:0004372 | HP:0001259 | Coma | 1 | YY1 CL E G H | 7528 | 12856 | ORPHA:97279 | Insulinoma | HP:0040283 - Occasional | | | 7 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | YY1 CL E G H | 7528 | 12856 | ORPHA:97279 | Insulinoma | HP:0040283 - Occasional | | | 7 | | |
HP:0004372 | HP:0007159 | Fluctuations in consciousness | 1 | YY1 CL E G H | 7528 | 12856 | ORPHA:97279 | Insulinoma | HP:0040282 - Frequent | | | 7 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | ZIC2 CL E G H | 7546 | 12873 | ORPHA:93925 | Alobar holoprosencephaly | HP:0040282 - Frequent | | | 34 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | ZIC2 CL E G H | 7546 | 12873 | ORPHA:93924 | Lobar holoprosencephaly | HP:0040283 - Occasional | | | 34 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | ZIC2 CL E G H | 7546 | 12873 | ORPHA:93926 | Midline interhemispheric variant of holoprosencephaly | HP:0040282 - Frequent | | | 34 | | |
HP:0004372 | HP:0001254 | Lethargy | 1 | ZIC2 CL E G H | 7546 | 12873 | ORPHA:220386 | Semilobar holoprosencephaly | HP:0040282 - Frequent | | | 34 | | |
HP:0004372 | HP:0001262 | Excessive daytime somnolence | 1 | ZNF365 CL E G H | 22891 | 18194 | ORPHA:2073 | Narcolepsy type 1 | HP:0040281 - Very frequent | | | 3 | | |
HP:0004372 | HP:0001262 | Excessive daytime somnolence | 1 | ZNF365 CL E G H | 22891 | 18194 | ORPHA:83465 | Narcolepsy type 2 | HP:0040281 - Very frequent | | | 3 | | |
HP:0004372 | HP:0002329 | Drowsiness | 1 | ZNHIT3 CL E G H | 9326 | 12309 | ORPHA:2836 | PEHO syndrome | HP:0040281 - Very frequent | | | 1 | | |
HP:0004372 | HP:0001325 | Hypoglycemic coma | 2 | ABCC8 CL E G H | 6833 | 59 | ORPHA:276575 | Autosomal dominant hyperinsulinism due to SUR1 deficiency | HP:0040283 - Occasional | | | 245 | | |
HP:0004372 | HP:0001325 | Hypoglycemic coma | 2 | ABCC8 CL E G H | 6833 | 59 | OMIM:256450 | Hyperinsulinemic hypoglycemia, familial, 1 | . | | | 245 | | |
HP:0004372 | HP:0001325 | Hypoglycemic coma | 2 | AKT2 CL E G H | 208 | 392 | ORPHA:293964 | Hypoinsulinemic hypoglycemia and body hemihypertrophy | HP:0040281 - Very frequent | | | 12 | | |
HP:0004372 | HP:0031258 | Delirium | 2 | ALAD CL E G H | 210 | 395 | ORPHA:100924 | Porphyria due to ALA dehydratase deficiency | HP:0040283 - Occasional | | | 62 | | |
HP:0004372 | HP:0031258 | Delirium | 2 | DNMT1 CL E G H | 1786 | 2976 | OMIM:614116 | Neuropathy, hereditary sensory, type IE | . | | | 145 | | |
HP:0004372 | HP:0001325 | Hypoglycemic coma | 2 | ETFA CL E G H | 2108 | 3481 | OMIM:231680 | Multiple acyl-coa dehydrogenase deficiency | . | | | 37 | | |
HP:0004372 | HP:0001325 | Hypoglycemic coma | 2 | ETFB CL E G H | 2109 | 3482 | OMIM:231680 | Multiple acyl-coa dehydrogenase deficiency | . | | | 27 | | |
HP:0004372 | HP:0001325 | Hypoglycemic coma | 2 | ETFDH CL E G H | 2110 | 3483 | OMIM:231680 | Multiple acyl-coa dehydrogenase deficiency | . | | | 77 | | |
HP:0004372 | HP:0031258 | Delirium | 2 | FIG4 CL E G H | 9896 | 16873 | ORPHA:208441 | Bilateral parasagittal parieto-occipital polymicrogyria | HP:0040283 - Occasional | | | 111 | | |
HP:0004372 | HP:0031258 | Delirium | 2 | FIG4 CL E G H | 9896 | 16873 | OMIM:612691 | Polymicrogyria, bilateral temporooccipital | . | | | 111 | | |
HP:0004372 | HP:0001325 | Hypoglycemic coma | 2 | GCK CL E G H | 2645 | 4195 | OMIM:602485 | Hyperinsulinemic hypoglycemia, familial, 3 | . | | | 237 | | |
HP:0004372 | HP:0001325 | Hypoglycemic coma | 2 | GLUD1 CL E G H | 2746 | 4335 | OMIM:606762 | Hyperinsulinemic hypoglycemia, familial, 6 | . | | | 56 | | |
HP:0004372 | HP:0001325 | Hypoglycemic coma | 2 | HADH CL E G H | 3033 | 4799 | OMIM:609975 | Hyperinsulinemic hypoglycemia, familial, 4 | . | | | 41 | | |
HP:0004372 | HP:0002330 | Paroxysmal drowsiness | 2 | HCRT CL E G H | 3060 | 4847 | OMIM:161400 | Narcolepsy 1 | . | | | 1 | | |
HP:0004372 | HP:0001325 | Hypoglycemic coma | 2 | HMGCL CL E G H | 3155 | 5005 | ORPHA:20 | 3-hydroxy-3-methylglutaric aciduria | HP:0040284 - Very rare | | | 35 | | |
HP:0004372 | HP:0001325 | Hypoglycemic coma | 2 | HNF1A CL E G H | 6927 | 11621 | ORPHA:324575 | Hyperinsulinism due to HNF1A deficiency | HP:0040283 - Occasional | | | 161 | | |
HP:0004372 | HP:0001325 | Hypoglycemic coma | 2 | INSR CL E G H | 3643 | 6091 | OMIM:609968 | Hyperinsulinemic hypoglycemia, familial, 5 | . | | | 229 | | |
HP:0004372 | HP:0001325 | Hypoglycemic coma | 2 | KCNJ11 CL E G H | 3767 | 6257 | ORPHA:276580 | Autosomal dominant hyperinsulinism due to Kir6.2 deficiency | HP:0040283 - Occasional | | | 127 | | |
HP:0004372 | HP:0001325 | Hypoglycemic coma | 2 | MC2R CL E G H | 4158 | 6930 | ORPHA:361 | Familial glucocorticoid deficiency | HP:0040284 - Very rare | | | 94 | | |
HP:0004372 | HP:0031258 | Delirium | 2 | MMACHC CL E G H | 25974 | 24525 | ORPHA:79282 | Methylmalonic acidemia with homocystinuria, type cblC | HP:0040284 - Very rare | | | 101 | | |
HP:0004372 | HP:0031258 | Delirium | 2 | MMACHC CL E G H | 25974 | 24525 | OMIM:277400 | Methylmalonic aciduria and homocystinuria, Cblc type | . | | | 101 | | |
HP:0004372 | HP:0001325 | Hypoglycemic coma | 2 | MRAP CL E G H | 56246 | 1304 | ORPHA:361 | Familial glucocorticoid deficiency | HP:0040284 - Very rare | | | 26 | | |
HP:0004372 | HP:0031258 | Delirium | 2 | NAGS CL E G H | 162417 | 17996 | ORPHA:927 | Hyperammonemia due to N-acetylglutamate synthase deficiency | HP:0040284 - Very rare | | | 36 | | |
HP:0004372 | HP:0001325 | Hypoglycemic coma | 2 | NFKB2 CL E G H | 4791 | 7795 | ORPHA:293978 | Deficiency in anterior pituitary function-variable immunodeficiency syndrome | HP:0040281 - Very frequent | | | 11 | | |
HP:0004372 | HP:0001325 | Hypoglycemic coma | 2 | NNT CL E G H | 23530 | 7863 | ORPHA:361 | Familial glucocorticoid deficiency | HP:0040284 - Very rare | | | 13 | | |
HP:0004372 | HP:0001325 | Hypoglycemic coma | 2 | NNT CL E G H | 23530 | 7863 | OMIM:614736 | Glucocorticoid deficiency 4 with or without mineralocorticoid deficiency | HP:0040283 - Occasional | | | 13 | | |
HP:0004372 | HP:0031258 | Delirium | 2 | PRDX1 CL E G H | 5052 | 9352 | OMIM:277400 | Methylmalonic aciduria and homocystinuria, Cblc type | . | | | | | |
HP:0004372 | HP:0031258 | Delirium | 2 | RYR1 CL E G H | 6261 | 10483 | ORPHA:466650 | Exercise-induced malignant hyperthermia | HP:0040283 - Occasional | | | 1200 | | |
HP:0004372 | HP:0031258 | Delirium | 2 | SLC25A13 CL E G H | 10165 | 10983 | ORPHA:247585 | Citrullinemia type II | HP:0040282 - Frequent | | | 82 | | |
HP:0004372 | HP:0011973 | Paroxysmal lethargy | 2 | SLC2A1 CL E G H | 6513 | 11005 | OMIM:606777 | Glut1 deficiency syndrome 1 | . | | | 255 | | |
HP:0004372 | HP:0001325 | Hypoglycemic coma | 2 | STAR CL E G H | 6770 | 11359 | ORPHA:361 | Familial glucocorticoid deficiency | HP:0040284 - Very rare | | | 45 | | |
HP:0004372 | HP:0031258 | Delirium | 2 | TRNE CL E G H | 4556 | 7479 | ORPHA:2596 | Myopathy and diabetes mellitus | HP:0040284 - Very rare | | | | | |
HP:0004372 | HP:0001325 | Hypoglycemic coma | 2 | TXNRD2 CL E G H | 10587 | 18155 | ORPHA:361 | Familial glucocorticoid deficiency | HP:0040284 - Very rare | | | 85 | | |
HP:0004372 | HP:0001325 | Hypoglycemic coma | 2 | UCP2 CL E G H | 7351 | 12518 | ORPHA:276556 | Hyperinsulinism due to UCP2 deficiency | HP:0040283 - Occasional | | | 15 | | |